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During the course of adult cortical plasticity, a number of signal transduction mechanisms are 
brought into play. To study regulatory genes implicated in this process, we inhibited gene expression 
by harnessing the machinery of RNA interference (RNAi) pathway via small hairpin RNAs (shRNA) 
delivered by viral vectors. Using this technology we sought to influence plasticity of the mouse 
vibrissal barrel cortex. In this model system, chronic whisker plucking reliably leads to the expansion 
of the cortical representation of the adjacent non-deprived whiskers. The mechanism underlying this 
process involves changes in synaptic efficacy and sprouting of axon collaterals. Initial studies 
describing the molecular events leading to synaptogenesis and remapping have implicated a number of 
signal transduction pathways, including neurotrophins such as brain derived neurotrophic factor 
(BDNF). Though previous experiments have shown up-regulation of neurotrophins and their receptors 
in reorganized cortex, it is necessary to remove these factors to definitively prove their involvement in 
adult cortical plasticity. We therefore repressed neurotrophic gene expression in the mouse 
somatosensory cortex to determine if these trophic factors are essential for cortical remodeling after 
sensory deprivation. We blocked gene expression in vivo using a non-replicative adeno-associated virus 
bearing genes encoding shRNA constructs. The shRNA nucleotide sequences were designed to target 
and destroy selected neurotrophin messenger RNAs by triggering the RNAi pathway, resulting in a 
reduction of BDNF protein levels by up to 80% in vivo. This knockdown of BDNF expression 
effectively repressed functional cortical reorganization induced by chronic whisker plucking. 
Unexpectedly, when transducing the somatosensory cortex with a viral vector carrying a control 
shRNA that does not target a gene in mouse, we saw no cortical reorganization after sensory 
deprivation. These results suggest that a non-specific blockade of cortical plasticity occurs when using 
shRNAs in the brain. Our results suggest that manipulating gene expression via virally delivered 
shRNAs may have limited value for blocking expression of specific genes involved in cortical 
plasticity.  However, the results suggest a potential role for RNA interference itself in regulating 
cortical plasticity. 
In the second part of this thesis, we study methods to visualize microRNAs in tissue sections. 
MicroRNAs (miRNAs) are small regulatory RNAs with many biological functions and disease 
associations. Association studies are rapidly linking miRNAs with cancers and neurological disorders. 
miRNAs have specific expression and function in specialized cell types, emphasizing the need to define 
cell–type–specific miRNA expression patterns. For pathologists, the most common method for 
visualizing gene expression in specific cell types is in situ hybridization (ISH). In our laboratory, 
conventional ISH worked for highly abundant miRNAs, however examining less abundantly expressed 
miRNAs often yielded inconsistent or negative results. A review of the literature indicates that 
zebrafish whole–mount ISH were robust, whereas ISH in D. melanogaster embryos were mostly 
unsuccessful. In tissue sections, several studies set the foundation for establishing miRNA ISH, and 
were used to support association to disease, or defined expression patterns in multiple cell types present 
in the brain and eye. The technical difficulties in miRNA ISH also led to development of transgenic or 
cell sorting methods that monitor cell–type–specific miRNA expression.  
To better understand the technical challenges associated with miRNA ISH, we investigated the 
importance of miRNA fixation and probe hybridization. For fixation of proteins and nucleic acids in 
tissues, a solution containing 3.7% formaldehyde (10% formalin) is commonly used. Formaldehyde 
crosslinks are reverted by incubation at elevated temperature and this process is facilitated by 
proteinase K treatment. Reversal of the formaldehyde–based nucleic acid base modifications is also 
necessary for probe hybridization, but it creates the problem of miRNA release and diffusion out of the 
tissue sections. Therefore, we examined the extent of miRNA escape from tissue during ISH. We 
conducted a mock ISH for conventionally fixed brain sections, isolated RNA from the tissue sections 
and the ISH buffer, and probed both fractions for the highly expressed neuronal miRNAs. We showed 
that in situ hybridization (ISH) using conventional formaldehyde fixation results in significant miRNA 
loss from mouse tissue sections, which can be prevented by fixation with 1–ethyl–3–(3–
dimethylaminopropyl) carbodiimide (EDC) that irreversibly immobilizes the miRNA at its 5' 
phosphate. 
Eliminating the possibility of miRNA diffusion by introducing an irreversible crosslink between 
the 5’ phosphate of the miRNA and protein side chains significantly improves miRNA retention in 
tissues. The advantage of EDC–based phosphoramidate–linked miRNA is that the sample can be 
exposed to higher temperatures for a longer time, resulting in a more complete reversion of the 
formaldehyde induced nucleobase modification of the miRNAs and less interference with probe 
hybridization. At present, we showed that different tissues and detection systems are compatible with 
our approach. This method paves the way for reliable disease association studies and the potential use 
of miRNA in situ hybridization expression analysis as a diagnostic tool for biopsy material. 
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Chapter I 
Regulation of gene expression by RNA interference  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 
  
  
  
Introduction  
Cortical plasticity in adult central nervous system 
Damage to the central nervous system (CNS) often results in devastating sensory and motor 
deficits that last a lifetime. Several neural systems demonstrate limited ability to partially 
reorganize damaged circuits after injury. With the loss of afferent input, the adult brain remodels 
to improve function by shifting neuronal receptive fields away from the damaged region and 
thereby enhancing the representation of the available sensory input. This observation was 
described in the adult somatosensory cortex after digit amputation1. After removing the 
forefinger, sensation for the amputated digit was lost, but within several months, the cortical 
neurons representing the lost digit shifted their receptive fields towards the adjacent fingers. In 
cases of partial deafness, damaging receptor cells in a restricted area of the cochlea resulted in 
loss of auditory information from a selected frequency range. Months later, the cortical area 
previously representing frequencies of the ablated neurons expanded its representation to stimuli 
collected from cochlear cells adjacent to the lesioned region2.  
In the visual system, several investigators describe cortical remodeling in the primary 
visual cortex (V1) following focal binocular and monocular retinal lesions in the adult cat and 
monkey3-10. Binocular lesions in the adult monkey silence a corresponding region of the visual 
cortex, known as the cortical lesion projection zone (LPZ), where neurons are no longer 
responsive to visual stimuli. After several months, however, neurons in the cortical LPZ recover 
stimulus-driven activity by shifting their receptive fields to the region of visual space just outside 
the lesion3. These receptive field shifts were determined to be cortically mediated4,5, by sprouting 
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of horizontal connections in the adult, which is strongly correlated with, and likely underlies, 
these changes in receptive field representation5,11.  
In mice, cortical remodeling occurs after partial vibrissectomy as sparing selected rows of 
vibrissae in adult animals results in the enlargement of areas representing the intact whiskers12. 
To induce plasticity, one can remove a selected group of whiskers for weeks, then after sensory 
deprivation, the cortical area representing the intact row expands into areas that previously 
represented chronically removed whiskers (Figure 1). Collectively, these studies from sensory 
systems suggest the adult brain has a remarkable ability to adapt to injury by cortical 
reorganization. Yet the extracellular signaling molecules and signal transduction pathways that 
mediate injury induced cortical plasticity are not fully characterized.  
3
 
  
  
 
Figure 1: Cortical plasticity in mouse somatosensory cortex induced by sensory 
deprivation. (a) An illustration showing the mouse vibrissa that are mechanically manipulated 
and stimuli is then represented in the somatosensory cortex. (b) The mouse vibrissa is organized 
into rows A-E. (c) Barrels in the somatosensory cortex represent specific whiskers (light blue 
circle; letter marks the whisker row and the number identifies the whisker within the row). (d) 
To induce cortical plasticity, whiskers from rows D and E are continuously removed for two 
weeks (illustrated by line strike). (e) The representation from the intact whiskers in row C 
expand into sensory deprived areas (expanded represenation is denoted by larger retangles). 
 
 
 
Neurotrophic factors are potential mediators of cortical remodeling after injury.  
Functional recovery of cortical areas after injury requires changes in cortical architecture, a 
process that must be regulated by signaling molecules. Neurotrophins have emerged as attractive 
candidates to potentially mediate cortical plasticity. The neurotrophin family of peptides is 
known to regulate neuronal differentiation13, axon sprouting14,15 and synapse formation16,17. 
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Nerve growth factor (NGF) was the first neurotrophin family isolated18, later others were cloned 
including brain-derived neurotrophic factor (BDNF), and neurotrophin 3 and 4/5 (NT3 and 
NT4/5)19. The mature peptides exert their action by binding to a specific tyrosine kinase receptor 
(Trk), NGF to TrkA, BDNF and NT4/5 to TrkB and NT3 exerts opposing effects on TrkA, TrkB 
and TrkC receptors20. Ligand-receptor coupling induces the dimerization of receptors, and then 
activates downstream signal transduction pathways like CREB16, which modulates axonal 
growth16. Neurotrophins signal changes in axon morphology by retrograde signaling, NGF for 
example, stimulates axonal sprouting when applied to the distal ends of cultured sympathetic 
neurons21. Other neurotrophins BDNF and NT-3 promote spontaneous synaptic plasticity22,23. 
Interestingly, BDNF and other neurotrophin expression levels elevate with increased neural 
activity24-27. For example, visual stimuli enhances BDNF messenger RNA (mRNA)27, 
conversely, rearing animals in the dark blunts BDNF mRNA expression levels. This 
interdependency between neurotrophin expression and neural activity is a likely mechanism for 
preferentially strengthening active neural circuits24,28. Limited amounts of neurotrophins present 
in the postsynaptic target neurons, act an activity-dependent retrograde signal, which strengthens 
more active pre-synaptic inputs. Evidence supporting this hypothesis comes from monocular 
deprivation (MD) studies in developing animals24. Normally, suturing an eyelid shut silences 
representation of cortical neurons mapped to the deprived eye, however, when NGF is applied in 
excess during sensory deprived, the neurotrophin rescues the animal from cortical blindness24,29. 
Other neurotrophins like BDNF also influence the formation of ocular dominance columns16 and 
the TrkB ligand NT-4 can rescue the visual cortex from MD induced cortical blindness30. BDNF 
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also regulates GABAergic interneurons by stimulating outgrowth, altering gene expression of 
GABA31 and regulates maturation of inhibitory neurons in the visual cortex during the critical 
period32. Neurotrophins appear to signal activity-dependent synaptic competition, a mechanism 
that is important in neuronal development33,34.  
Neurotrophin upregulation can be observed in the adult reorganized cortex. In the adult monkey 
V1, after a restricted region of the retina is damaged, BDNF, NT-3 and NGF protein expression 
is enriched at the cortical LPZ (Figure 2)35. Up-regulation of the TrkA, TrkB, TrkC, and p75 
receptors were also observed at early time points (3 days) and for the long-term (up to 87 weeks). 
Enhanced expression occurred within the large cortical LPZ at early time points, and protein 
expression patterns shrank in size as the cortical LPZ was filled in over time. The location of 
enriched neurotrophin expression correlated with the site of the cortical scotoma (also defined as 
the LPZ) following retinal lesions, suggesting a role for neurotrophins in V1 repair. Yet, no study 
has directly demonstrated that neurotrophins are necessary for cortical reorganization. To study 
cortical plasticity in the intact adult brain one can integrate approaches in molecular biology and 
systems neuroscience to block gene expression in vivo. 
Figure 2. BDNF expression within the 
cortical LPZ. Retinal injury enriches 
BDNF, protein expression within the 
cortical LPZ in adult primate V1 shown 
by assaying with immunohistochemistry 
35. Up-regulation of BDNF was observed 
at early time points (3 days) and for up to 
87 weeks. 
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Gene delivery using adeno-associated viral vectors 
Cortical reorganization occurs over weeks; therefore a gene delivery system to alter this process 
should persistently attenuate gene expression for the long-term. Adeno-associated virus (AAV) 
vectors are non-pathogenic human single stranded DNA parvoviruses 36,37, suitable to deliver 
transgenes into the brain. Since the vast majority of AAV exists as extrachromasomal circular 
DNA, AAV vectors effectively and stably transduce non-dividing neurons37. AAV vectors have 
proven to be efficient and safe means of transducing non-dividing cells in vivo.  Up to 80% of 
the human population is likely to be infected with AAV and no malignancy has been associated 
with this virus38.  Nor has AAV infection evoked a stress response39. Long-term expression has 
been demonstrated in the monkey CNS for five years without initiating the host immune 
system38. A small percentage of AAV forms have been reported to recombine into host cell 
genomes40, however the side-effects are rare and the potential for complication in brain 
transduction studies are minimal. 
 The technical advantages of using these vectors include rapid production of viral stocks, 
ability to obtain a high titer, and ease of cross-packing AAV plasmids into several different 
serotypes.  The AAV shuttle vector or cis plasmid contains two 145 nucleotide (nt) inverted 
terminal repeats (ITRs), between which are up to 4.8 kb of foreign DNA can be inserted (Figure 
3).  AAV Rep and cap genes are required for replication of the viral genome and the structural 
envelope of the capsid, respectively.  To complete the life cycle AAV requires a helper virus, 
usually Adenovirus.  While shuttle vectors AAV2 ITRs and rep gene usually remain constant, 
capsid genes coding for various serotypes are interchangeable, these AAV hybrids are called 
7
 
  
  
pseudotypes. Recent studies demonstrate AAV serotype 1 capsid and AAV2 rep gene (termed: 
AAV2.1) enhance transgene expression and spreads more widely in areas of the midbrain, when 
compared to wild type AAV2 virus41. Transgene expression can be controlled by a hybrid CMV-
chicken-beta-actin (CBA) promoter, which has enhanced expression when compared to the CMV 
promoter42.  To further enrich GFP labeling, one can recombine the Woodchuck hepatitis virus 
element posttranscriptional regulator (WPRE) to the 3’ end of the transgene to increase the 
steady-state level of mRNA and improve translation efficiency43.  
8
 
  
  
 
 
Figure 3:  Schema of Adeno-Associated Viral (AAV) vectors encoding small interfering RNAs 
and a fluorescent protein:  (Top, left) Diagram of transgenes cloned into an AAV shuttle vector 
flanked by inverted terminal repeats (ITRs).  The shuttle vector contains two separate expression 
cassettes for a fluorescent protein (eGFP or RFP) and a small interfering RNA (shRNA) duplex.  To 
enrich fluorescent protein levels, the chicken beta actin promoter drives expression, along with a 
woodchuck hepatitis virus element posttranscriptional regulator (WPRE) recombined toward the 3’ 
end.  An RNA polymerase III promoter, H1 controls small hairpin RNA (shRNA) expression. (Top, 
right) To package the DNA between the ITRs of the shuttle vector, AAV requires structural proteins 
(cap) and non-structural genes (rep) encoded on a separate vector (top, right).  (Center) Completion 
of the viral life cycle AAV requires proteins and RNA genes from a helper virus Adeno virus vector 
(center). 
 By combining the AAV gene delivery system with RNA interfering molecules (reviewed 
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below) one can attenuate gene expression in the living brain. The emergence of the RNAi has 
revolutionized biological research by harnessing the cell’s natural ability to inhibit any gene with 
specific small RNA triggers.  
Post-transcriptional genetic control by small RNAs 
The recent discovery of gene regulation by different classes of small non-coding RNAs 
illustrates the complexity of regulation of gene expression in higher vertebrates44. Classes of 
mammalian small RNAs include ubiquitously expressed microRNAs (miRNAs) and germline-
specific piwi-interacting RNAs (piRNAs), as well as synthetic mimics that use the natural RNAi 
pathway, such as small interfering RNAs (siRNAs) and small hairpin RNAs (shRNAs). miRNAs 
represent the most abundant family of small regulatory RNAs in animals, but are also present in 
plants and some viruses45. miRNAs are matured from double-stranded RNA (dsRNA) 
precursors46-48 and rely on the RNA silencing or RNA interference (RNAi) machinery to 
destabilize and/or translational repress partially sequence-complementary target mRNAs; fully 
complementary target mRNAs, though they are extremely rare for animal miRNAs, are 
effectively cleaved and the mechanism is exploited for siRNA-mediated gene knockdown49-55.  
RNAi processing pathway 
miRNAs are encoded within intronic or exonic regions of protein-coding or non-coding 
transcripts, and miRNAs are often organized in polycistrons56-58. The primary transcripts of 
miRNAs (pri-miRNAs), with exception of some viral miRNAs, are transcribed from polymerase 
(pol) II promoter46-48 and matured in a multi-step process (Figure 4)46-48. Within the pri-miRNA, 
exists a hairpin RNA known as the pre-miRNA, which is recognized by dsRNA-binding 
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proteins. These two RNase III enzymes process the pre-miRNA to yield a double-stranded 
processing intermediate, where one strand represents the miRNA, and the opposing strand is 
annotated as miRNA*. The mature miRNA is predominatly incorporated into an Argonaute 
(Ago) protein containing complex, also known as RNA-induced silencing complex (RISC), 
which facilitates target recognition and mediates the miRNA regulatory function59-66. The 
miRNA* is usually lost during this process and less frequently incorporated in the silencing 
complex15. Humans contain 4 Ago proteins, Ago1 through 4, which bind miRNAs and target 
RNAs with similar specificity67;Ago2 is the only protein that has an active endonuclease domain 
and is responsible for potent cleavage of target RNAs by siRNAs in gene knockdown 
experiments68,69. More recently it was also shown that the three members of the TNRC6 protein 
family, also known as P-body marker GW182 family, associate with miRNA-containing Ago 
complexes and their targets67. The miRNA-containing ribonucleoprotein complexes (miRNPs) 
binding reduce the target mRNA and protein levels by interfering with either translation 
initiation or elongation (Figure 4)70-77. 
11
 
  
  
 
Figure 4. Model of posttranscriptional gene silencing pathways guided by small 
RNAs. Drosha RNase III and its interacting partner, DGCR8, process pri-miRNA to pre-
miRNA. The pre-miRNA is subsequently exported to the cytoplasm using the export 
receptor exportin-5 and processed by Dicer RNase III to a “siRNA-like” miRNA-
miRNA* duplex intermediate. The single-stranded miRNA is loaded onto a member of 
the Ago protein family and the miRNA* is degraded. miRNPs associate with partially 
complementary sequences in the 3' UTR to inhibit translation. Both siRNAs and miRNAs 
can be assembled into Ago2-containing RISC complexes (siRISC, miRISC). Ago2 in 
mammals mediates the cleavage of complementary targets. Abbreviated.: 7mG, 7-methyl 
guanosine; AAAA, poly-adenosine tail; p, 5' phosphate. 
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Blocking gene expression using RNA interference (RNAi) 
The recent discovery of RNA interference has emerged as a powerful tool for specific gene 
knockdown. By activating endogenous RNAi machinery, one can specifically inhibit any 
transcript in the genome78,79. Collectively, the processes of post-transcriptional gene silencing by 
small double-stranded RNA are termed RNA interference (RNAi), a highly conserved 
mechanism in eukaryotes (Figure 4). Initial studies in C. elegans showed exogenous and 
endogenous double stranded RNA (dsRNA) are more potent silencers of gene expression when 
compared to antisense RNA alone80. Tuschl and colleagues elicited transient degradation of 
targeted messenger RNA by introducing short 21-28 nucleotide RNA (siRNAs) duplexes in 
vitro81. For stable RNAi induction, plasmid based small hairpin RNAs (shRNAs) can be 
expressed using a polymerase III promoter82 and shRNA can be inserted into viral vectors for 
long-term expression. Both shRNA and siRNAs are essentially homologues of processed 
miRNAs and enter the RNAi pathway at the same stage of the pre-miRNA. The processing of 
shRNAs is reviewed (Figure 4). 
Tissue-specific expression patterns of miRNAs 
The biological function for many small RNAs is largely unknown, yet the RNA interference 
pathway plays an essential role in nature, as the sequence of many miRNAs are conserved from 
invertebrates to humans85,86. Moreover, several studies using gene knockouts of several RNAi 
components proved to be embryonic lethal in mice87,88.  Cell- and tissue-type-specific mature 
miRNA expression is best determined by small RNA cDNA library sequencing or more recently 
by using miRNA microarrays89,90. An example of a cell-type enriched and conserved miRNA 
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family is miR-1 and its close relative miR-206, which are predominantly expressed during 
development in muscle of vertebrate and invertebrate specimens91-93, and highly abundant in the 
heart of adult mammals86,94. Other examples of tissue specific miRNAs include miR-122 in the 
liver86, miR-124 in neurons86,95, or miR-375 specific to endocrine cell-types such as pancreatic 
alpha and beta cells or the pituitary gland96. Analysis of expression patterns of close to 100 
miRNAs in the developing zebrafish revealed that about 68% of the miRNAs have a distinct 
expression in tissues during or after the blastula period91. Virtually every cell type or tissue 
examined expresses some unique combination of miRNAs, and miRNA expression profiles were 
shown to be useful for certain diagnostic applications97. 
miRNAs influence cellular function 
The biological relevance and exact gene targets of most miRNAs remain unclear, however the 
like miRNAs are conserved, so are many of their target sites98. Several miRNAs have been 
implicated in a variety of developmental and physiological processes, affecting cell lineage 
decisions, cell proliferation, apoptosis, morphogenesis, fat metabolism, hormone secretion, and 
the stress response55,99-102. In C. elegans, lin-4 -miRNA is involved in controlling larval 
developmental steps by targeting sites in the 3' untranslated region (3' UTR) of lin-14 mRNA. 
Other studies deleted a processing enzyme in the RNAi pathway, the RNase III Dicer, which is 
essential for miRNA maturation. This perturbation of the miRNA pathway severely affects 
mouse embryonic development88,103,104. To overcome lethality associated with early deletion of 
dicer in mice, the allele can be removed using a cre-inducible conditional allele, generating a 
conditional knockout (cKO). Dicer cKO in the mouse impaired T cell differentiation, survival, 
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and proliferation105,106. In another mouse study, dicer cKO expressing cre in the limb mesoderm 
resulted in perturbed morphogenesis, but no effect was observed for patterning of the developing 
limb107. Attenuating dicer expression in mouse embryonic stem resulted in development defects 
in vitro and in vivo, the effect was linked to a lack of miRNAs108. Dicer also functions to process 
other small RNA species in addition to miRNAs109. Despite these potential complications, the 
knockout studies provided the first clues about the physiological function of miRNA regulatory 
networks in developing vertebrates.  
Another approach to gain insight regarding miRNA function in development is to 
attenuate DGCR8 protein expression in vivo. DGCR8 is thought to exclusively be involved in the 
maturation process of miRNAs110-112, with no other known cellular function. Inhibiting DGCR8 
in mouse embryonic stem cells yielded phenotypes similar to Dicer cKO animals. However, 
DGCR8 negative embryonic cells showed accelerated growth rate, when compared to Dicer cKO 
cells108. In the mouse skin, DGCR8 cKO mice had abnormal hair follicle development and 
altered epidermal cell differentiation, phenotypes also observed in Dicer null mice. In the latter 
study, the observed phenotypes suggest Dicer and DGCR8 removal were responsible for reduced 
follicle development, solely due to reduction of miRNA levels.  
Molecular targets of miRNAs 
The precise number of miRNAs targets, especially those not evolutionary conserved, remains 
unclear. Computational studies provide guidance in addressing this key question113-128. Over 500 
human miRNAs have been identified and thousands of gene targets predicted. Conservative 
estimates suggest that over one third of the mammalian genome is potentially regulated by 
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miRNAs125. Yet experimental validation of specific gene targets for the majority of miRNAs 
remains incomplete. Experimental approaches to pair miRNA and mRNA targets using cDNA 
array analysis of cells over-expressing miRNAs in cell culture set the foundation for identifying 
mRNA targets129. Immunoprecipitation of Ago proteins and analysis of associated mRNAs by 
array and deep sequencing shows promise in identifying these interactions67. Due to the 
complexity and the large numbers of genes implicated in these studies, further functional 
validation is necessary. Almost certainly, given the large number of interactions (mis-expression 
of miRNAs and/or deletion, insertion or mutation of miRNA targeting sites), this process will 
likely be linked to some diseases. Most recently it was shown that progressive hearing loss in 
some families was linked to mutations in miR-96130,131. Association of miRNA mis-regulation 
and various types of cancer have also been described47,91 and miRNA expression profiles have 
been suggested to be useful for classifying diseased specimens132.  
The identification and spatial localization of miRNAs in the nervous system 
Given the neuron-specific expression of certain conserved miRNAs, it is likely that the RNAi 
pathway also plays an important regulatory role in the nervous system. The nervous system is 
comprised of complex cell types with unique functions, and miRNA expression patterns may 
contribute to this diversity. Several early studies focused on identifying miRNA expression in 
different brain regions and identified the highly abundant and conserved miR-9, miR-124, and 
miR-128a, which are specifically expressed in the brain89,133. miRNA expression patterns are 
thought to be characteristic of distinct neuronal lineages134, as the timed expression of miRNA 
families correlates with cortical development135-137.  
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To elucidate specific expression patterns of miRNAs in complex tissues, several 
techniques were developed, such as generating transgenic models that express miRNA constructs 
with reporters138, using single cell detection by quantitative PCR139, and profiling FACS sorted 
hematological cells89,140. To localize miRNAs at the sub-cellular level, others combined laser 
capture microscopy and multiplex PCR to show miRNAs are also present in neuronal 
dendrites141. Several studies set the foundation to image the cell-type specificity of miRNAs in 
the neuronal and other tissue sections using conventional or a modified in situ hybridization 
techinque95,142-147. For example, the highly abundant miR-124 is exclusively expressed in 
neurons. Other miRNAs such as miR-23, miR-26, and miR-29 were present in neurons and 
astrocytes148.  
The role of the miRNA pathway in the nervous system 
An early example of a miRNA associated with function in the nervous system occurred in C. 
elegans, as the miRNA lsy-6 controlled left/right neuronal asymmetry149-151. In cultured cells, 
exogenous expression of neuron-specific miR-124 in HeLa cells induced a down-regulation of 
hundreds of target mRNAs, effectively switching the gene expression profile of these human 
carcinoma cells to mirror gene expression patterns of a mature neuron129,152. In neuroblastoma 
cells, the over-expression of the highly abundant miR-124, induced neuronal differentiation, 
while blocking miR-124 expression with a 2’-O-methyl RNA oligonucleotide, inhibited neurite 
outgrowth and synaptogenesis in primary cultured neurons. In the adult brain, miR-124 regulated 
the process of cell maturation in the subventricular zone (SVZ)134. miR-124 expression increased 
as cells matured and differentiated. Knockdown of miR-124 resulted in increased populations of 
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cells similar to those present early in the neurogenesis pathway, while over-expression of miR-
124 promoted neuronal differentiation. These studies demonstrate that a single strongly 
expressed miRNA influences function in the brain.  
Blocking proteins in the miRNA pathway in neurons 
To further investigate the function of miRNAs in the brain, a number of studies manipulate 
components of the RNAi machinery to block miRNA biogenesis. In zebrafish, depleting mature 
miRNAs by knocking-out Dicer resulted in abnormal brain morphogenesis153. In the adult 
mouse, Dicer conditional knockout (cKO) in the forebrain resulted in gross abnormalities 
including microcephaly and reduced dendrite branch elaboration154. In the cerebellum of adult 
mice, removing Dicer resulted in a cerebellar degeneration and ultimately functional ataxia103. 
Engineered mouse strains with 22p11.2 micro-deletions, with one copy of the gene for DCGR8 
removed, showed impaired and abnormal biogenesis of miRNAs. The phenotype of the reduced 
miRNA levels led to smaller dendritic spines and less complex dendritic trees, similar to the 
Dicer cKO. The functional consequences of reducing miRNA expression from DGCR8 cKO 
animals caused impaired spatial working memory-dependent tasks and experienced reduced 
sensorimotor gating155. Blocking the miRNA-processing pathway demonstrates that RNAi is an 
important regulator of the nervous system. 
Fragile X mental retardation protein, an RNA binding proteins involved in neurological 
disease 
The importance of the miRNA pathway in the nervous system may be, at least in part, through its 
reported association with the fragile X mental retardation protein (FMRP)156,157. In humans, 
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Fragile X syndrome is one of the most common inherited cognitive deficiency disorders. The 
etiology of this disease is related to a trinucleotide repeat expansion of CGG in the 5' 
untranslated region (UTR), which inactivates the X-linked FMR1 gene that encodes FMRP, 
ultimately leading to the reduction in FMRP. FMRP is an RNA binding protein, which regulates 
mRNAs at the post-transcriptional level.  While the mechanism of FMRP-dependent regulation 
remains unknown, FMRP appears to control protein synthesis in response to synaptic activity158.  
FMRP is also thought to be critical for messenger RNA transport within dendrites, possibly 
affecting axon guidance, synaptic development and formation of neuronal circuits.  In 
Drosophila, FMRP was shown to associate with RISC protein components157,159,160. A 
compelling model is that FMRP elicits its function through an association with the RISC 
complex.  There appears genetic evidence that FMRP and RISC functions do overlap.  Studies in 
flies using olfactory conditioning showed that long-term memory formation requires FMRP and 
Ago proteins159. Future studies are still needed to prove miRNAs and FMRP function directly 
together to regulate protein translation in neural systems. 
miRNAs in synaptogenesis 
In the neuron, the size, shape, and number of postsynaptic structures are dynamically regulated 
throughout its life. miRNAs have emerged as potentially important molecular mediators of 
synaptic plasticity. At the neuromuscular junction (NMJ), the conserved miRNA let-7 is highly 
expressed, and when artificially mutated in the fly, the NMJ develops abnormally. The loss of 
let-7 results in a phenotype of abnormal flight, impaired motility, and infertility161. In the rodent, 
the neuron specific miR-134 is located near dendritic spines and regulates dendrite spine size, via 
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down-regulation of the Lim domain containing protein kinase (Limk1). When stimulated with 
brain derived neurotrophic factor, the inhibition of miR-134 is released and limK mRNA is 
upregulated, showing miRNA participation in activity dependant plasticity162. Interestingly, 
BDNF is also involved in a regulatory loop with miR-132 and methyl CpG-binding protein 2 
(MeCP2)163. MeCP2 mutations are responsible for the pathology in Rett's syndrome, a neuro-
developmental disorder with X-linked inheritance. Blockade of miR-132 in cultured rat neurons 
resulted in up-regulation of MeCP2 and BDNF, possibly forming a miRNA-regulated control 
mechanism. While further validation is necessary to assess the role of most miRNAs in the brain, 
these studies suggest the miRNA pathway is an important regulator of gene expression in the 
nervous system. 
Summary of Thesis 
The present thesis will describe methods to manipulate and study the RNAi pathway in 
neuronal tissues. In the second chapter, we used RNAi to block brain derived neurotrophic factor 
(BDNF) to determine if BDNF is a molecular mediator that facilitates cortical plasticity after 
sensory deprivation. In the latter part of the thesis, we describe a modified in situ hybridization 
(ISH) method that we developed to image high, medium, and low abundant miRNAs in neuronal 
tissues. Together, these findings studied the RNAi pathway as a candidate regulation mechanism 
in neurons, by which gene-expression is likely modified to support dynamic events including 
cortical plasticity. 
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Chapter II 
Using virally delivered RNA interference molecules to influence 
cortical plasticity 
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Summary of Chapter II 
During the course of adult cortical plasticity, a number of signal transduction mechanisms are 
brought into play. To study regulatory genes implicated in this process, we inhibited gene 
expression by harnessing the machinery of RNA interference (RNAi) pathway via small hairpin 
RNAs (shRNA) delivered by viral vectors. Using this technology we sought to influence 
plasticity of the mouse vibrissal barrel cortex. In this model system, chronic whisker plucking 
reliably leads to the expansion of the cortical representation of the adjacent non-deprived 
whiskers. The mechanism underlying this process involves changes in synaptic efficacy and 
sprouting of axon collaterals. Initial studies describing the molecular events leading to 
synaptogenesis and remapping have implicated a number of signal transduction pathways, 
including neurotrophins such as brain derived neurotrophic factor (BDNF). Though previous 
experiments have shown up-regulation of neurotrophins and their receptors in reorganized 
cortex, it is necessary to remove these factors to definitively prove their involvement in adult 
cortical plasticity. We therefore repressed neurotrophic gene expression in the mouse 
somatosensory cortex to determine if these trophic factors are essential for cortical remodeling 
after sensory deprivation. We blocked gene expression in vivo using a non-replicative adeno-
associated virus bearing genes encoding shRNA constructs. The shRNA nucleotide sequences 
were designed to target and destroy selected neurotrophin messenger RNAs by triggering the 
RNAi pathway, resulting in a reduction of BDNF protein levels by up to 80% in vivo. This 
knockdown of BDNF expression effectively repressed functional cortical reorganization induced 
by chronic whisker plucking. Unexpectedly, when transducing the somatosensory cortex with a 
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viral vector carrying a control shRNA that does not target a gene in mouse, we saw no cortical 
reorganization after sensory deprivation. These results show a non-specific blockade of cortical 
plasticity occurs when using shRNAs in the brain. Our results suggest that manipulating gene 
expression via virally delivered shRNAs may have limited value for blocking expression of 
specific genes involved in cortical plasticity.  However, the results suggest a potential role for 
RNA interference itself in regulating cortical plasticity. 
Introduction 
Injuries to the central nervous system (CNS) often result in debilitating sensory and motor 
function. Several neural systems demonstrate limited ability to partially reorganize damaged 
circuits after injury.  Whereas cortical plasticity during a critical period in early postnatal life is a 
well established phenomenon, a growing body of evidence indicates that, for certain cortical 
connections, plasticity is maintained well into adulthood. Adult cortical reorganization was seen 
in the somatosensory cortex after digit amputation1. Similar cortical recovery also occurs in 
instances of partial deafness2, incomplete spinal cord injury164,165, and focal binocular retinal 
lesions3-10. Vibrissectomy sparing selected vibrissae in adult mice results in the enlargement of 
areas representing the intact whiskers12. Studies from these sensory systems suggest that the 
adult brain adapts to lesions by adjusting the cortical representation of sensory neurons. These 
receptive field shifts after injury were determined to be cortically mediated4,5, by anatomical 
sprouting of horizontal connections in the adult, which is strongly correlated with, and likely 
underlies, these changes in receptive field representation5,11.  
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 During the course of adult cortical plasticity, a cascade of signal transduction molecules 
likely supports the shift in receptive field maps. Initial studies describing molecular events 
leading to synaptogenesis and remapping have implicated a number of signal transduction 
pathways, in including neurotrophins. The neurotrophin protein family regulates neuronal 
differentiation13, axon sprouting14,15 and synapse formation16,17. Brain derived neurotrophin 
(BDNF) promotes spontaneous synaptic plasticity22,23 and expression levels were upregulated 
with increased neural activity24-27. A molecular association between neurotrophin expression and 
neural activity is a potential mechanism for preferentially strengthening active neural circuits24,28. 
Though previous experiments have shown up-regulation of neurotrophins and their receptors in 
reorganized cortex35,166, attenuating neurotrophin expression is required to establish a direct link 
to adult cortical plasticity. We hypothesize that neurotrophins are the signaling molecules that 
mediate remapping of the barrel cortex after sensory deprivation. Therefore, we integrated 
molecular, physiologic and anatomical modalities to block the neurotrophin BDNF’s gene 
expression to study injury induced cortical plasticity 
 To study cortical reorganization, we used the adeno-associated viral (AAV) vector gene 
delivery system to stably transduce transgenes in non-dividing neurons of the brain36,37. We 
combined this technology with RNA interference (RNAi), which utilizes the cell’s native ability 
to regulate gene expression with specific small RNA triggers. By activating endogenous RNAi 
machinery, one can specifically block any transcript in the genome78,79. For stable RNAi 
induction, plasmid based small hairpin RNAs (shRNAs) are expressed using a polymerase III 
promoter82 and shRNA can be inserted into viral vectors for long-term studies. Using this 
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approach, we explored using RNAi to study cortical reorganization.  
Results  
Silencing BDNF gene expression   
To block BDNF using RNAi, we designed small hairpin RNAs (shRNA) to target and reduce all 
BDNF isoforms (BDNF variants 1-4) (Figure 1). We designed candidate shRNAs according to 
siRNA rules167, then chemically synthesized and recombined these constructs into an expression 
vector upstream of a H1, RNA polymerase III promoter (Figure 2). To validate these 
oligonucleotide duplexes in vitro, we screened several BDNF shRNA plasmids and tested the 
knockdown potency using an artificial dual-luciferase reporter assay (Figure 2). We created a 
BDNF messenger RNA reporter vector by recombining the Renilla-Luciferase (RL) gene with 
BDNF-mRNA, generating a BDNF-reporter fusion product (BDFN-RL). Candidate shRNAs 
were co-transfected with the BDNF–RL reporter vector in vitro and reduced reporter activity by 
50% (Figure 2). Effective BDNF shRNA constructs (shRNA BDNF #1 and #2) and a control 
luciferase shRNA (shRNA luc) were later packaged into adeno-associated viral (AAV) vectors 
for in vivo validation. 
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Figure 1: Design of small hairpin RNAs targeting BDNF: BDNF nucleotide sequences were 
aligned to identify regions of 100% identity in mouse, human, rat and monkey. A computer 
algorithm was employed to select shRNA candidates. Several shRNAs were designed to target 
the messenger RNA within these homologous regions (red arrows).  
 
Packaging small hairpin RNAs shuttle vector into AAV 
Cortical reorganization in the barrel cortex occurs over a period of weeks12, therefore we chose a 
gene delivery system to persistently block BDNF protein levels for the long-term. We delivered 
shRNAs and other transgenes in the mouse brain using adeno-associated viral (AAV) vectors, 
which are ideal vehicles for delivering foreign genes to the brain36,37.  The AAV constructs 
served dual purposes, labeling neurons with a fluorescent protein and/or delivering a RNA 
interfering molecule. To infect neurons in the barrel cortex more effectively, we pseudotyped 
AAV serotype-1 capsid and AAV2 replication (rep) gene (abbreviated; AAV2.1), which has 
enhanced gene expression in the brain41. AAV shuttle plasmids encoded eGFP or RFP (AAV2.1 
eGFP or AAV2.1 RFP) for neuron labeling. Other shuttle plasmids contained an shRNA cassette 
(shRNA BDNF #1, shRNA BDNF #2, or shRNA luc) downstream of a separate RFP expression 
cassette. AAV shuttle plasmids were packaged into AAV2.1 pseudotype, with a final viral titer 
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yield of at least 1x1013 viral particles/mL (Figure 2 and 3). 
 
 
Figure 2: small hairpin RNAs reduce mouse BDNF in vitro: (top panel) Schematic diagram 
of a custom designed AAV vector expressing a small hairpin RNA. AAV shuttle vector silences 
gene expression using an shRNA cassette driven by an RNA polymerase III H1 promoter and 
expresses a fluorescent protein controlled by a hybrid CMV-chicken-beta-actin (CBA) 
promoter. (Middle) Representation of two BDNF shRNAs cassette sequences including the 
stem loop structure and terminator sequence. (Bottom) Results from in vitro screening of 
BDNF shRNAs by a dual luciferase reporter assay showed the shuttle vector encoding a BDNF 
specific-shRNA reduced luciferase activity in the mouse BDNF-RL reporter by approximately 
45-50%.  
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Figure 3: AAV viral vectors packaged at high titers: Graph illustrating the viral titer of AAV 
vectors expressing eGFP, RFP, and shRNAs vectors targeting luciferase as a control (AAV 2.1 
shRNA luc), and two different shRNAs targeting mouse BDNF (AAV 2.1 shRNA BDNF #1 
and #2) with a titer measured in viral particles/mL. 
BDNF-specific shRNAs delivered via AAV reduced protein expression by 80% in vivo.  
To directly test the potency of these BDNF RNAi constructs in vivo, we stereotaxically injected 
the AAV 2.1 shRNA virus into the mouse hippocampus, which is rich in BDNF expression. On 
one side of the hippocampus, we delivered a bolus of AAV2.1 shRNA BDNF (shRNA BDNF #1 
or #2). In the contralateral hemisphere and at the same depth, we injected a control (AAV2.1 
shRNA Luc or saline). Six week post-surgery, animals were sacrificed and the hippocampus was 
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immediately dissected and tissues were isolated. The samples were homogenized and the total 
protein lysates were measured and then analyzed by western blotting. After transfer, we probed 
the membrane with an anti-BDNF (Sigma) or anti-beta-actin (Chemicon) antibody, and 
immunoreactive bands were quantified by densitometry (Figure 4). shRNAs targeting BDNF 
demonstrated a potent blockade of BDNF protein in the adult mouse hippocampus, reducing 
BDNF protein levels in this region by 80% (AAV 2.1 BDNF shRNA #1) and 65% (AAV 2.1 
BDNF-shRNA #2), respectively. These data support that the RNAi viral vectors effectively 
inhibit BDNF protein levels in vivo. 
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Figure 4: BDNF shRNA delivered substantially inhibit endogenous BDNF protein levels 
in vivo:  (a) Image detailing Pro-BDNF processing. The shRNAs targeting BDNF block the 
mRNA transcript, reducing the pro-BDNF protein and the mature form and the BDNF 
cleavage product. BDNF knockdown was validated using an anti-BDNF antibody (Sigma) 
that detected the pro-BDNF peptide and the BDNF cleavage product. (b) Western blotting 
image demonstrates pro-BDNF and the BDNF cleavage product protein levels were reduced 
in the mouse hippocampus after transduction with AAV vectors encoding two different small 
hairpin RNAs targeting BDNF. Beta-actin protein levels were also analyzed (b, bottom 
image). (c) Immunoreactive bands were quantified (ImageJ) and reduction in BDNF protein 
levels graphically represented. Viral vectors encoding BDNF shRNA #1 reduced endogenous 
BDNF protein level in the mouse hippocampus by 80% compared to the control, and AAV 
delivering BDNF shRNA #2 reduced BDNF protein levels 65%. BDNF bands were 
normalized to beta-actin controls.  
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shRNAs delivered by viral vectors block cortical plasticity in vivo.  
We sought to alter plasticity in the mouse vibrissa barrel cortex by blocking neurotrophin gene 
expression with AAV vectors carrying RNAi constructs. First, we mapped the cortical 
representation of each vibrissa by mechanically stimulating the whisker and then recorded the 
location of the corresponding receptive field using electrophysiology (Figure 5a). Following 
cortical mapping, we transduced viral vectors (AAV2.1 RFP; AAV2.1 shRNA BDNF #1; AAV 
shRNA BDNF #2; AAV shRNA luc; or saline), in and immediately surrounding the superficial 
layer of the cortex representing the vibrissa positioned in row C (Figure 5b). One month after 
surgery, we remapped the barrel cortex of AAV injected animals and observed no changes in the 
barrel map.  
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Figure 5:  Electrophysiology guided injection of viral vectors into mouse somatosensory 
cortex: (a) Photograph of mouse somatosensory cortex and vasculature structures. The 
vibrissa receptive fields (RF) were mapped in the mouse barrel cortex using electrophysiology 
following mechanical stimulation of the mouse vibrissa. Whiskers in rows B, C, and D were 
mechanically manipulated and the receptive field location recorded, then plotted on the 
photograph (location of the RF marked with black dot; the letter and number describe the 
vibrissa stimulated). (b) Photograph of the somatosensory cortex demonstrating the location of 
AAV vector injections at selected sites (red dot) in and surrounding RF representing vibrissa 
stimulated in row C. 
 To induce cortical remodeling in the barrel cortex, we removed vibrissa from row D and 
E continuously for 2 weeks.  Following sensory deprivation, we remapped the location of the 
receptive fields (RF) in the barrel cortex. In saline (n=3) and AAV2.1 RFP (n=3) injected 
animals, the cortical representation of the intact vibrissa in row C expanded into regions that 
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were sensory deprived (Figure 6a-b). Next, we examined the influence of shRNAs that target 
and destroy BDNF. For AAV2.1 shRNA BDNF #1 injected animals (n=3), the cortical map did 
not reorganize after injury, as the somatosensory cortex maintained the original RF map prior to 
sensory deprivation. We tested a second shRNA targeting a different region of the mouse BDNF 
gene (AAV shRNA BDNF #2; n=3) and the RF map in the somatosensory cortex did not 
reorganize (Figure 6 c-d). We also examined the effect of a control shRNA that does not target a 
gene expressed in the brain (AAV2.1 shRNA luc), which unexpectedly showed no shift in the 
cortical map after chronic vibrissa removal (Figure 6e). Interestingly, animals transduced in the 
barrel cortex with any of the described shRNAs failed to show cortical reorganization after 
whisker removal. Since animals injected with saline or AAV 2.1 RFP consistently reorganized 
after injury, neither the injection procedure nor the viral vector itself were responsible for 
blocking cortical plasticity in vivo. In these experiments, the presence of a small hairpin RNA 
was sufficient to inhibit adult cortical plasticity after injury.  
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Figure 6:  AAV delivered 
shRNAs block cortical 
plasticity in vivo: (a-e) 
Photographs showing the 
RF map of the 
somatosensory cortex 
following sensory loss. (a) 
RF map after injection of 
(a) saline or (b) AAV2.1 
RFP showed after persistent 
whisker trimming. RF 
representing intact vibrissa 
in row C expanded into the 
cortical areas previously 
represented by vibrissa 
plucked rows in rows D and 
E. (c-e) RF map in the 
mouse barrel cortex 
following transduction of 
(c) AAV2.1 shRNA BDNF #1, (d) AAV2.1 shRNA BDNF #2, or (e) AAV2.1 shRNA luc 
showed no cortical reorganization following continuous sensory deprivation. 
Evaluating potential toxicity associated with AAV delivered shRNAs 
A recent study reported sustained high-level shRNA expression caused a lethal phenotype in 
adult mice168. The cause of the mortality was associated with saturation of the nuclear 
karyopherin exportin-5, a shuttling protein in microRNA pathway, which processes shRNAs and 
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miRNAs. In our experiments, cell morphology and RF maps remained normal after 5 months 
post injection for animals transduced with AAV shRNA viruses (Figure 7). In addition, to 
determine if an AAV delivered shRNA reduced microRNA levels in the brain, we transduced the 
mouse hippocampus with AAV2.1 shRNA luc and on the contralateral side we introduced a non-
shRNA containing virus (AAV2.1 RFP). Next, we determined the level of the highly abundant 
and neuron-specific miR-124 present in AAV2.1 luc and compared this with a non-shRNA 
carrying virus (AAV2.1 RFP). By using quantitative northern blotting, we determined that miR-
124 amounts in AAV shRNA luc injected animals were equivalent to RFP injected controls 
(Figure 7). We also examined levels of miR-124 expressing via in situ hybridization and 
observed that miR-124 expression in AAV2.1 shRNA luc injected animals expressed miR-124 at 
similar intensity to samples injected with the AAV2.1 RFP alone (Figure 7). Using these 
methods, brain tissue injected with viral vectors carrying shRNAs showed no gross reduction of 
the most highly abundant miRNA expressed in the brain, when compared to the control.  
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Figure 7: AAV viral vectors encoding shRNAs are not toxic to neurons in vivo. (a) 
Photomicrographs of mouse brain hippocampus show miR–124 expression detected by in situ 
hybridization in regions injected with AAV shRNA targeting luciferase. (b) Quantitative 
northern blotting image shows miR–124 levels from brain regions injected with adeno–
associated virus expressing RFP (marked; “C”) or an AAV virus expressing an shRNA 
cassette targeting luciferase (marked #1) or an shRNA targeting BDNF (marked #2). (c) Two–
photon microscopy images of the mouse cerebral cortex area showing expression of an AAV 
virus expressing a shRNA targeting luciferase with a RFP also encoded in the virus. Image 
captured 5 months after injection. 
Discussion: 
Adeno-associated viral vectors employed to deliver small RNAs hold the potential to rapidly 
block gene expression for long-term in vivo studies. Yet, the present data supports that this set of 
virally delivered shRNAs causes non-specific blockade of cortical recovery after injury.  The 
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phenotype observed in the control shRNA may be due to off-target binding and silencing of an 
unknown mRNA (other than BDNF), which participates in cortical plasticity. However, this is 
unlikely since the shRNA does not bind other gene targets with high affinity, according to 
computational programs that compared the shRNA to the mouse genome.  
 Alternatively, the effects of sustained shRNA expression in adult mice consistently 
resulted in the lack of cortical plasticity after shRNA transduction, possibly due to introducing 
sustained high-levels of shRNA into the neurons. These effects may be due to shRNAs 
competing with miRNAs for the RNAi machaniery and preventing miRNAs from regulating 
their gene targets. Moreover, the overexpression of an shRNA may saturate the RNA induced 
silencing complex (RISC) and exclude endogenous miRNAs from performing their natural 
function of controlling gene expression. While the specific small RNA that is ultimately involved 
in dynamically altering the local circuitry is unknown. The results suggest the endogenous RNAi 
machinery itself may regulate cortical plasticity. 
Follow up studies 
Determining the relative levels of small RNAs 
The regulatory potency of small RNAs depends on relative abundance and the spatio-temporal 
expression patterning of miRNAs in a given tissue. To determine the relative levels of shRNAs 
produced, we will profile the small RNA content (both miRNA and shRNA) in AAV shRNA 
infected tissues and non-shRNA transduced samples. We will characterize the siRNA produced 
and determine the relative amount of the siRNA verses the endogenous molecular substrate for 
the RNA interference (RNAi) pathway, the microRNAs (miRNA) fraction169. We will infect 
37
 
  
  
brain tissue with an shRNA that does not target any gene expressed in the brain (AAV2.1 luc) 
and the control samples will be transduced with a non-shRNA containing virus (AAV2.1 RFP). 
We will then isolate the transduced tissues; prepare RNA from infected areas. miRNA and 
siRNA cloning will be performed as previously described170, the cDNA library will be sequenced 
using 454 sequencing, and miRNA sequences annotated as described89. We will compare the 
clone frequencies of the virally delivered siRNAs to endogenous miRNAs clone frequency. Our 
expected outcome is that the level of siRNA is equal or greater than the relative amount of the 
highly abundant miRNAs. For the control tissues injected with AAV RFP, we anticipate that the 
miRNA profile will show no shifts in miRNA relative abundance when compared to small RNA 
profiles from naive mice.  
Methods: 
AAV expression vectors  
For recombinant AAV shuttle vectors, the fluorescent protein (GFP or RFP) was controlled by a 
hybrid CMV-chicken-beta-actin (CBA) promoter. Downstream of this cassette, we recombined a 
RNA polymerase III, H1 promoter to express an shRNA duplex. The vector was designed for 
rapid directional insertion of chemically synthesized shRNAs with EcoR1 and Xho1 restriction 
sites. We generated separate shuttle vectors encoding shRNA BDNF #1, shRNA BDNF #2, and 
shRNA that targeted a luciferase sequence as a control (shRNA luc; which does not target a gene 
expressed in the mouse brain). To target BDNF variants (BDNF mRNA variants 1-4), we 
identified regions of 100% nucleotide identity (Megalign, Lasergene), and selected candidate 
small hairpin RNAs to target homologous regions. Candidate shRNAs were selected according 
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to predefined “siRNA rules” using a computer algorithm167, then chemically synthesized and 
recombined into our expression vector with a RNA polymerase III termination sequence 
encoding a six thymidine nucleotides terminator sequence.  
shRNA Validation 
The shRNAs constructs were prevalidated using an in vitro dual-luciferase assay. To assess the 
degree of knockdown, we recombined a mouse-BDNF-messenger-RNA with a Renilla-
Luciferase (RL) gene, creating an mRNA fusion product (BDFN-RL) that is separated by a 
translational stop codon. To test for shRNA potency, the shRNA plasmid was co-transfected 
with the reporter vector in vitro. Briefly, a BDNF-RL was cloned into psiCHECK-2 and 
plasmids were cotransfected into HEK293 cells according to manufacturer's protocol. Effective 
shRNAs targeted the BDNF-reporter mRNA and reduced luciferase activity as measured by a 
luminometer. Two shRNA duplexes, “BDNF #1” and “BDNF #2” resulted in an in vitro 
knockdown of more than 50% and were chosen for viral packaging and in vivo infusion 
experiments. As control shRNA duplex, a shRNA targeting GL2 firefly luciferase (luc) was 
used.  
AAV vector packaging 
Validated AAV shRNA plasmids were packaged into AAV2.1 pseudotype capsids.  AAV shuttle 
vector, rep/cap and helper plasmids were cloned and isolated using a polyethylene glycol (PEG) 
plasmid purification procedure (Molecular Cloning).  The concentration of the purified DNA 
was determined, and then the integrity of cis vector ITR was analyzed by SmaI restriction digest. 
Recombinant AAV vectors were produced by a standard calcium phosphate transfection method 
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(Molecular Cloning) in HEK 293T cells (ATCC), with the AAV shuttle plasmids, 
transpackaging (serotype 2.1), and Ad helper (delta F6). The plasmid ratio for the shuttle vector, 
rep/cap and helper plasmids was 1:2:2, respectively. Viral particles were harvested from cells 
after a series of freezing and thawing, followed by brief sonication. AAV vectors were purified 
using a High-trap ion exchange column (Amersham). Packaged virus was concentrated and 
dialyzed using size filtration columns (Millipore). Vector titers were determined by real-time 
PCR and the yield was between 1 and 3 x 1013 DNase-resistant particles per ml. Vector 
infectivity was assessed by transduction in a U87 glioblastoma cell line. 
Receptive field mapping 
The Institutional Animal Care and Use Committee at the Rockefeller University approved all 
animal protocols. The receptive fields (RF) of the mouse vibrissa were mapped in the barrel 
cortex via electrophysiology. Briefly, a small craniotomy was performed in anesthesitized, 
animals directly above and surrounding the mouse barrel cortex (the center of the craniotomy 
was approximately –2.00 mm posterior and +/– 4.00 mm lateral, relative to the cranial landmark 
bregma). A picture of the cortical vasculature taken and insulated tungsten microelectrode was 
placed based on vasculature landmarks. Penetrations were made perpendicular to the cortical 
surface and restricted to the superficial layers. Multiple recordings were made in each barrel. RFs 
were mapped according to “minimum response” characteristics after mechanical stimulation of 
individual vibrissa. Following RF mapping, the bone was replaced, skin sutured, and animal 
resuscitated. Mice were housed in a controlled temperature environment on a 12-h light/dark 
cycle. 
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AAV injection in the barrel cortex 
The location of vibrissa receptive fields in the barrel cortex were identified as described above. 
Viral vectors were pressure injected through glass micropipettes in the superficial layer of the 
cortex immediately in, and surrounding the cortical areas representing the vibrissa row C. To 
deliver enough viruses to infect the desired region, we injected AAV2.1 shRNA, AAV2.1 GFP, 
or AAV2.1 RFP viruses via a series of injections separated from each other by approximately 1 
mm. To avoid damaging cortical tissue, small volumes of the AAV vector were delivered at each 
site (100 nl injected per site; rate 10 nl/min; viral titer of 1 x 1013 particles/ml).  
AAV injection in the hippocampus  
AAV vectors were directly injected into the adult mouse hippocampus area 3A. A craniotomy 
was burrowed directly above the hippocampus, using stereotaxic surgical coordinates (posterior 
2.30 mm and 2.25 mm lateral from a cranial landmark, bregma, described in Paxinos Brain 
Atlas). A spear–tipped glass pipette penetrated below the surface of the cortex (1.9 mm). We 
delivered 100 nl of AAV (rate of 10 nl/min, viral titer, 1 x 1013 viral particles/ml) expressing an 
shRNA targeting BDNF (AAV2.1-BDNF-shRNA #1 or AAV 2.1-BDNF-shRNA-#2; n=3) to the 
hippocampus area 3A. On the opposite side and at the same depth, a control virus expressing an 
AAV 2.1-RFP (n=3) or saline alone (n=3) was injected under identical conditions. Animals were 
sutured, resuscitated and placed in Rockefeller University animal housing facility following 
survival surgery.  
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Brain tissue collection 
Animals were sedated and sacrificed in accordance with NIH Animal Welfare guidelines using 
ketamine and xylazine cocktail before organ perfusion with 50 ml of Tris-HCl buffered Saline 
(TBS) containing 50 mM Tris-HCl, 150 mM NaC1 and the pH adjusted to 7.4. The hippocampus 
was dissected and bisected at the midline, and then isolated and frozen in liquid nitrogen for 
Northern blotting or Western blotting analysis.  
Western blotting analysis 
Tissue samples were lysed in lysis buffer (20 mM Tris, pH 8.0/1% Triton X-100/150 mM 
NaCl/protein and phosphatase inhibitors; Sigma). Total protein lysate was cleared of debris by 
centrifugation; equal amounts of protein were measured (30 µg of total protein) and were 
denatured in a sample buffer. Samples were loaded onto a NuPAGE 10% (Bistris [bis(2-
hydroxyethyl)amino]tris(hydroxymethyl)methane) gel (Invitrogen) and protein separated by 
electrophoresis. After transfer, we probed the membrane with an anti-BDNF (Sigma) or anti-
beta-actin (Chemicon) antibody, followed by secondary antibodies and enhanced 
chemiluminescent detection (Amersham Pharmacia Biosciences). Immunoreactive bands were 
quantified and analyzed by densitometry (Image J). BDNF immunoreactive bands were 
normalized to the loading control beta-actin.  
Northern blotting 
Northern blotting was performed as described89 using Hybond-N+ membrane (Amersham GE 
healthcare), and the hybridization and wash steps were performed at 50°C. The 
oligodeoxynucleotide probes were 5'-labelled with [γ-32P] ATP. The probe for miR-124 was 5' 
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TTGGCATTCACCGCGTGCCTTA. To control for loading of the gel, 5S rRNA was detected by 
ethidium bromide staining of the polyacrylamide gel prior to transfer. Probe samples were 
recorded by phosphoimaging and quantified. Northern blotting images were quantitated using 
ImageJ software171.   
microRNA in situ hybridization 
For in situ hybridization experiments, mice were sedated and immediately perfused with TBS, 
and then 4% paraformaldehyde (PFA). Tissues were collected, immersed in 4% PFA for 24 h, 
then placed in 0.5 M sucrose for 48 h. Tissues were mounted in Tissue-Tek OCT Compound, 
frozen in a dry-ice/ethanol bath in a Cryomold (Tissue-Tek), immediately serial sectioned at 10 
µm with a cryostat (Leica) and mounted on SuperFrost Plus glass slides (Thermo Fisher 
Scientific). Mouse brain tissue was fixed with formaldehyde–EDC as previously described147. 
After fixation the samples were exposed to 4 pmol of a locked nucleic acid probe complementary 
to miR-124. The probe was diluted in a formamide-containing solution and hybridized overnight 
at a temperature 20ºC below the experimentally determined melting temperature147. Then tissue 
sections were subsequently exposed to stringency washes and antibody staining. Finally, miRNA 
expression was detected using a tyramide Cy3 non-isotopic detection system, then washed in 
TBS and prepared for microscopy analysis. Images were captured on an Olympus BX50 
microscope equipped with a DP70 camera and Olympus DP controller software. 
Small RNA cloning protocol 
Small RNAs were isolated by gel electrophoresis from total RNA or by immunoprecipitation 
using anti-Argonaute monoclonal antibodies. First, a chemically preadenylated 3' adapter 
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oligonucleotide is ligated to the small RNAs. The ligation products are gel-purified and the 5' 
adapter is ligated with regular RNA ligase in the presence of ATP. The 3' adapter was blocked 
with an aminolinker at its 3' end. The ligation product is again gel-purified, then reverse 
transcribed, PCR amplified, concatamerized and sequenced. 
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tissues 
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Summary, Chapter III 
MicroRNAs (miRNAs) are small regulatory RNAs with many biological functions and disease 
associations. We showed that in situ hybridization (ISH) using conventional formaldehyde 
fixation results in significant miRNA loss from mouse tissue sections, which can be prevented by 
fixation with 1–ethyl–3–(3–dimethylaminopropyl) carbodiimide (EDC) that irreversibly 
immobilizes the miRNA at its 5' phosphate. We determined optimal hybridization parameters for 
130 LNA probes by recording nucleic acid melting temperature under ISH conditions. 
Introduction: 
Association studies are rapidly linking miRNAs44 with cancer and neurological disorders172. 
miRNAs have specific expression and function in specialized cell types89, emphasizing the need 
to define cell–type–specific miRNA expression patterns. For pathologists, the most common 
method for visualizing gene expression in specific cell types is in situ hybridization (ISH). In our 
laboratory, conventional ISH worked for highly abundant miRNAs, however examining less 
abundantly expressed miRNAs often yielded inconsistent or negative results. A review of the 
literature indicates that zebrafish whole–mount ISH were robust142, whereas ISH in D. 
melanogaster embryos were mostly unsuccessful92. In tissue sections, several studies set the 
foundation for establishing miRNA ISH95,144,173-175, and were used to support association to 
disease176,177, or defined expression patterns in multiple cell types present in the brain103 and 
eye146. The technical difficulties in miRNA ISH also led to development of transgenic138 or cell 
sorting methods89 that monitor cell–type–specific miRNA expression.  
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 To better understand the technical challenges associated with miRNA ISH, we 
investigated the importance of miRNA fixation and probe hybridization. For fixation of proteins 
and nucleic acids in tissues, a solution containing 3.7% formaldehyde (10% formalin) is 
commonly used178. Formaldehyde crosslinks are reverted by incubation at elevated temperature 
and this process is facilitated by proteinase K treatment179. Reversal of the formaldehyde–based 
nucleic acid base modifications is also necessary for probe hybridization, but it creates the 
problem of miRNA release and diffusion out of the tissue sections. Therefore, we examined the 
extent of miRNA escape from tissue during ISH. We conducted a mock ISH for conventionally 
fixed brain sections, isolated RNA from the tissue sections and the ISH buffer, and probed both 
fractions for the highly expressed neuronal miR–124 by Northern blotting. At hybridization 
temperatures above 40ºC, at least 50% of miR–124 initially present in the tissue section 
accumulated in the buffer as early as 1 h (Figure 1a–c). At 4ºC, the hybridization buffer showed 
no signal for miR–124 (Figure 1d), which would suggest that RNA–protein crosslinks were still 
intact at lower temperatures. 
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Figure 1: miRNAs retained in 
formaldehyde + EDC fixed 
tissues. (a) Northern blotting 
analysis shows escape of miR–
124 from formaldehyde–fixed 
tissues into ISH buffer after 24h 
incubation at temperatures of 40 
ºC and higher. (b) 
Quantification of Northern blots 
show approx. 50% of miR–124 
were present in the hybridization 
buffer after overnight incubation, P < 0.05, n = 3. (c) Time course of hybridization at 50 ºC 
shows miR–124 accumulates in ISH buffer after 1 h. (d) At 4 ºC, miR–124 was not detectable in 
the hybridization buffer, which would suggest that RNA–protein crosslinks were intact at lower 
temperatures. (e) Samples fixed with formaldehyde + EDC show negligible amounts of miR–124 
in ISH buffer at pH 7.0 and 8.0. 
Results 
  To prevent the loss of miRNAs, we added an additional miRNA fixation step taking 
advantage of the miRNA 5’ phosphate end44, which does not react with fomaldehyde178. The 
water–soluble 1–ethyl–3–(3–dimethylaminopropyl) carbodiimide, EDC, reacts with phosphate 
and condenses it with amino groups in the protein matrix to form stable linkages180,181. When 
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formaldehyde–fixed specimens were additionally treated with EDC, miR–124 no longer escaped 
from the tissue sections, and only trace amounts of miR–124 were detected in the ISH buffer 
(Figure 1e). EDC treatment alone, without prior formaldehyde fixation insufficiently retained 
miRNAs in tissues (data not shown). 
The second critical factor affecting ISH is probe hybridization. Probes that bind to 
miRNAs with high thermodynamic stability such as DNA probes containing locked nucleic acid 
(LNA) residues are well suited for miRNA ISH142,182. The melting of LNA/miRNA duplexes can 
be observed experimentally by UV spectrophotometry182. Thermodynamic analysis of LNA–
modified deoxynucleotide duplexes led to models that predict their melting temperatures (TM) 
for any LNA/RNA pair. Unfortunately the TMs cannot be predicted accurately for ISH, as the 
programs do not consider the presence of formamide denaturant. To derive optimal hybridization 
conditions, nucleic acid melting studies were conducted and the melting profiles of 130 
miRNA/LNA probe pairs were measured (Supplementary Table 1, appendix). With these data, 
we provide a correction factor for these programs, by manipulating the salt parameter of 
LNA/RNA TM prediction programs, and obtained useful starting points for estimating 
hybridization temperature in formamide–containing ISH buffer (Supplementary Table 1, 
appendix). Based on miRNAs expressed with a clone frequency of at least 0.04% based on 
small RNA library sequencing from 5 regions of the mouse brain (Supplementary Table 2, 
appendix), we generated an LNA probe set. 
To determine the range of the ISH sensitivity, we conducted ISH for miRNAs identified at 
varying frequencies from small RNA cloning libraries in mouse brain; miR–9, 9.3%; miR–124, 
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8.8%; miR–26a, 3.3%; miR–26b, 0.25%; miR–370, 0.14%; miR–130a, 0.12%; and miR–410, 
0.07% (Supplementary Table 3, appendix). Tissue sections were fixed with 
formaldehyde/EDC and then ISH performed (Methods). We determined the effect of 
formaldehyde/EDC versus formaldehyde fixation alone by ISH of the most abundant miR–124 
and the 73–fold less abundant miR–130a. ISH images show that signal for miR–124 were 
improved moderately, but miR–130a signals were only detectable in formaldehyde/EDC–fixed 
samples (Figure 2). Since the abundant miR–124 presumably retained enough miRNA to nearly 
saturate the signal the improvement remained modest, but for lowly expressed miRNAs, loss by 
diffusion hindered its detection in formaldehyde alone samples. miR–124 is mostly detected in 
neuronal cells present in different regions of the brain (Figure 3a–d and Figure 4) and 
predominately localized in the cytoplasm, while the cell nuclei were excluded. Another highly 
expressed miRNA in brain, miR–9, also preferentially localizes in neurons, and is particularly 
enriched in the Purkinje cell layer (Figure 3e). We also observed robust ISH signal for the less 
abundant miRNAs tested (Figure 3f–i), with unique miRNA distributions. Interestingly, miR–
26a and miR–26b, which differ by 2 nucleotides (C11U, C21U) and originate from different 
clusters, showed differential expression patterns in the mouse cerebellum (Figure 3h,i). The 
absolute signal intensities for the miRNAs tested were not directly correlated with the abundance 
of miRNAs and were likely attributed to differences in kinetics of probe hybridization. 
Nevertheless, for a given probe, the signal intensities accurately reflected miRNA differential 
expression. 
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Figure 2: Comparison of formaldehyde + 
EDC and conventional formaldehyde 
fixation for detection of a high and low 
abundance miRNA in mouse brain by ISH. 
(a–d) Fluorescence microscopy images of 
ISH using mouse brain tissue sections fixed 
with formaldehyde + EDC (left) or 
conventional formaldehyde alone (right), 
captured with identical camera settings and 
exposure times. Highly abundant nervous 
system specific miR–124 (clone count 
frequency 8.8%) showedformaldehyde + 
EDC fixation moderately improved signal 
intensity (a), compared to formaldehyde fixation alone (b). (c–d) Detection of lower expressed 
miR–130a (clone count frequency 0.12%) using formaldehyde + EDC (c). Conventional 
formalin fixed samples showed no signal (d). The digoxigenin–labeled LNA– modified DNA 
probe was hybridized to a specific miRNA and the signal was amplified using the tyramide–
Cy3 (orange) detection system. Cell nuclei were counterstained with DAPI (blue; bottom 
panel). Scale bars were 200 µm 
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Figure 3: Visualization 
of miRNAs expressed 
at different levels in the 
mouse brain. (a) Low 
magnification images of 
nervous system specific 
miR–124 (orange) shows 
broad expression in 
neurons. (b–c) High 
magnification images of miR–124 demonstrate ubiquitous expression in the neurons of the 
cerebellum (top, orange), (b) cerebral cortex and hippocampus (c). (d) Higher magnification 
images show that miR–124 signals are not present in all cells, marked with arrows. (e) 
Fluorescence images of mouse brain sections probed for highly expressed miR–9 (Cy3, red) 
localized in Purkinje cells of the cerebellum. (f,g) Image depicting miR–410 (f) and miR–
370 (g), which have an intermediate expression. (h,i) Images demonstrate robust signals for 
miRNAs differing by 3 nucleotides, miR–26b (h) and miR–26a (i) and these miRNAs were 
differentially expressed. Cell nuclei were counterstained with 4’, 6–diamino–2–phenylindole 
dihydrochloride (DAPI, blue; bottom panel of b–d; right panel of e–i). Scale bars, 500 µm 
(f–i). 
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Figure 4: Images of miR–124 ISH show the majority 
of staining occurs in neurons. (a) Photomicrograph 
from ISH of miR–124 (red; Cy3) in mouse 
hippocampus (see Supplemental Methods for details). 
(b) Prior to miRNA ISH, samples were stained to 
visualize the localization of neurons with a primary 
antibody for NeuN (green; Fluor488), a known neuron-
specific nuclear protein. (c) Nuclear staining (DAPI; 
blue). (d) Overlay of miR–124 (red; Cy3), NeuN 
(green; Fluor488), and nuclear staining (DAPI; blue). 
Scale bars, 200 µm (a–d). Note: double labeling for the 
miRNA ISH and immunohistochemistry resulted in a 
weaker signal for both the immunohistochemistry and 
miRNA ISH. 
 
To examine probe hybridization specificity, we selected miR–124 and introduced 
mismatches in the probe seed or central regions. The melting temperatures of the mismatched 
probe/miR–124 duplexes dropped within the range of 0.7ºC to 14.6ºC (Supplementary Table 3, 
appendix). The ISH was performed at constant temperature 20ºC below the TM of the fully 
complementary miR–124 probe. The probes with the greatest difference in TM showed the least 
signal and central mismatches abolished detection (Figure 5). Interestingly, signal strength 
53
 
  
  
observed for mismatched probes with minor reduction in TM dropped disproportionately, again 
indicative of altered kinetics of probe hybridization.  
 Instead of a mismatch approach to control for probe specificity, conducting ISH using 
two probes directed against the mature miRNA and miRNA* sequence and/or clustered members 
may be useful to help rule out signals derived from cross–hybridization. We probed for 
cistronically expressed miRNAs that are distinct in sequence for co–localization, including 
members in the mir–99a/mir–125b–1/let–7c–1 cluster. The ISH for let–7c and miR–99a reveal 
mostly identical patterns that showed superimposable band–like patterns (Figure 5g). Other let–
7 family members also show similar expression, however, the signal observed in the band–like 
region of the cortex likely originated from let–7c due to co–localization of miR–99a. We also 
tested the miRNA* sequences as a specificity control for miRNA ISH signals. We examined 
miR–140 and its complementary miR–140* sequence, expressed at relative clone frequency of 5 
to 1, respectively. The ISH with both probes revealed superimposible expression in the cortex 
(Figure 5h).  
54
 
  
  
Figure 5: Controls 
for miRNA probe 
specificity. The 
melting temperatures 
of the mismatched 
probe–miR–124 
duplexes dropped 
between 0.7ºC to 
14.6ºC 
(Supplementary Table 
3). (a) Images of 
neuron–specific miR–
124 ISH (Cy3, 
orange) of fully 
complementary 
probes show robust 
staining in the mouse 
cerebellum. miR–124 mismatch probes miR–124–T19A (b) and miR–124–C3A (c) signal is 
reduced but visible. miR–124 mismatched near the middle or seed region, miR–124–C9A, C10A 
and miR–124–C9A respectively, show the least signal (d,e), similar to background (f). (g) 
Cistronically expressed miRNAs miR–99a (left, Cy3; red) and let–7c (center) exhibit similar 
band-like distributions in the cortex (Cy3; red), marked by arrows. Nuclei were counter–stained 
(right, DAPI; blue). (h) miR–140 (left, Cy3; red) and miR–140* (center, Cy3; red) co–localize 
in cortex and DAPI stain (right, blue). Scale bars, 1.0 mm (a–f), 500 µm (g), 200 µm (h). For 
images (a–e), ISH was performed at 47.5ºC, which was 20ºC below the TM of the perfect LNA 
probe–miR–124 duplex determined at 1.5 µM strand concentrations. For image (g), a second gene 
copy of let–7c (clone count frequency 4.1%) is present in the cluster of mir–let–7c–2/mir–let–7b, 
which was approx. 2.5 fold more abundant than miR–let–7b (clone count frequency 1.7%). 
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miRNAs are known to localize to subcellular compartments for local regulation of 
mRNA, possibly to the dendrites of neurons141,172. We tested several miRNAs for expression in 
dendrites including miR–370 (Figure 6a–d), miR–9 (Figure 6e), and miR–124 (Figure 6g,h), 
which extended up to 50 µm from the cell body. Interestingly, compared to miR-9, the 20–fold 
less expressed miR–9* did not reveal localization in dendrites (Figure 6f). Furthermore, we 
noted that the ISH signal for a miRNA expressed at higher levels than miR–370, miR–99a (0.9% 
clone count frequency), also expressed in non–neuronal cells, showed no signal in dendrites 
(data not shown). Together, these data demonstrate this method detects miRNAs in subcellular 
compartments. 
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Figure 6: Formaldehyde–EDC–fixed 
sections show miRNA localized in the 
dendrites of neurons. (a) Low 
magnification fluorescent images 
demonstrate a robust and broad 
distribution of miR–370 expression 
(white) with intense staining in the 
hippocampus (inset). (b,c) High 
magnification images show a single 
neuron in the CA1 region of the 
hippocampus for which miR–370 is 
localized both in the cell body and the 
dendrites (arrows) (c,d), represented by 
inset (a). miR–370 localization extends 50 
µm from the cell body (b), and 30 µM in 
other neurons (c,d). (e) The mature miRNA miR–9 expressed in dendrites of Purkinje cells in the 
cerebellum, yet the miR–9* (f) was absent in dendrites. (g) Pyramidal cells in the hippocampus 
(arrows) show staining of miR–124 in hippocampus dendrites and in neurons located in the pons. 
Finally, to broaden this technique for sections not amenable to fluorescent imaging, we 
compared the NBT/BCIP pigment detection system for miR–370 in the brain to fluorescent 
detection and observed similar staining (Figure 7). We also tested the pigment detection for 
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miR–122 and miR–126–3p in the mouse liver, miR–1 in the mouse heart, and observed cell–
type–specific staining (Figure 8). Furthermore, we combined the detection of proteins by 
immunohistochemistry with miRNA ISH (Figure 4), although immunostaining that preceded 
EDC fixation reduced the signal strength for the miRNA ISH. 
Figure 7: Fluorescence and formazan deposition 
NBT/BCIP detection systems. (a) Fluorescent image of 
mouse brain cerebellum using Tyramide–Cy3 detection 
system. (b) Light microscopy image of serial sections of 
mouse brain cerebellum using NBT/BCIP detection 
system show similar cellular distribution as in 
fluorescent detection. (c) Images of DAPI nuclear stain. 
Scale bars, 1.0 mm (a–c). 
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Figure 8: Detection of miRNAs 
in mouse heart and liver sections 
using formazan deposition 
NBT/BCIP detection system. (a) 
Images of a highly abundant 
miR–122 ISH in the mouse liver 
sections, (b) the lower expressed 
miR–126, and a no probe control 
(c). (d) Images of the mouse heart 
sections show expression of 
highly abundant miR–1 (d), with 
a no probe, negative control (e). 
Cell nuclei were counterstained 
with DAPI (blue; right panel (a–
e); Scale bars, 200 µm (a–e). 
 
Discussion and Conclusion 
In summary, eliminating the possibility of miRNA diffusion by introducing an irreversible 
crosslink between the 5’ phosphate of the miRNA and protein side chains significantly improves 
miRNA retention in tissues. The advantage of EDC–based phosphoramidate–linked miRNA is 
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that the sample can be exposed to higher temperatures for a longer time, resulting in a more 
complete reversion of the formaldehyde induced nucleobase modification of the miRNAs and 
less interference with probe hybridization. Furthermore, the melting temperature determined for 
many probe/miRNA duplexes under ISH conditions more accurately defined ISH hybridization 
temperatures. At present, we showed that different tissues and detection systems are compatible 
with our approach. This method paves the way for reliable disease association studies and the 
potential use of miRNA ISH expression analysis as a diagnostic tool for biopsy material. 
Methods  
Design and synthesis of LNA-modified oligodeoxynucleotide probes 
LNA-spiked oligodeoxynucleotide probes (LNAs) were identical in length and fully 
complementary to the predominantly cloned mature miRNA or miRNA* sequence89. On 
average, we placed 5 to 8 LNA residues in a 22-nt oligodeoxynucleotide probe. To optimize 
probe hybridization, we avoided inserting LNA bases in positions that may stabilize internal 
secondary structures, so LNA residues were placed outside of predicted secondary self-structures 
(http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/)183. The LNA probe sequences 
are listed in Supplementary Table 1. Probes were synthesized at 0.2 or 0.4 µmol scale on an ABI 
3400 DNA synthesizer using 3'-amino-modifier C7 CPG (500 Å) solid glass support (Glen 
Research) and LNA and DNA phosphoramidites (Sigma-Proligo and Glen Research). The 
aminolinker Fmoc and phosphate cyanoethyl protecting groups were removed by gently passing 
back and forth 3 ml of freshly prepared 20% piperidine (Sigma) in N,N-dimethylformamide 
(DMF, Sigma) for 5 min over each column. Columns were washed three times with 3 ml of 
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acetonitrile and dried with pressurized air. For further deprotection, the CPG was transferred to a 
1.5 ml screw cap tube and incubated with 1.2 ml of 28% aqueous ammonium hydroxide solution 
for 16 h at 55ºC. The tube was placed on ice for 5 min, and the supernatant transferred to a 13 ml 
centrifugation tube. 10 ml of 1-butanol was added, vigorously mixed and the LNA pellet was 
collected by centrifugation at 13,000 rpm in an SS-34 rotor at 4ºC for 20 min in Sorvall RC5C 
Plus centrifuge. The supernatant was removed completely, the pellet dried in an Eppendorf 
concentrator and redissolved in 282 µl water. In order to exchange ammonium ions with sodium, 
the LNA solution was adjusted to 0.3 M NaCl by addition of 18 µl of 5 M NaCl and precipitated 
by addition of 900 µl of 100% ethanol. The pellet was collected by centrifugation and 
redissolved in 300 µl water. The LNA concentration was determined by measuring its UV 
absorbance at 260 nm using an average absorbance coefficient of 11,000 M-1cm-1 per nucleotide. 
To 3’-digoxigenin-label the LNA probe, an aliquot corresponding to 30 nmol of the 
LNA, was dried in an Eppendorf concentrator and redissolved in 50 µl of 100 mM sodium 
carbonate buffer at pH 8.5. 240 nmol of digoxigenin-3-O-methylcarbonyl-ε-aminocaproic acid-
N-hydroxysuccinimide ester (Roche) freshly dissolved in 50 µl anhydrous DMF was added, 
mixed and incubated for 16 h at 25ºC. The yield of a typical labeling reaction was 80%. The 
DIG-labeled probes, which showed reduced mobility compared to the starting material, were 
separated on a 43 x 23 x 0.2 cm denaturing 18% PAGE gel (200 ml gel volume) for 6 h at 50 W. 
Product bands were visualized by UV shadowing, excised, and eluted from the gel slice 
overnight into 3 volumes (w/v) of 0.3 M NaCl, ethanol precipitated and resuspended in 100 µl 
water.  
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DIG-labeling was examined by spotting 1 pmol, 100 fmol and 10 fmol on a Nylon 
membrane (Amersham Hybond- N+) followed by incubation of the membrane with anti-DIG 
antibody fragment conjugated to peroxidase antibody (Roche) with NBT/BCIP (Roche). 
Formazan Blue deposition is observed between 10 min to 1 h for all amounts spotted. 
UV Melting profiles of miRNA/LNA-probe duplexes 
The UV absorbance change associated with melting of the LNA probe and miRNA duplex was 
recorded at 280 nm on an Uvikon UV/VIS spectrophotometer (LifePower software) equipped 
with temperature-controlled cuvette holders. The rate of cuvette heating and cooling was 
0.3ºC/min and the absorbance was recorded every min. The melting temperature (TM) of duplex 
formation was obtained by curve-fitting the absorbance change as a function of temperature to a 
two-state model using Meltwin 3.5 software. To prepare samples for TM analysis, miRNA/probe 
pairs in a volume of 300 µl of 1.5 µM of unlabeled LNA probe and 1.5 µM of synthetic miRNA 
in 750 mM NaCl, 75 mM sodium citrate, 50 mM sodium phosphate (pH 7.0) and 50% 
formamide were incubated for 5 min at 95ºC, for 5 min at 80ºC, gradually cooled for 3 h to 50ºC, 
and then held at room temperature for 1 h or longer. The solution was then transferred to a quartz 
cuvette, overlayed with 500 µl mineral oil (Sigma) and degassed for 10 min by applying vacuum 
to a small dessicator holding the cuvettes. 
Adjusted parameters for prediction programs to estimate TM for miRNA/LNA probe 
duplex in formamide containing ISH buffer. 
To best emulate our experimental TM analysis, we tested several salt concentrations in the 
prediction program and determined that 50 mM salt, instead of the actual 750 mM for ISH 
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buffer, yielded an average predicted TM of 0.26ºC higher than the average of our experimental 
values with a standard deviation of 4.4ºC.  
We constructed non-parametric prediction intervals to determine the error. From a sample 
of 127 miRNA/LNA probe pairs, we found that the distribution of the predicted TM error had a 
mean of 0.26ºC (the predicted TM tended to be slightly higher than the real TM) and a standard 
deviation of 4.4ºC. To derive estimates for the likelihood that the predicted TM error will fall 
within a specified range, we constructed nonparametric prediction intervals184. We found that 
with 95.3% probability, the error in the predicted TM for any miRNA/LNA probe pair will fall 
between -9.2ºC and 8.6ºC. With 68.8% probability, the predicted TM error will fall between -
4.1ºC and 4.7ºC. Within a broad range of ±2 standard deviations of the mean, the sampled 
distribution of predicted TM errors is closely approximated by a normal distribution with µ = 
0.26 ºC and σ = 4.4 ºC. We therefore repeated the same analysis under the assumption of 
normality and found closely similar results. We found that with a 95.3% probability, the error in 
the predicted TM for any miRNA/LNA pair falls within -9.2ºC and 8.6ºC of the experimental TM 
in formamide-containing ISH buffer or a 68% probability that the true TM will fall between -3ºC 
and 5.1ºC.  
Tissue preparation and processing 
Male, 2-month-old C57BL/6J mice (Jackson Labs) were maintained on a 12 h light/dark cycle. 
Animals were sedated in accordance with NIH Animal Welfare guidelines using ketamine and 
xylazine cocktail before organ perfusion with 50 ml of Tris-HCl buffered Saline (TBS) 
containing 50 mM Tris-HCl, 150 mM NaC1 and the pH adjusted to 7.4. Immediately after TBS, 
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we perfused with of 30 ml of 4% paraformaldehyde (PFA) in TBS. Tissues were collected, 
immersed in 30 ml of 4% PFA in TBS for 24 h at 4ºC, then in 30 ml of 0.5 M sucrose diluted in 
TBS at 4ºC for 48 h. The tissues were mounted in Tissue-Tek OCT Compound, frozen in a dry-
ice/ethanol bath in a Cryomold (Tissue-Tek), immediately serial sectioned from 5 to 40 µm with 
a cryostat (Leica) and mounted on SuperFrost Plus glass slides (Thermo Fisher Scientific). 
Unprocessed specimen or mounted slides can also be stored at -80ºC. 
In situ hybridization procedure 
Processing or wash steps were generally carried out by placing up to 20 slides in 75 ml glass 
Coplin jars (Electron Microcopy Sciences) filled with specified solutions and all wash steps were 
in 50 ml of the stated solution for 5 min at 25ºC, unless otherwise noted. Tissue sections 
mounted on glass slides were thawed and air-dried for 1 h at 25ºC and then incubated in a 75 ml 
solution containing 20 µg/ml proteinase K (Roche) in TBS, pH 7.4 for 20 min. Thereafter, the 
slide was washed two times in 75 ml TBS. Samples were fixed in 75 ml of 4% PFA in TBS for 
10 min, washed with 0.2% (w/v) glycine in TBS, and washed two times in 75 ml TBS.  
To remove residual phosphate from the TBS washes, slides processed with EDC fixation 
were incubated twice for 10 min in 75 ml of a freshly prepared solution containing 0.13 M 1-
methylimidazole, 300 mM NaCl, pH 8.0 adjusted with HCl. To prepare 160 ml of imidazole 
buffer, add 1.6 ml of 1-methylimidazole to 130 ml water, adjust the pH by adding approximately 
450 µl 12 M HCl to pH 8.0, then add 16 ml 3 M NaCl and water to a final volume of 160 ml. In 
the meantime, prepare a solution of 0.16 M l-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDC) (Sigma) by adding 176 µl EDC into 10 ml of 1-methylimidazole/NaCl (pH 8.0) solution, 
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and then readjust the pH of the EDC solution by further addition of approximately 100 µl 12 M 
HCl to pH 8.0. It is important for storage of commercial EDC to handle the reagent under 
anhydrous conditions and protect it with a layer of argon. Aqueous solutions containing EDC 
and/or 1-methylimidazole cannot be stored. Place slides in a humidified chamber and add 500 µl 
of EDC solution to each slide and incubated for 1 to 2 h at 25ºC. The slides were washed in 0.2% 
(w/v) glycine/TBS and then washed twice in TBS.  
For inactivation of enzymes in tissues, e.g. alkaline phosphates and peroxidases, slides 
were acetylated by incubating for 30 min in a 75 ml solution of freshly prepared 0.1 M 
triethanolamine and 0.5% (v/v) acetic anhydride. Slides were then rinsed twice in TBS.  
For pre-hybridization, the tissue sections on the slides were covered with 500 µl of 
hybridization buffer containing 50% formamide, 5x SSC, 5x Denhardt’s solution (Applichem), 
250 µg/ml yeast tRNA (Sigma), 500 µg/ml salmon sperm DNA (Sigma), 2% (w/v) Blocking 
Reagent (Roche), 0.1% 3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate 
(CHAPs) (Sigma), 0.5% Tween at 25ºC for 2 h in a humidified chamber. The hybridization 
buffer was removed by tilting the slide. 
For hybridization, 40 pmol of DIG-labeled LNA probe diluted in 100 µl of hybridization 
buffer were applied per section, and covered with coverslips (LifterSlips, Fisher) . The slides 
were incubated in a sealed humidified chamber for 16 h at a temperature 20ºC below the TM of 
the experimentally determined miRNA/LNA probe duplex. Hybridization conditions were 
adjusted 20ºC below the LNA probe’s experimentally determined TM, taking into account that 
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the probe concentration for an ISH experiment is 40 nM compared to 1.5 µM required for optical 
TM measurements. 
The slides were immersed in 20 ml of 5x SSC at 25ºC so the coverslip can be removed 
and then washed twice in 75 ml of a solution containing 50% formamide, 1x SSC, and 0.1% 
Tween for 30 min at the same temperature as probe hybridization. Finally slides were washed in 
75 ml 0.2x SSC for 15 min and once in 75 ml of 0.1% Tween in TBS.  
To inactivate endogenous peroxidase activity, slides were incubated in 75 ml of 3% 
hydrogen peroxide in TBS with 0.1% Tween for 30 min, followed by three 1 min washes of 
TBS/0.1% Tween.  
In preparation for probe detection, 500 µl of blocking solution containing 0.5% Blocking 
reagent (Roche), 10% heat inactivated goat serum, and 0.1% Tween 20 in TBS was applied to 
each slide for 1 h at 25ºC, then incubated in anti-DIG-FAB peroxidase (POD) (Roche) diluted 
1:500 in blocking solution for 1 h at 25ºC. Slides were then washed as described below in 
preparation for the application of the various detection reagents. 
Cy3 fluorescent detection system 
The slides were washed twice in a solution containing 0.1% Tween 20, in TBS and 200 µl of 
TSA Plus Cy3 System working solution was applied onto to the sections for 10 min at 25ºC in 
the dark according to the manufacturer’s protocol (PerkinElmer Life Sciences). The slides were 
then washed three times in TBS with a tilting rotator. The slides were mounted using 2 drops of 
Vectashield mounting medium with DAPI (Vector Laboratories) and samples processed for 
microscopy. 
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Alkaline phosphatase double amplification detection system 
This detection method was adapted from studies by Lein et al.145. The slides were washed three 
times in 75 ml in TNT buffer, consisting of 0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, and 0.1% 
Tween 20. Thereafter, 250 µl of biotinylated tyramide solution from the Individual Indirect 
Tyramide Reagent kit (PerkinElmer Life Sciences) was applied to each slide for 30 min at 25ºC, 
according to the manufacturer’s protocol. The slides were washed three times in 75 ml maleate 
buffer (0.09 M maleic acid, 0.175 M NaOH, 1 M NaCl, 0.5% Tween 20, pH 7.5). A 1:500 
solution of 350 µl of NeutrAvidin-conjugated alkaline phosphatase (Thermo Scientific) in 
maleate buffer supplemented with 10 mg/ml blocking reagent (Roche) was applied to the slide 
for 40 min at 25ºC. Slides were then washed twice in 75 ml maleate buffer, and four times in 75 
ml TMN buffer (0.1 M Tris base, pH 9.5, 0.05 M MgCl2, 0.5 M NaCl, 0.5% Tween 20, 2 mM (-
)-tetramisole hydrochloride). The formazan deposition was performed by applying 200 µl of a 
solution containing 0.375 mg/ml NBT (Roche) and 0.188 mg/ml BCIP (Roche) in TMN buffer. 
Upon deposition of the blue pigment, typically visible after 30 min, the slides were washed twice 
in 75 ml water, three times in 75 ml of 0.01 M Tris-HCl, pH 7.5, 0.5 M NaCl, 5 mM EDTA, 
0.05% Tween 20, and incubated for 10 min in 75 ml of 4% aqueous paraformaldehyde solution. 
Finally, the slides were washed in 75 ml water and mounted using 2 drops of Vectashield 
mounting medium with DAPI (Vector Laboratories). 
Immunohistochemistry and miRNA ISH co-staining 
To assess whether miR-124 was localized specifically to neurons, brain sections were processed 
for double immunofluorescence staining to visualize the simultaneous localization of miR-124 
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(red; Cy3) and a primary antibody for NeuN (green; TRITC), a known neuron-specific nuclear 
protein. First we performed immunohistochemistry to label neuronal cells. Brain sections 
mounted on slides were rinsed three times for 5 min in 50 ml of TBS. Sections were incubated 
for 1 h in 500 µl of “working solution of M.O.M. Mouse Ig Blocking Reagent” (Vector 
Laboratories) at 25ºC, according to the manufacturers protocol. Sections were washed twice for 5 
min in 50 ml of TBS, followed by incubation for 5 min in a “working solution of (M.O.M.) 
diluent” (Vector Laboratories) for 5 min at room temperature. The “working solution of 
(M.O.M.) diluent” was removed. To visualize neurons, we incubated the samples with a primary 
anti-NeuN-clone-A60-AlexaFluor488 conjugated antibody (Chemicon International, Temecula, 
CA) diluted 1:300 in a “working solution of M.O.M. diluent” (Vector Laboratories) for 1 h at 
25ºC. Slides were then washed 3 times for 5 min in 50ml TBS. Slides were mounted using 2 
drops of Vectashield mounting medium with DAPI (Vector Laboratories). Please note that the 
glass coverslips were not sealed, as the samples were later used for ISH to detect miR-124. After 
image acquisition, coverslips were removed by washes in 50 ml of TBS and the tissue sections 
were then processed for ISH for miR-124 (Cy3; red) by applying our miRNA ISH protocol 
described earlier. After miRNA-ISH, the sections were mounted using 2 drops of Vectashield 
mounting medium with DAPI (Vector Laboratories) and samples processed for microscopy. 
Photomicrographs of the nuclear staining are required to superimpose images for the 
immunohistochemistry and the miR-124 ISH. Images were combined to generate an overlay 
using Olympus Microsuite Five software.  
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Please note that the immunohistochemistry procedure for NeuN protein detection 
somewhat reduced the efficiency for miRNA detection; performing miRNA ISH before protein 
staining was not possible as EDC fixation interfered with protein immunohistochemistry.  
Microscopy and image processing 
Images were captured on an Olympus BX50 microscope equipped with a DP70 camera and 
Olympus DP controller software. For fluorescent imaging we used the following filter sets; U-
MWU2 (Olympus) for DAPI, 41001 HQ (Chroma) for Fluro488, 49004 ET (Chroma) for Cy3. 
The images from both the immunohistochemistry and the ISH were captured using DP70 camera 
and processed using Olympus Microsuite Five software (Olympus).  
Small RNA isolation from formalin-fixed tissue 
Formalin-fixed brain tissues used for RNA extraction were cut into 1 mm sections and incubated 
with a 200 µl solution containing 20 µg/ml proteinase K (Roche) in TBS and incubated at 45ºC 
for 1 h. The samples were then processes for RNA isolation. Total RNA was isolated from 4% 
formaldehyde fixed tissue by using the commercial Trizol (Invitrogen) reagent. We added 1 ml 
of Trizol per 1 mm slice of brain. The mixture was immediately homogenized while kept on ice. 
Cells were homogenized using a Dounce glass homogenizer and then further mechanically 
homogenized using a Polytron homogenizer (Kinematica AG). Following tissue disruption, 1/10 
volume of 3 M sodium acetate (pH 4.2) was added. The mixture was transferred to an Eppendorf 
tube and centrifuged for 15 min at 12,000g at 4ºC. The aqueous phase was transferred to a new 
tube without the white interphase. RNA was further extracted with 1/2 volume of acid-buffered 
phenol:chloroform:isoamyl alcohol (25:24:1) and centrifuged for 15 min at 4ºC at 12,000g. 
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Finally, we extracted the aqueous phase with 1/2 volume chloroform. The upper (aqueous) phase 
transferred to a new tube. We added 3 volumes of ethanol to precipitate the RNA and incubated 
the sample overnight at –20ºC in the freezer. The RNA pellet was collected by centrifugation for 
15 min at 4 °C at 12,000g and the supernatant was removed. The pellet was then dissolved in 30 
µl water and used for Northern blotting. 
We were unable to isolate miR-124 from the formalin/EDC-treated tissue, presumably 
because miRNAs remained cross–linked to the protein matrix and the small RNAs were lost to 
the phenol- or inter-phase during RNA isolation. 
Northern blotting 
Northern blotting was performed as described89 using Hybond-N+ membrane (Amersham GE 
healthcare), and the hybridization and wash steps were performed at 50°C. The 
oligodeoxynucleotide probes were 5'-labelled with [γ-32P] ATP. The probe for miR-124 was 5' 
TTGGCATTCACCGCGTGCCTTA. To control for loading of the gel, 5S rRNA was detected by 
ethidium bromide staining of the polyacrylamide gel prior to transfer. Probe samples were 
recorded by phosphoimaging and quantified. Northern blotting images were quantitated using 
ImageJ software171.  
Small RNA library preparation and sequencing 
The regulatory potency of miRNAs (miRNAs) depends on relative abundance and spatio-
temporal expression patterning of miRNAs in a given species or local concentration within in a 
tissue. The Tuschl laboratory developed a small RNA cloning technique to characterize small 
interfering (siRNA) processing intermediates that were the molecular substrates for the RNA 
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interference (RNAi) pathway169. Further application of the technique lead to the identification of 
the majority of miRNAs expressed in fruitfly, zebrafish, mouse, human, and herpes viruses 
86,96,122,133,185-188. Methods for cloning and identifying small RNAs improved over the recent 
years (Figure 9) 90,187-189. Using these optimized protocols, we prepared RNA extracted from 
dissected mouse brain regions and size-fractionated by a denaturing PAGE. miRNA cloning was 
performed as described previously170. The cDNA library was sequenced by 454 sequencing. 
MiRNA sequences were annotated as described89 and obtained about 90,000 sequence clones.  
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Figure 9. Small RNA cloning protocol 
188. Small RNAs are isolated by gel 
electrophoresis from total RNA or by 
immunoprecipitation using anti-Argonaute 
monoclonal antibodies. First, a chemically 
preadenylated 3' adapter oligonucleotide is 
ligated to the small RNAs. The ligase in 
this step can only accept pre-adenylated 
donor oligonucleotides and, in contrast to 
other ligases, has reduced activity to transfer the adenylate to the 5' phosphorylated input small 
RNAs, thereby minimizing losses of input material due to ligase-catalyzed circularization. The 
ligation products are gel-purified and the 5' adapter is ligated with regular RNA ligase in the 
presence of ATP. Because the 3' adapter is blocked with an aminolinker function at its 3' end, 
and the 5' adapter is not 5' phosphorylated, only intermolecular ligation reactions occur. The 
ligation product is again gel-purified, then reverse transcribed, PCR amplified, concatamerized 
and sequenced. 
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Chapter IV 
Improved in situ hybridization method to detect microRNAs in 
mammalian tissue sections fixed with formaldehyde and EDC and 
Cyanogen Bromide under optimized hybridization conditions. 
73
 
  
  
Summary of Chapter IV 
MicroRNAs (miRNAs) are 20- to 23-nucleotide small regulatory RNAs are associated with 
many normal physiological process and associated with diseases such as cancer, neurological 
disorders, and cardiovascular diseases. Defining cell-type specific expression of miRNAs is 
critical for understanding the natural function of miRNAs and their role in pathology. The most 
widely used method for imaging messenger RNA and microRNA in tissue sections is in situ 
hybridization (ISH). We previously showed that conventional ISH using formaldehyde fixation 
can result in reversal of RNA crosslinks and subsequent loss of miRNAs during probe 
hybridization. Here in this protocol, we describe a fixation method to eliminate miRNA loss by 
introducing a permanent crosslink that immobilizes the miRNAs by condensing the miRNA 5' 
phosphate to protein amino groups using an additional treatment with 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) and or cyanogen bromide (BrCN). This modified 
miRNA ISH procedure requires 2 days to complete and is adaptable to existing ISH protocols by 
applying EDC and or BrCN treatment to samples previously fixed with formaldehyde. This ISH 
procedure can be automated, setting the stage for high throughput screening studies for large 
numbers of miRNAs in normal and disease tissues. The results from tissues crosslinked with 
formaldehyde–EDC and or formaldehyde–BrCN solution, yields miRNA ISH signals that are 
substantially more robust, when compared to conventional formaldehyde fixation alone.  
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Introduction 
MicroRNAs (miRNAs) are important regulators of mRNA translation and stability in 
eukaryotes52,54,190-194. They participate in many biological processes including developmental 
timing, cell differentiation, stress response, and apoptosis50,195-197, often in a tissue-specific 
manner. Recent investigations are assigning miRNAs to specific functions in given cell types, 
emphasizing the need to precisely define their endogenous expression. Association studies in 
human patient samples are linking miRNAs with diseases, the most studied examples being 
cancers195,198, neurological disorders155,172,199 and cardiovascular diseases200. To help clarify the 
role of miRNA in normal and disease phenotypes, identifying the spatial and temporal 
localization of miRNAs using ISH in tissues with diverse cell types is crucial200. 
Methods for imaging miRNAs in tissue sections 
The most widely used procedure for imaging mRNA and miRNA in specific cell types is 
in situ hybridization (ISH) in tissues fixed with formalin. Whole-mount ISH for microRNAs in 
the zebra fish and mouse142,201 set the foundation for miRNA ISH. In fresh-frozen tissue sections, 
miRNA ISH protocols were described95,144,173-175 and results were shown in the brain103 and 
eye146. Other groups used miRNA ISH to support disease association studies176,177. In our 
laboratory, miRNA ISH using formalin–fixed tissues often yielded inconsistent results, and other 
groups also reported that ISH for lower expressed miRNAs were challenging146,147. The technical 
limitations of conventional miRNA ISH led investigators to develop novel methods to monitor 
miRNA expression that include generating transgenic models expressing miRNA constructs with 
reporters138, single cell detection using quantitative PCR139, and profiling FACS sorted 
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hematological cells89,140. While useful, these methods are limited compared to ISH, as 
localization of miRNA location in the context of the natural tissue morphology will be needed 
for a broad range of studies.  
Formaldehyde crosslinks are reverted under ISH conditions 
We examined steps of the ISH protocol that may hamper miRNA detection, the most critical 
being defining the hybridization temperatures under the conditions of ISH, inadequate fixation 
and crosslinking of miRNAs, which results in loss of miRNAs during probe hybridization147. 
Conventional ISH is based on treating specimens with 10% formalin (3.7% formaldehyde), a 
universal fixative178,202 used to inactivate, stabilize, and immobilize proteins and nucleic acids, 
which preserves tissue morphology. Formalin reacts with primary amino, imino and thiol groups 
present in proteins or nucleic acid bases forming N-methylol (N-CH2OH) derivatives or Schiff-
bases (RN=CH2)178,202. The primary reaction products may undergo secondary reactions with 
amines, imines and reactive aromatic nuclei, such as tyrosine, yielding methylene–bridged 
condensation products of varying stability178. Formaldehyde reacts with nucleic acids by forming 
reversible crosslinks between nucleic acids and proteins. Crosslinks are biochemically unstable 
and partially revert when the ribonucleoprotein structures are exposed to elevated temperature, 
and or limited proteinase K treatment147,179. For most ISH procedures, formaldehyde–fixed 
tissues require exposure to proteinase K treatment and hybridization temperatures above 37ºC, 
which subsequently leads to loss of miRNA from the tissue section147 and ultimately results in 
lower or no miRNA ISH signal. 
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Stable crosslinks with the miRNA 5’ phosphate withstand hybridization conditions 
To eliminate diffusion of the miRNA during hybridization, we introduced an irreversible 
fixation step of the miRNA 5’ phosphate. Formaldehyde crosslinks at the nucleobases and leaves 
the miRNA 5’ phosphate group unmodified178 and available for condensation. The first reagent 
agent suitable for generating stable crosslinks at the miRNA 5’ phosphate is thewater soluble 1-
ethyl-3-(3-dimethylamino-propyl) carbodiimide (EDC), which reacts with phosphates and 
condenses it with aliphatic primary and secondary amino groups present in the protein matrix 
and results in a stable phosphoamidate linkage181,203. In combination with formaldehyde, EDC 
retains miRNAs under ISH conditions and substantially increases the miRNA ISH signal147.  
To optimize the formaldehyde–EDC–based miRNA ISH procedure, we determined the 
level of miRNA expression in the mouse brain by isolating RNA from 5 distinct brain regions, 
including the cerebral cortex, hippocampus, then profiled the miRNAs present using 454 deep 
sequencing147. The relative amount of miRNAs present in the tissue are represented as the clone 
count frequency. For our ISH experiments, we use DNA oligonuclotide probes with 
approximately one third of the nucleobases substituted with a locked nucleic acid (LNA) 
residues. Furthermore, we determined the optimal hybridization temperature for a probe set of 
130 miRNA–LNA probes by measuring the UV absorption of the miRNA–LNA probe duplex in 
ISH buffer as a function of temperature. The melting profiles were recorded and we calculated 
the melting temperatures (TM) for each miRNA–probe pair147. For our miRNA ISH experiments, 
we adjusted the hybridization temperature to be –20ºC below the experimentally determined TM. 
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To validate this protocol, we examined formaldehyde–fixed fresh–frozen mouse brain 
tissue sections for expression of medium abundant miRNAs by hybridizing LNA probes 
targeting miR-129-3p (clone count frequency 0.35%)147 and miR–130a (clone count frequency 
0.12%), followed by detection using a sequence of tyramide signal amplification reactions with 
the fluorescent product being a Cyanine 3 (Cy3) precipitate (Fig. 1a–d). We observe robust 
detection of both miRNAs in formaldehyde–EDC fixed tissues (Fig. 1a, c; left), but the signal 
remained nearly blank in tissues fixed with formaldehyde alone (Fig. 1b, d; left). We applied the 
formaldehyde–EDC fixation in fresh–frozen mouse brain tissue sections to examine miRNAs 
expressed at various expression levels, and observe specific signal for the medium abundant 
miR–30b (clone count frequency 0.49%), and for the low abundant miR–145–5p (clone count 
frequency 0.05%) and miR–28–3p (clone count frequency 0.005%) (Fig. 2 a–c). miR–30b 
showed expression in distinct expression in the mouse cerebral cortex, hippocampus and 
cerebellum (Fig. 2a). For miR–28–3p, which is almost 100 fold less than miR–30b, we observe 
signal in the cerebellum (Fig 2b) and miR–145 showed robust staining in the cortex, yet absent 
in the superior colliculus (Fig 2c). 
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Figure 1: Tissues fixed with 
formaldehyde–EDC 
improves miRNA ISH 
signal for less abundant 
miRNAs. (a) Low–power 
fluorescent micrograph 
images showing medium 
expressed miR-130a (clone 
count frequency 0.12%) in 
regions of the olfactory bulb 
and cerebral cortex from 
mouse brain in tissues fixed 
formaldehyde–EDC (a, Cy3; 
orange, left) or formaldehyde 
alone (b, Cy3; orange, left). 
(c) Low–power fluorescent 
micrograph images of miR–
129–3p (clone count 
frequency 0.35%) in the 
hippocampus and cerebral 
cortex from mouse brain 
tissues fixed with 
formaldehyde–EDC (c, Cy3; orange, left) or formaldehyde alone (d, Cy3; orange, left). Nuclei 
were stained (DAPI, a–d, blue; right). Scale bars 500 µm in a–d. 
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Figure 2: Detection of miRNAs 
expressed at various amounts in the 
mouse brain tissues fixed with 
formaldehyde–EDC. (a) Low–power 
fluorescent micrograph images of the 
medium expressed miR–30b (a, Cy3; 
orange, left) in the cerebellum, 
cerebral cortex and hippocampus. 
Low–power magnification micrograph 
images of miR–129–3p expression in 
a single cell layer (b, Cy3, left, 
arrows). (c) Fluorescent micrograph 
images show miR–145–5p expression 
in the cerebral cortex, without staining 
in the superior colliclus (c, Cy3, left, 
arrows), and the low abundant miR–
28–3p shows expression in the 
cerebellum. Nuclei were stained 
(DAPI, blue; right, a–d). Scale bars 
1.0 mm in a, c–d; 200 µm in b. 
 
To determine if EDC–based ISH signal intensity is pH–dependent, we examined ISH 
signal for miR–129–3p in tissues treated with formaldehyde and then adjusted the pH of the 
EDC solution and observed a notably weaker signal for EDC solution at pH 5.5 and 6.0 (Fig. 3a, 
b), compared to EDC solution adjusted to pH 6.5 and above (Fig. 3, c–h). The most intense 
miRNA ISH signal occurred using EDC solution at pH 7.0–8.5 (Fig. 3, d-g) and the signal 
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became moderately less intense at pH 9.0 (Fig. 3h). To minimize the degree of pH drift and 
reduced crosslinking yields, we recommend working with EDC solution at pH 8.0 (Fig. 3f).  
Figure 3: miRNA ISH signal 
intensity is EDC fixation pH 
dependent. (a) Low–power 
fluorescent micrograph 
images of mouse brain tissues 
fixed with formaldehyde and 
then EDC solution at pH 5.5 
(a) and 6.0 (b) show reduced 
signal for miR–129–3p (a–c, 
Cy3; orange), compared to 
ISH signal for miR–129–3p in 
tissues fixed with EDC 
solution at pH 6.5 to 9.0 (d–h, 
Cy3; orange). Scale bars 500 
µm in a–h. 
 
 
We also evaluated an alternative method for permanently crosslinking the phosphate at 
the miRNA 5’ end using the fixation reagent cyanogen bromide (BrCN), which also forms stable 
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phosphoamidate crosslinks by condensing phosphates to amino groups204. Using formaldehyde–
fixed tissues, we applied 0.5 M BrCN in 0.16 M N-morpholinoethanesulfonate (MES)–buffer 
(initial MES buffer pH adjusted to 7.5) for 1 h. Formaldehyde–BrCN fixed tissues showed robust 
signal for miR-129-3p (Fig. 4a), while tissues fixed with formaldehyde alone show almost no 
staining (Fig. 4b), and the signal intensity of formaldehyde–BrCN tissues moderately improved 
the signal compared to formaldehyde–EDC (Fig. 4a, c). BrCN fixation alone showed no signal 
(data not shown). We examined the ISH signal strength as the BrCN solution pH varied (Fig. 5 
a–h). At an initial MES buffer pH 5.5–9.0, we observed notably improved miRNA ISH signal 
for miR–129–3p (Fig. 5 a–h). We settled on using BrCN at pH 7.5 (Fig. 5e). We also examined 
the dose dependence of BrCN (Fig. 6a–h) and the brightest signal for miR–129–3p occurred at 
100 mM BrCN solution (Fig. 6c) diluted in 1 M MES solution (initial pH adjusted to 7.5). 
Advantages of the BrCN–formaldehyde fixation include faster reaction time, when compared to 
the 1-methylimidizole buffer for EDC, the MES buffer is more user friendly to handle and the 
MES buffer does not require handling under anhydrous conditions. However, BrCN is more 
toxic and needs to be handled with caution including proper management of cyanide waste.  
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Figure 4: Fixation with formaldehyde–BrCN 
enhances miRNA ISH detection in tissues. 
Fluorescent micrograph images of the mouse cerebral 
cortex and hippocampus show expression of miR-
129-3p (a–c, Cy3; orange) in tissue sections fixed 
with formaldehyde–BrCN fixation (a, Cy3; left), 
formaldehyde fixation (b, Cy3; left), and 
formaldehyde–EDC fixation (c, Cy3; left). Scale bars 
1 mm in a-c. 
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Figure 5: miRNA ISH signal 
strength for formaldehyde–
BrCN tissue fixation is 
dependent on the BrCN 
solution pH. (a) Low–power 
fluorescent micrograph images 
of tissue sections of the mouse 
hippocampus and cerebral cortex 
from tissues fixed with 
formaldehyde–BrCN in MES 
buffer show expression of miR-
129-3p (a–h, Cy3; orange). 
Images for miR–129–3p in 
tissues fixed with formaldehyde 
and subsequent BrCN in MES 
buffer adjusted to pH of pH 5.5–
9.0 (a-g, Cy3; orange) with 
intense signal strength at pH 5.5, 
6.0, 7.5, and 8.5 (a-b, e, g; Cy3; 
orange). Scale bars 1.0 mm in a–
h. 
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Figure 6: miRNA ISH signal strength for formaldehyde–BrCN tissue fixation is dose 
dependent. (a) Low–power fluorescent micrograph images of tissue sections of the mouse 
cerebellum from tissues fixed with formaldehyde–BrCN in MES buffer show expression of miR-
129-3p (a-h, left, Cy3; orange). Images of tissues fixed with formaldehyde and subsequent BrCN 
at concentration of 10 mM to 500 mM show robust detection (b-e, left, Cy3; orange) with intense 
signal strength at 100 mM BrCN (c, rightCy3; orange). Nuclei were stained (DAPI, blue; right, 
a–h). Scale bars 1.0 mm in a–h. 
 
To determine if applying the EDC and BrCN reagents in series results in results that are 
greater than either reagent alone. We tested tissues fixed with formaldehyde–EDC–BrCN and for 
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miR–129–3p the ISH signal was notably more intense than all other combinations (Fig. 7 a–c). 
These improvements may be due to synergistic mechanisms of action of the EDC and BrCN. In 
the presence of an N-morpholinoehanesulfonate (MES)–buffer, BrCN forms the condensed 
products considerably faster (1–3 min) than compared to the reaction rate of EDC in imidzole 
buffer (3–20 h)204. The rates of reactions suggest the mechanism of EDC and BrCN differ. The 
reaction efficiency for each reagent may depend on reacting groups or the adjacent nucleobases, 
suggesting a combination of formaldehyde–EDC–BrCN provides a wider coverage for miRNA 
varying in sequence, possibly improving the crosslinking efficiency for a diverse set of miRNAs. 
Figure 7: Fixation of with formaldehyde–EDC– BrCN 
improves microRNA detection in mammalian tissues. 
Fluorescent micrograph images of the mouse brain show 
expression of miR-129–3p (a–c, Cy3; orange) in tissue 
sections fixed with formaldehyde alone (a, Cy3; orange), 
formaldehyde–EDC solution diluted in 1–methylimidazole 
buffer at pH 7.5 (c, Cy3; orange) and formaldehyde–EDC–
BrCN (c, Cy3; orange). Scale bars 200 µm in a–c.d 
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Application of miRNA ISH in other tissues 
To broaden this method to other tissues, we conducted ISH in other tissues including the eye and 
liver. We fixed samples with formaldehyde–EDC–BrCN and then detected the miRNA using a 
series of enzymatic reactions with the product being a colorimetric precipitate of 5–bromo–4–
chloro–3–indolyl phosphate (BCIP) and nitro blue tetrazolium (NBT). In the mouse eye, we 
were able to identify cell layer–specific staining for multiple miRNAs using this technique. 
While miR–124 (Fig. 8a–b) showed wide expression throughout the retina, let–7a expression 
displayed a more restricted expression pattern in ganglion cells, photoreceptor segments, and 
cells comprising the inner nuclear layer (Fig. 8c–d). In the mouse liver, we detected miR–122 
and miR–26a (Fig. 8e–f) in hepatocytes and not the endothelium. In order to adapt this method to 
other samples or tissues, supplement existing ISH protocol by applying the formaldehyde–EDC 
or formaldehyde–BrCN fixation, or both combined. 
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Figure 8: Detection of miRNAs in mouse eye 
and liver using alkaline phosphatase 
NBT/BCIP detection system. Low–power 
light microscopy images show staining of 
miR-124 in the mouse retina (a–d; Nitro blue 
tetrazolium chloride/5-Bromo–4-chloro–3–
indolyl phosphate (NBT/BCIP); blue) and 
higher power images shown in b demonstrate 
staining in several layers of the retina (b, blue; 
retinal layers represented by; retinal pigment 
epithelium, RPE; photoreceptor outer and 
inner segment, OS/IS; outer nuclear layer, 
ONL; outer plexiform layer, OPL; inner 
nuclear layer, INL; inner plexiform layer, IPL; 
ganglion cell layer, GCL). (c–d) Low–power 
micrographs show specific staining of let–7a in 
the inner nuclear layer of the retina (c), and higher magnification images shown in d. Light 
microscopy micrographs show specific detection of miR–122 and miR–26a in hepatocytes 
using a pigment detection (e–f, NBT/BCIP; blue). Nuclei were stained (DAPI, blue; left, b, d, 
e, f). Scale bars 2.0 mm in e–f. 
Automation of miRNA ISH protocol 
To reduce the variability of the miRNA ISH procedure and to simultaneously process multiple 
samples in higher throughput, we automated the protocol on two mechanized platforms. First, we 
adapted the formaldehyde–EDC fixation procedure to the Ventana Molecular Discovery System, 
Discovery XT immunohistochemisty and in situ hybridization automated stainer. The tissue 
sections were processed on the Discovery XT, which automated the formaldehyde–EDC 
88
 
  
  
fixation, probe hybridization, subsequent stringency washes and antibody staining, after which 
we manually applied a tyramide Cy3 detection system to obtain a positive signal for miR–124 
(Fig. 9a–b). We also used a second high–throughput platform described by the Allen Institute for 
Brain Science145. Mouse brain tissue was manually fixed with formaldehyde–EDC–BrCN, then 
samples transferred to an automated platform developed on a Tecan liquid handling robot. The 
robot performed probe hybridization at 20ºC below the Tm, a series stringency washes and 
finally miRNA expression was detected with NBT/BCIP non-isotopic detection system. The 
slides were removed from the robot, cover–slipped and then images digitized and scanned on an 
automated high–throughput Aperio ScanScope(r) XT scanner. The miRNA ISH signal showed 
strong signal for miR–124 and let–7a (Fig. 9c–f), and were substantially more robust when 
compared to samples fixed with formaldehyde alone (data not shown).  
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Figure 9: Automation of 
formaldehyde–EDC miRNA ISH 
protocol. Fluorescent micrograph 
images of the mouse cerebellum 
show expression of miR-124 (a–b, 
Cy3; orange) in tissue sections fixed 
with formaldehyde–EDC fixation 
(a, top, b, left Cy3;orange) after 
processing on a Ventana Discovery 
XT Automated Stainer. Light 
microcopy images show expression 
of miR–124 and let–7a at high and 
low power (c, d; alkaline 
phophatase NBT/BCIP; blue) and 
let–7a at high and lower 
magnification (e, f alkaline phophatase NBT/BCIP; blue). 
 
  
In summary, the formaldehyde–EDC or formaldehyde–BrCN fixation prevents miRNA 
diffusion by generating a stable cross-link between the 5’ miRNA phosphate and amino acid side 
chains, which substantially improves miRNA detection in tissues, most notably enabling 
detection of medium and lower abundant miRNAs. The advantage of formaldehyde–EDC or 
formaldehyde–BrCN, or formaldehyde–EDC–BrCN–based miRNA ISH is that fixation on the 5’ 
end provides the probe with greater access to the miRNA target and less interference with probe 
hybridization, which facilitates detection. We show this method is useful in the mouse brain, 
liver, and eye tissue sections and that two detection systems are compatible with our approach. 
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Finally, automating the protocol allows 
the way for reliable high-throughput 
studies to map several hundred miRNAs 
in the brain and other organs, or for 
screening large tissue sets to associate 
miRNAs and disease. 
Procedure 
The protocol presented below has been 
optimized for the fresh-frozen mouse 
brain sections and a flow diagram 
outlining the procedure is presented (Fig. 
10).  
 
Designing and digoxigenin (DIG’) 
labeling of probes 
To design LNA–substituted DNA probes, 
obtain the miRNA sequence89, then 
reverse complement the sequence, and 
replace approximately one third of the 
DNA nucleobases with an LNA base142. 
To decrease the probability that an oligonucleotide probe will from a hairpin with itself due 
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secondary structure, avoid substituting for LNA at positions of predicted secondary structure. A 
useful tool for predicting oligonucleotide secondary structure is freely available using mfold 
software (http://www.idtdna.com/Scitools/Applications/mFold/)183. Probes can be custom 
ordered from several commercial vendors using a 0.4 µM scale synthesis. The oligonucleotide 
probe must include a 3’ amino modifier linker to enable digoxigenin conjugation. 
We determine the LNA probe concentration by measuring the UV absorbance at 260 nm 
using an average absorbance coefficient of 11,000 M-1cm-1 per nucleotide. To conjugate the 
digoxigenin-label to the 3’ end of the LNA probe, we use 30 nmol of the LNA that was dried in a 
concentrator and re-dissolve in 50 µl of 100 mM sodium carbonate buffer at pH 8.5. In a separate 
tube, we prepared 240 nmol of digoxigenin–3–O–methylcarbonyl–ε–aminocaproic acid–N–
hydroxysuccinimide ester (Roche) dissolved in 50 µl anhydrous DMF. Mix 50 µl LNA probe 
solution with 50 µl of digoxigenin–3–O–methylcarbonyl–ε–aminocaproic acid–N–
hydroxysuccinimide ester solution, then incubate the reaction for 16 h at 25ºC. The DIG-labeled 
probe is loaded on a 43 x 23 x 0.2 cm denaturing 18% PAGE gel (200 ml gel volume) with 8M 
urea, along with the unlabeled probe in an adjacent lane, then separate the products by 
electrophoresis for 6 h at 50 W. The product bands can be visualized by UV shadowing and the 
DIG–labeled probe shows reduced mobility compared to the starting material (Fig. 11a). The 
typical yields are 80% of DIG labeled product, which is then excised and eluted from the gel 
slice by adding 3 volumes (w/v) of 0.3 M NaCl, incubated overnight, then precipitate with 3 
volumes of ethanol and re-suspend in 100 µl water.  
 
Quality control for DIG labeling of probes 
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DIG–labeling should be verified using an alkaline–phosphatase–based formazan blue detection 
system. Apply 1 pmol, 100 fmol and 10 fmol of the DIG–labeled LNA product on a positively 
charged nylon membrane followed by incubation of the membrane with anti–DIG antibody 
fragment conjugated to peroxidase antibody. Subsequent treatment with NBT/BCIP solution 
typically produces formazan blue deposition. In our experience, the reaction is completed within 
10 min to 1 h, with the darkest staining for 1 pmol of LNA probe and less staining for lower 
amounts (Fig. 11b). Verification of LNA probe DIG labeling is a crucial quality control for ISH 
experiments. 
Designing ISH controls to assess specific miRNA staining  
To differentiate miRNA signal from non-specific background staining due to the detection 
system or mishybridization of the probe, several controls and optimized hybridization conditions 
are necessary. We adjust the hybridization temperature to be approximately 20ºC below the 
Figure 11: 3’ Labeling LNA probe with digoxigenin (DIG). 18% polyacrylamide gel after 
electrophoresis showing separation of 22–nt LNA probe targeting miR–129–3p labeled with 
DIG conjugated to the 3’ end (a, left, top 
band) and the un–reacted probe below (a, 
left, bottom band), the unlabeled LNA probe 
(a, right band). 3’ labeled LNA probe targeting 
miR–129–3p crosslinked to a H+ nylon 
membrane at 1 pmol, 100 fmol, and 10 fmol 
after reaction with NBT/BCIP substrate (b). 
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experimentally determined melting temperature (TM)147. 
To rule out miRNA ISH signal derived from cross–hybridization, we conduct ISH 
experiments using serial sections. For the first tissue section, apply a probe that targets the 
mature miRNA. For the next serial section, use a probe that binds the opposing fragment in the 
miRNA duplex, known as the miRNA* sequence, or a probe that targets a cluster member 
miRNA, which exist in a polycistronic miRNA transcript. As for negative controls, a probe 
targeting a miRNA not expressed in the tissue of interest is ideal.  
For maximum signal from miRNA ISH using the formaldehyde–EDC or formaldehyde–
BrCN fixation method, it is imperative to refrain from using phosphate and carbonate–containing 
buffers prior to EDC fixation, as these buffers inhibit EDC or BrCN mediated condensation of 
the miRNA 5’ phosphate and the amino group present in the tissue protein matrix. If phosphate–
containing buffers are necessary, we recommend adequate removal of phosphate buffers by 
increasing the number of washes with imidizole buffer prior to EDC fixation or washes with 
MES buffer before BrCN application.  
After fixation, a number of signal detection systems can be used to amplify or detect the 
miRNA–LNA signal. Our results were obtained using a tyramide signal amplification (TSA)–
CY3 detection system that relies on an anti-DIG antibody conjugated to a peroxoidase enzyme. 
In our experience, the anti-DIG antibody activity is variable depending on the batch purchased 
from the vendor. For each lot of anti–DIG antibody, we evaluated the minimum concentration of 
antibody needed. For example, in these experiments we used the antibody using dilutions of 
1:1000 and 1:500 to detect miR–129–3p in the mouse brain (Fig. 12a–b), however at antibody 
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dilutions of 1:250 and 1:100 the signal is not detected (Fig. 12c–d). We observed notable 
increases in signal intensity with negligible background staining (data not shown). These data 
suggest that antibody dilutions for detection are critical for optimizing miRNA ISH and in our 
experience. New batches of antibody require experiments to verify the optimal concentration. 
 
Figure 12: Dose curve for antibody 
concentration. (a) Low–power fluorescent 
micrograph images from the mouse brain 
showing miRNA ISH by applying dilutions 
of the Peroxidase (POD) detection antibody 
(a–d). Antibody diluted at 1:1000 and 1:500 
show no signal for miR–129–3p (a–b, Cy3; 
orange) and ISH using antibody dilutions of 
1:250 and 1:100 show staining (c–d, Cy3; 
orange). Scale bars 500 µm in a-d. 
 
95
 
  
  
Methods and Materials 
REAGENTS 
All reagents use double distilled water (ddH2O). 
Acetylation buffer CRITICAL STEP 5 min before use 
873 µl of Triethanolamine ≥98% (Sigma cat. no. T1377–500ML). 
375 µl Acetic anhydride ≥97.0% (Fisher cat. no. A10–500). 
Fill to 75 ml with ddH2O. 
Alkaline phosphatase enzyme (Roche, Cat no 11093274910) 
Antibody–blocking solution  
0.1 g Blocking powder (heat gently in to solution)   
1.0 ml heat inactivated goat serum (Sigma, cat. no. G9023–10ML) 
20 µl Tween 20 (Sigma, cat. no. P1379-500 ml) 
19 ml 1X TBS 
Anti–Digoxigen–POD  
Fab fragments 150 U/ml (Roche, cat. no. 11207733910)  
Dilute Fab fragments in antibody blocking solution (1:100, however for 
each batch of antibody determine optimal concentration) 
Blocking buffer (used for DIG labeling quality control) 
1% Blocking reagent (Roche cat no. 11096176001) 
dilute in maleic acid buffer 
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Cyanogen bromide (BrCN) solution, 1 ml CRITICAL STEP 
10 µl of 5 M BrCN in acetonitrile (Sigma cat. no. 261610) 
CRITICAL STEP Keep BrCN reagent under argon gas.  
Dilute BrCN in 990 µl of MES buffer. 
BrCN solution reacts quickly. Make BrCN solution immediately 
before use and discard unused solution. Discard BrCN reagent in a 
hazardous waste container. 
Cryomold Standard (Sakura, cat. No. 4557) 
Vectashield mounting medium for fluorescence with DAPI (Vector Laboratories, Inc., cat no H-
1200) 
DIG-labeled LNA probe stock  
EDC buffer CRITICAL STEP 
1.5 ml of 1–methylimidazole (Sigma Cat. No. 336092–
1L). Keep under argon gas and protect from humidity. 
15 ml of 3 M NaCl 
100 ml dH2O 
Adjust pH to 8.0 with HCl. 
Fill to 150 mL with ddH2O. 
EDC solution CRITICAL STEP CAUTION 
1 ml of 3 M NaCl 
100 µl of 1-methylimidazole ≥99% 
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176 µl of EDC ≥97.0% (Sigma cat. no. 39391) Keep under argon gas 
and protect from humidity. 
Adjust the pH to 8.0 with HCl. 
Fill to 10 ml with ddH2O. 
Formamide wash buffer  
50% Formamide (99% GC) 
1X SSC 
0.1% Tween 20  
0.2% Glycine diluted in 1X TBS 
Hybridization solution 
In a siliconized tube, add 1 µl of 4 µM LNA probe stock diluted in 100 
µl of hybridization buffer and mix. 
(Approximately 1 µl of 4 µM LNA probe per tissue section. 
Determining the optimal probe concentration is highly recommended.) 
3% Hydrogen peroxide solution 
5 ml of 30% Hydrogen Peroxide (Fisher, cat. no. H325–100) 
45 ml of 1X TBS 
0.1% Tween 20 (Sigma, cat. no. P1379-500 ml) 
Individual Indirect Tyramide Reagent (PerkinElmer, cat. no. SAT700)  
Dilute biotinyl tyramide reagent 1:50 in amplification diluent. 
MES buffer, pH 7.5, for 30 ml 
5.86 g of 2-(N-morphoino)ethanesufonic acid (MES) (Sigma cat. no. 
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M3671–250G) 
20 ml of ddH2O 
600 µl of 1 M MgCl2 
1.5 ml of 3 M NaCl 
Adjust pH to 7.5 with NaOH. 
Adjust volume to 30 ml with ddH2O. 
Make immediately before use.  
Discard unused solution. 
4% Paraformaldehyde (PFA) in 1X TBS (16% Paraformaldehyde; Electron Microscopy Suites 
Cat. No. 15710) CAUTION  
Pre-hybridization solution (store at –20ºC for up to 1 week) 
10 ml Formamide 99% GC (Sigma cat. no. F7503–1L) 
5.0 ml 20X SSC 
2.0 ml 50X Denhardt’s Reagent (Applichem cat. no. A3792,0050)  
250 µl Baker’s yeast tRNA 20 mg/ml (Sigma cat. no. 
R8759–2KU), dilute stock powder with ddH2O. 
1.0 ml Salmon sperm DNA 10 mg/ml (Applichem, cat. no. 
A2159,0001), ), dilute stock powder with ddH2O. 
0.4 g Blocking reagent (Roche cat. no. 11096176001) 
500 µl Chaps 100mM (Sigma cat. no. 198899-1ML-F) 
100 µl Tween 20 (Sigma, cat. no. p1379-500 ml) 
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1150 µl dH2O  
Proteinase K (20 µg/ml) stock solution (Roche cat. no. 03115879001), diluted in water 
NBT/BCIP stock solution (Roche, cat. no. 11 681 451 001) 
Dilute NBT/BCIP stock in  
0.1 M Tris–HCl  
0.1 M NaCl 
Adjusted pH to 9.5. 
Nailpolish, clear   
 Obtain from local store 
Neutravidin Alkaline Phosphatase conjugated 2 mg (Fisher Scientific, cat. no. PI–31002)  
Neutravidin Alkaline Phosphatase conjugated blocking solution:  
Dissolve 0.1 g Blocking powder in Maleate wash buffer.  
Dilute Neutravidin 1:200 in blocking solution  
Nitro blue tetrazolium chloride/5-Bromo–4-chloro–3–indolyl phosphate (NBT/BCIP Stock 
solution; Roche, cat. no. 11681451001) 
Maleate wash buffer  
10.45 g Maleic Acid 
150 mM NaCl 
0.05% Tween 20 (Sigma, cat. no. P1379-500 ml) 
Maleic acid buffer 
0.1 M Maleic Acid 
0.15 M NaCl 
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Sigmacote (Sigma, cat. no. SL2–100mL) 
Sodium carbonate  (100 mM), pH adjusted to 8.5 
20x SSC  
175.3 g NaCl 
88.2 g Sodium citrate 
Adjust pH to 7.0 with NaOH. 
Adjust volume to 1L with ddH2O. 
0.2X SSC Dilute 20X SSC to 0.2X SSC in ddH2O. 
0.5 M Sucrose in 1X TBS 
TBS–Tween wash 
1X TBS  
0.1% Tween 20 (Sigma, cat. no. P1379-500 ml) 
 
Tissue Tek O.C.T. compound (Sakura, cat. No. 4583) 
TNT Buffer 
10 mM Tris-HCl (pH 7.2) 
150 mM NaCl 
0.05% Tween 20 (Sigma, cat. no. P1379-500 ml) 
TMN buffer (Prepare fresh before use) 
100 mM Tris Base (pH 10.0) 
500 mM NaCl 
2 mM Tetramisole hydrochloride (Sigma, cat. no. T1512–10g) 
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0.05% Tween 20 
Adjust pH to 9.5 with 5 M NaOH 
1X Tris Buffered Saline (TBS) pH 7.4 
10 ml of 1 M Tris-HCl (pH 7.4) 
20 ml of 5 M NaCl  
970 ml dH2O 
TSA–Plus Cyanine 3 System (PerkinElmer, cat. no. NEL744B001KT) working solution 
Dilute cyanine 3 amplification reagent 1:50 in 1X amplification diluent. 
Sodium Tris EDTA solution 
500 mM NaCl 
10 mM Tris HCl (pH 8.0) 
5 mM EDTA 
0.05% Tween 20 
Vectashield DAPI + Mounting Media (Vector Laboratories, cat. no. H-1200) 
REAGENT SETUP 
TMN buffer, EDC buffer, EDC solution, MES buffer, and BrCN solution should be prepared 
fresh immediately prior to use. EDC stored at –20°C. BrCN in acetonitrile stored at 4ºC. 
CAUTION. CRITICAL STEP. EDC or BrCN reagent is disabled by humidity and must be kept 
under inert conditions by flushing the syringe with argon gas prior to withdrawing the EDC. 
CRITICAL STEP. 
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Equipment 
Cryomold 
Coplin jars (Electron Microcopy Sciences, cat. no. 70312–20) 
Cryostat (Leica CM3050 S) 
Cy3 filter (Chroma, cat. no. 49004 ET) 
DAPI filter (Olympus, cat. no. U–MWU2)  
27 1/2 gauge sterile needle 
LifterSlips (Fisher, cat. no. 22–035–804) 
InSlide Out Hybridization Oven (Boekel, cat. no. 241000) 
Olympus BX51 microscope with DP70 camera 
Olympus DP controller software 
Olympus MicroSuite Five imaging software (http://www.olympusamerica.com) 
Positively charged nylon transfer membrane (GE Healthcare, cat no RNP303B) 
1.5 ml siliconized tubes (Bio Plas Inc, cat no 4165SL) 
Stainless Steel Humidified Slide Rack (Aluminum tray and insert; Boekel, cat. no. C2403973, 
and C2403754 respectively) 
1 ml sterile syringe 
Stratalinker 
SuperFrost Plus glass slides (Thermo Fisher Scientific, cat no 1255015) 
Super PAP pen (Beckman Coulter cat. no. IM3580) 
EQUIPMENT SETUP 
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Humidified Chamber 
1 Humidified slide racks should be soaked with clean water prior to EDC or BrCN fixation, 
hybridization, antibody blocking steps, and detection. 
Argon gas for EDC withdrawal.  
Argon gas is used to layer the reagent with an inert gas such as argon. Store to exclude 
humidity as humidity leads to inactivation of the reagent.  
Siliconize coverslips (LifterSlips) for hybridization 
A Siliconize the LifterSlips by adding one drop (approximately 50 µl) of Sigmacote.   
B Spread the Sigmacote evenly over the coverslip using a tissue or Kimwipe. 
C Rinse with 5 ml ddH2O then rinse with 5 ml 100% ethanol. 
 
DIG labeling of the LNA probe  
1 To 3’–digoxigenin–label the LNA probe, dry an aliquot of 30 nmol of the LNA probe in 
an Eppendorf tube using an Eppendorf concentrator. 
2 Redissolve the LNA probe in 50 µl of 100 mM sodium carbonate buffer at pH 8.5.  
3 In a separate tube, dissolve 240 nmol of digoxigenin-3–o–methylcarbonyl–ε–
aminocaproic acid–N–hydroxysuccinimide ester (Roche) in 50 µl anhydrous DMF.  
4 Mix solution prepared in step 2 with solution from step 3, then incubate the mixture for 
16 h at 25ºC. 
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5 Separate the DIG–labeled probes on a 43 x 23 x 0.2 cm denaturing 18% PAGE gel (200 
ml gel volume) for 6 h at 50 W in 1X TBE running buffer. The DIG labeled probe will 
show reduced mobility compared to the starting material (Fig. 11a).  
6 Visualize the product bands by UV shadowing, excise the upper band (Fig. 11a) and 
place the gel slice in a 1.5 ml siliconized tube. The expected yield of a labeling reaction is 
80%.  
7 To elute the DIG-labeled LNA from the gel slice and add 3 volumes (w/v) of 0.3 M 
NaCl, incubate samples at 4ºC for 16 hr while rotating at 300 rpm. Then ethanol 
precipitate the solution by adding 3 volumes (v/v) of 100% cold ethanol. Incubate for 1 h 
at –20ºC, centrifuge at 12,000g, remove the supernatant and dry the pellet, then resuspend 
in 100 µl of ddH2O. 
Quality controlling DIG–labeled probes 
8 To examine the efficiency of DIG–labeling, obtain a positively charged nylon transfer 
membrane and apply 1 pmol, 100 fmol and 10 fmol of DIG–labeled probe on to the 
membrane. Allow the membrane to dry for 10 min at 25ºC. 
9 Expose the nylon membrane to UV crosslinking at 254 nm using 1200 J (UV stratalinker 
2400, Stratagene).  
10 Equilibrate the membrane by applying 1 ml of maleic acid buffer per 15 spotted DIG–
labeled probes, for 10 seconds at 25ºC.   
11 Remove the maleic acid buffer, and apply 1 ml of blocking buffer for 30 min at 25ºC.  
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12 Discard the blocking buffer and incubate the membrane with 1 ml of anti–DIG–AP Fab 
fragments (1:10,000 dilution in antibody blocking buffer) conjugated to alkaline 
phosphatase enzyme for 30 min at 25ºC.  
13 Wash twice with maleate buffer for 15 min each at 25ºC.  
14 Apply 20 µl of NBT/BCIP stock solution (Roche, cat no 11681451001) per 980 µl of 0.1 
M Tris–HCl in 0.1 M NaCl, pH adjusted to 9.5. Apply 1 ml of this solution to the 
membrane and incubate for 10 min to 1 hr at 25ºC.  
15 Formazan Blue deposition is observed between 10 min to 1 h for all amounts spotted and 
a positive reaction is shown (Fig. 11b). 
Tissue preparation and processing 
16 Sedate and anesthetize animals in accordance with NIH Animal Welfare guidelines using 
ketamine and xylazine cocktail. Perfuse animal with 50 ml of 1X TBS at pH 7.4, 
followed by 40 ml of 4% paraformaldehyde (PFA) pepared in 1X TBS.  
17 Dissect organs and tissues of interest.  
18 Immediately immerse the sample in 30 ml of 4% PFA in 1X TBS in a 50 ml Falcon tube 
for 16 h at 4ºC. 
19 Transfer the specimen to a new 50 ml falcon tube containing 30 ml of 0.5 M sucrose 
diluted in 1X TBS and incubate the sample for 48 h at 4ºC.  
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Mounting Tissue Sections 
20 Mount tissues in OCT Compound in a Cryomold, and position the immersed sample as 
desired. Then immediately freeze in dry–ice–ethanol bath. Liquid nitrogen is not a 
recommended method for flash freezing samples.  
21 This step can be performed by using option A or option B, depending on the timing of the 
sectioning. PAUSE POINT 
A. Immediately section the tissues at 5–40 µm using a cryostat or microtome, then 
mount sections on SuperFrost Plus glass slides. 
B. Unprocessed specimen or mounted slides can be stored for up to four months at        
–80ºC. 
Proteinase K treatment 
22 Thaw and air–dry tissue mounted slides for 1 h at 25ºC. 
23 Draw a hydrophobic barrier encircling the tissue section using a Super PAP Pen, PAP 
Pen, or nail polish, then allow barrier to dry before continuing. 
24 Incubate the tissue-mounted slides in a coplin jar containing 75 ml of 1X TBS with 37.5 
µl of 20 µg/ml proteinase K stock solution for 20 min at 25ºC. Avoid using phosphate–
containing buffers, such as phosphate buffered saline (PBS), prior to the EDC or BrCN 
fixation step, as this interferes with EDC and BrCN fixation. 
Formaldehyde tissue fixation 
25 Wash slides twice in 75 ml of 1X TBS for 5 min at 25ºC.  
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26 Fix tissue sections in 40 ml of 4% formaldehyde diluted in 1X TBS for 10 min at 25ºC. 
CRITICAL STEP Prepare fresh formaldehyde for each experiment. 
27 Wash the slides in 0.2% (w/v) glycine diluted in 1X TBS for 5 min at 25ºC. 
28 Wash twice with 1X TBS for 5 min at 25ºC. 
Option A, Fixation of tissues with EDC  
29 Prepare 150 ml of EDC buffer as described in Reagents section and prepare a humidified 
chamber. 
30 CRITICIAL STEP Avoid using phosphate buffered saline before fixation. Using buffers 
containing phosphates interferes with EDC and BrCN fixation and should not be used. 
31 This step can be performed by using fixation option A (EDC) or option B (BrCN), 
depending on preference for fixative.  
32 Incubate slides in 75 ml of freshly prepared EDC buffer for 10 min at 25ºC. CRITICAL 
STEP. Check pH of EDC buffer (pH 8.0) before use. 
33  Repeat wash step and prepare EDC solution during second incubation. 
 CRITICAL STEP Store EDC at –20ºC. Handle the reagent under anhydrous conditions 
by protecting the stock EDC reagent with a layer of argon. EDC is liable in aqueous 
solutions therefore apply EDC solution to the slides quickly. Aqueous solutions 
containing EDC and/or 1–methylimidazole cannot be stored and unused EDC solution 
should be discarded. CAUTION EDC should be handled according to the MSDS 
guidelines. 
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34 Check pH of EDC solution (pH 8.0) before use. EDC reactivity is dependant on pH. 
CRITICAL STEP 
35 In a humidified chamber, place slides face up in a slide rack. Remove EDC wash buffer 
by tilting the slide and decanting the solution. 
36 Add 500 µl of EDC solution to each slide and incubate samples for at least 1 h (up to 2 h) 
at 25ºC in a sealed humidified chamber. 
37 Decant EDC solution into a hazardous waste container. EDC reagent is hazardous. See 
MSDS for details in handing and disposing of the reagent. CAUTION 
Option B, Tissue fixation with BrCN 
38 In a humidified chamber, place slides face up in a slide rack. Remove wash buffers by 
tilting the slide and decanting the solution. 
39 Apply 1 ml of freshly prepared MES buffer to the slides for 10 min at 25ºC. Check pH of 
MES buffer (pH 7.5) before use. Note, checking the initial pH of the MES buffer is 
crucial as fluctuations in pH reduce signal intensity. CRITICAL STEP 
40  Repeat wash step and prepare BrCN solution immediately following the second 
incubation. 
 CRITICAL STEP Store BrCN at 4ºC. Handle the reagent under anhydrous conditions by 
protecting the stock BrCN solution with a layer of argon. After adding BrCN to the MES 
buffer, apply the BrCN solution to the slides quickly. Aqueous solutions containing 
BrCN cannot be stored. Discard the remaining reagent. CAUTION BrCN should be 
handled according to the MSDS guidelines. 
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41 Immediately add BrCN solution. CRITICAL STEP BrCN in MES buffer reacts rapidly, 
and applying the solution to the slides quickly is crucial. 
42 Add 1 ml of BrCN solution to each slide and incubate samples for 20 min to 1 h at 25ºC 
in a sealed humidified chamber. Repeat step 39. 
43 BrCN reagent is hazardous. Decant BrCN solution into a hazardous waste container. See 
MSDS for details in handing and disposing of the reagent. CAUTION 
For formaldehyde–EDC–BrCN fixation, follow steps 22–43. 
Wash steps after fixation 
44 For the remainder of the protocol, use either 1X TBS or phosphate buffer saline (PBS, pH 
7.4) to wash slides after fixation.  
45 Wash the slides with 75 ml of 0.2% (w/v) glycine diluted in 1X TBS for 5 min at 25ºC.  
46 Wash the samples twice with 75 ml of 1X TBS for 5 min at 25ºC.  
Acetylation for inactivation of enzymes in tissues  
47 Prepare fresh acetylation buffer immediately before use and mix vigorously by shaking. 
48 Incubate slides in 75 ml of acetylation buffer for 30 min at 25ºC. (OPTIONAL Place a 
small magnetic stir bar at the bottom of the coplin jar to continuously mix the solution 
during the incubation.) 
49 Rinse slides twice in 75 ml of 1X TBS for 5 min at 25ºC. 
 
Pre–hybridization and hybridization of probe and microRNA 
50 Place the slides with the tissue side up on a slide rack in a humidified chamber. 
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51 Add 500 µl of freshly prepared pre–hybridization solution to each slide within the 
hydrophobic barrier. Incubate slides in a sealed humidified chamber for 1–4 h at 25ºC. 
52 Remove pre–hybridization buffer by tilting the slide and decant the solution.  
Preparing the probe and Hybridization 
53 Select the desired probes and pre–heat hybridization oven to the appropriate 
hybridization temperature, approximately 20ºC below the TM.  
54 In a siliconized 1.5 ml tube, mix 100 µl of hybridization buffer, with 1 µl of 4 µM LNA 
probe directly into the buffer. For typical mouse brain sections we use 1 µl of 4 µM LNA 
probe per tissue section. 
55 Add 100 µl hybridization solution to each slide and gently place the coverslip (siliconized 
LifterSlips) over the tissue sections. Avoid forming bubbles below the coverslip. When 
testing more than one probe, handle the slides carefully to prevent cross contamination 
between probes. 
56 Incubate the slides in a sealed humidified chamber for 16 h at the hybridization 
temperature, typically which is 20ºC below the TM of the experimentally determined 
miRNA–LNA probe duplex.  
Post–hybridization stringency washes 
CRITICAL STEP When working with more than one probe, assign one Coplin jar for each 
probe. This will help prevent cross–contamination during the wash steps. 
57 Prepare a small container, (e.g. lid of a pipette tips box). Immerse the slides in 20 ml of 
5X SSC at 25ºC to remove the coverslip. 
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58 Wash the samples two times in a Coplin jar filled with 75 ml of 50% formamide–1X 
SSC–0.1% Tween 20 for 30 min at respective hybridization temperature.  
59 Wash the samples in 75 ml of 0.2X SSC for 15 min at 25 ºC. 
60 Rinse the samples in 75 ml of TBS–Tween Wash for 5 min at 25 ºC. 
Inactivation of endogenous peroxidase activity 
61 Incubate the slides in 75 ml of 3% hydrogen peroxide solution for 30 min at 25 ºC. 
CRITICAL STEP Hydrogen peroxide is used to block endogenous peroxidases before the 
Anti–Digoxigen–POD antibody is added and expired hydrogen peroxide can lead to high 
background levels. 
62 Wash the slides three times in 75 ml of TBS–Tween Wash for 5 min at 25 ºC.  
 
Anti–DIG detection and Peroxidase conjugation  
63 Place the slides horizontally, face up in a humidified slide rack and add 500 µl of 
antibody blocking solution to each slide within the hydrophobic barrier.  Incubate for 1 h 
at 25ºC.  
64 Remove antibody–blocking solution by tilting the slides and decant the solution.  
65 Dilute the Anti–Digoxigen–POD, FAB fragments in antibody blocking solution, and add 
500 µl to each slide within the hydrophobic barrier. Incubate for 1 h at 25ºC. 
66 Wash the slides as described below.  
67 This step can be performed by using option A or option B, depending on preference of 
the detection. For fluorescent detection use option A, for tissues not amenable to 
fluorescent detection, use option B.  
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A. Cy3 fluorescent detection system 
68 Wash the slides two times in 75 ml of TBS–Tween Wash for 15 min at 25 ºC. 
69 Place the slides with the tissue side face up in a humidified slide rack and add 200 µl of 
TSA Plus Cy3 System working solution onto to the sections for 10 min at 25ºC in the 
dark.  
70 Wash the slides three times in 75 ml of TBS–Tween Wash for 5 min at 25 ºC on a tilting 
rotator, proceed to step 78.  
 
B. Alkaline phosphatase detection system 
71 Wash the slides three times in 75 ml of TNT buffer for 5 min at 25 ºC.  
72 Place the slides face up in a humidified slide rack and add 250 µl of the Individual 
Indirect Tyramide Reagent kit working solution to each slide and incubate for 30 min at 
25ºC. 
73 Washed the slides three times in 75 ml of maleate wash buffer for 5 min at 25 ºC. 
74 Place the slides horizontally, face up in a humidified slide rack and apply a 1:200 dilution 
of NeutrAvidin–conjugated alkaline phosphatase in maleate buffer supplemented with 10 
mg/ml blocking reagent. Apply 500 µl to each slide for 40 min at 25ºC. 
75 Wash the slides two times in 75 ml of maleate buffer for 5 min at 25 ºC 
76 Wash the slides four times in 75 ml of TMN buffer for 5 min at 25 ºC 
77 Dilute 200 µl of NBT/BCIP stock solution in 10 ml TMN buffer. Place the slides face up 
in a humidified slide rack and add 250 µl of the solution to each slide for 30 min at 25ºC. 
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While incubating, protect the samples from light. Note: the time to form Formazan Blue 
deposits (blue color) may vary between samples. Typically the reaction finishes after 30 
min.  
78 Immerse the slides two times in 75 ml of water upon completion of the reaction for 20 
sec at 25ºC.  
79 Wash the slides three times in 75 ml of Sodium Tris EDTA solution for 5 min at 25 ºC. 
80 Incubate slides in 80 ml of 4% formaldehyde solution for 10 min at 25 ºC.  
Mounting slides for microscopy 
81 Mount the slides using 2 drops of Vectashield mounting medium with DAPI. 
82 Carefully place a glass coverslip over the tissue sections. 
83 Seal glass coverslip by covering the edges the coverslip with clear nail polish and allow 
to air dry. 
84 Store samples and protect from light. 
Microscopy 
85 Images were captured on an Olympus BX50 microscope equipped with a DP70 camera 
and Olympus DP controller software. 
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TIMING 
Step 1–15, probe preparation: four to several days 
Steps 16–21, tissue preparation and processing, mounting tissue sections: 3 d 
Steps 22–24, proteinase K treatment 1 h 20 min 
Steps 25–28, tissue fixation formaldehyde: 40 min  
Steps 29–37, tissue fixation with EDC:1 h 20 min 
Steps 38–43, tissue fixation with BrCN: 30 min 
Steps 44–49, wash steps and acetylation: 40 min 
Step 50–51, prehybridization: 1–4 h  
Step 52–56, hybridization: 16 h 
Steps 57–60, post-hybridization stringency washes: 1 h 25 min 
Steps 61–62, inactivation of endogenous peroxidases: 33 min 
Steps 63–67, anti–DIG detection and Peroxidase conjugation: 1 h 
Steps 68–70, Cy3 fluorescent detection system: 55 min 
Steps 71–80, alkaline phosphatase detection system: 3 h 5 min 
Steps 81–83, mounting slides for microscopy: 5 min 
Steps 84, microscopy: 30 min to 2 h 
Troubleshooting 
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Here we present common pitfalls and areas of the miRNA ISH protocol that can be adjusted to 
optimize the signal. Troubleshooting suggestions are presented in the table below. 
 
Problem Possible reason Solution 
Tissue detaches 
from slide during 
ISH procedure. 
• Drying time insufficient. 
• Glass slides need special coating 
to hold on to tissue. 
• Increase drying time. 
• Use Superfrost Plus microscopy slides. 
• Apply substrates such as poly–L lysine 
or gelatin to coat microscopy slide.  
High background 
levels in the blank 
and test samples. 
• Endogenously expressed 
peroxidase enzymes present and 
were not adequately inhibited. 
• Concentration of the POD–
antibody is too high.  
• Tissue folds due to cryostat 
sectioning or ISH procedure and 
intense staining present in folded 
regions. 
• Increase acetylation time to inhibit 
endogenous peroxidase activity. 
• Check the activity of hydrogen 
peroxide as this reagent expires and 
loses its activity. Also increase 
hydrogen peroxide concentration. 
• Conduct a dose curve to determine the 
minimal amount of antibody necessary. 
• Optimize the time and concentration of 
TSA reagent. 
• For alkaline phosphatase NBT/BCIP 
detection, use and optimize the dose of 
levamisole to inhibit endogenous 
alkaline phosphatase activity. 
• To avoid folds in the tissue while using 
the cryostat, adjust the cryostat 
temperature to improve sectioning. 
• Tissue folding can solved by altering 
the coating of the glass slides  
No signal • miRNA is not expressed. 
• miRNA has been lost to 
diffusion prior to EDC fixation. 
• Insufficient DIG labeling of the 
probe. 
• Probe may have secondary 
structure and poorly hybridizes. 
• Melting temperature of the 
probe–miRNA is inaccurate. 
• EDC reagent may have been 
exposed to air, and unreactive. 
The shelf life of the EDC reagent 
is approximately 1 week after 
initial use. 
• The concentration of the 
antibody used for detection is too 
• Check miRNA cloning expression atlas 
to verify miRNA is expressed in the 
tissue of interest. 
• At temperatures above 37ºC, 
formaldehyde crosslinks are 
susceptible to reversion and subsequent 
miRNA diffusion, keeping samples 
stored at –80ºC greatly reduces the rate 
of crosslink reversion. 
• Verify the LNA probe is properly DIG 
labeled using a dot blot and the 
detection system described. 
• LNA probe may not be optimal for 
hybridization. Alter the positions of the 
LNA residues, which greatly enhance 
the ISH signal.  
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low. 
• Using solutions that contain 
phosphates or carbonate, such as 
PBS, inhibit EDC or BrCN 
crosslinking.  
• For miRNA with secondary structure, 
increasing the concentration of the 
probe, however adequate controls are 
necessary to rule out cross–
hybridization.  
• Conduct miRNA–LNA probe melting 
temperature experiment as described147. 
• Replace EDC reagent with a new vial. 
• Conduct a dose curve for antibody. 
• Substitute phosphate buffers for TBS 
buffers, as TBS does not interfere with 
EDC or BrCN fixation.  
LNA probe does 
not hybridize or 
DIG labeling is not 
verified. 
• DIG labeling inefficient. 
• Probe or miRNA contains 
significant. secondary structure 
and poorly hybridizes. 
• Repeated freezing and thawing of 
the probe damages the reagent.  
• Test probe using a dot blot and if test is 
negative, perform DIG’ labeling again. 
• Change the position of the LNA 
residue and avoid inserting at positions 
of predicted secondary structure.  
• Store LNA probe in aliquots to prevent 
repeated freezing and thawing.  
 
 
Conclusion 
We present the results of a typical miRNA ISH experiments in Fig. 1–5. For highly abundant 
miRNAs, we observed a moderate improvement of the miRNA ISH signal in tissues fixed with 
formaldehyde–EDC, when compared to the formaldehyde alone147. For the medium and low 
abundant miRNAs, using the formaldehyde–EDC fixation results in substantial improvement of 
the miRNA ISH signal (Fig. 1 a, c), when compared samples fixed with formaldehyde alone 
(Fig. 1 b, d). In our experience, a successful miRNA ISH experiments using formaldehyde–EDC 
fixed tissues depend on the adequate crosslinking of miRNA using EDC buffer at an optimized 
pH (Fig. 3a–h) and accurately determining the hybridization conditions147. In summary, this 
EDC–based miRNA ISH protocol provides a sensitive method for detecting miRNAs in the 
brain, eye, and liver, and should be easily adapted to other tissue types.  
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Supplementary tables and charts 
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Supplementary Table 1 List of miRNA, LNA probes and star sequence probes used in this study, as well as melting profiles of miRNA/LNA probe pair. 
 
 miRNA Sequence (5’ to 3’) LNA probe  Sequence (5’ to 3’) Transcription unit  Exiqon TM  (ºC)  Exp TM  (ºC) TM(up) –TM(down) (ºC)
  ISH confirmed 
 mmu-miR-21 UAGCUUAUCAGACUGAUGUUGA LNA-21 TC[A]AC[A]TC[A]GTCT[G]AT[A]AGC[T]A cluster-mmu-mir-21(1) 63.0 64.5 1.2 Y  
 mmu-let-7i UGAGGUAGUAGUUUGUGCUGUU LNA-let-7i AA[C]AG[C]AC[A]A[A]CT[A]CTA[C]C[T]CA cluster-mmu-mir-let-7i(1) 69.0 69.8 1.3 Y 
 mmu-miR-101a UACAGUACUGUGAUAACUGAA LNA-101a T[T]C[A]G[T]T[A]T[C]ACA[G]TA[C]TGTA cluster-mmu-mir-101a(1) 63.0 66.6 0.2 Y 
 mmu-miR-133a UUUGGUCCCCUUCAACCAGCUG LNA-133a C[A]GC[T]GG[T]TG[A]AGG[G]G[A]CCA[A]A cluster-mmu-mir-1-2(2), 75.0 79.8 0.9 Y 
     cluster-mmu-mir-1-1(2)  
 mmu-miR-1 UGGAAUGUAAAGAAGUAUGUAU LNA-1 ATA[C]ATA[C]T[T]C[T]TTA[C]AT[T]C[C]A cluster-mmu-mir-1-1(2), 61.1 77.6 1.9 Y 
     cluster-mmu-mir-1-2(2)  
 mmu-miR-124 UAAGGCACGCGGUGAAUGCC LNA-124 GGCA[T][T]C[A]CCGCGTGCC[T][T][A] cluster-mmu-mir-124-1(1), 75.0 67.5 1.1 Y 
     cluster-mmu-mir-124-2(1), 
     cluster-mmu-mir-124-3(1) 
 mmu-miR-126 UCGUACCGUGAGUAAUAAUGCG LNA-126 C[G]CG[T]ACC[A]A[A][A]GT[A]AT[A]ATG cluster-mmu-mir-126(1) 65.0 60.6 0.5 
 mmu-miR-126* UCGUACCGUGAGUAAUAAUGCG LNA-126* CGCA[T]TAT[T]AC[T]C[A]CGG[T][A]CGA cluster-mmu-mir-126(1) 66.0 71.4 1.0 Y 
 mmu-miR-136 ACUCCAUUUGUUUUGAUGAUGG LNA-136 CCATC[A][T]C[A]A[A][A]CA[A]ATGG[A]G[T] cluster-mmu-mir-127(13) 65.0 58.4 0.2 
 mmu-miR-434-5p GCUCGACUCAUGGUUUGAACCA LNA-434-5p TGG[T]TCA[A]ACCA[T]GA[G]TC[G]AGC cluster-mmu-mir-127(13) 68.0 63.9 0.9 Y 
 mmu-miR-370 GCCUGCUGGGGUGGAACCUGGU LNA-370 A[C]CA[G]GT[T]CC[A]CCCC[A]GC[A]GGC cluster-mmu-mir-127(13) 82.0 80.1 1.0 Y 
 mmu-miR-431 UGUCUUGCAGGCCGUCAUGCA LNA-431 TGCA[T]G[A]C[G]G[C]CTGCA[A]G[A]C[A] cluster-mmu-mir-127(13) 79.0 77.1 0.8 
 mmu-miR-673-3p UCCGGGGCUGAGUUCUGUGCACC LNA-673-3p GG[T]GC[A]CA[G]AA[C]TC[A]GC[C]CC[G]GA cluster-mmu-mir-127(13) 83.0 80.8 0.2 
 mmu-miR-341 UCGGUCGAUCGGUCGGUCGGU LNA-341 A[C]CG[A]CCGA[C]CG[A]TCG[A]CC[G]A cluster-mmu-mir-127(13) 79.0 73.7 0.6 
 mmu-miR-770-5p AGCACCACGUGUCUGGGCCACG LNA-770-5p CGTG[G]CC[C]AG[A]CACG[T]GG[T]G[C]T cluster-mmu-mir-127(13) 81.0 83.0 3.3 
 mmu-miR-770-3p CGUGGGCCUGACGUGGAGCUGG LNA-770-3p C[C]AG[C]TC[C]ACGT[C]AG[G]CC[C]ACG cluster-mmu-mir-127(13) 81.0 85.1 0.1  
 mmu-miR-128a/128b UCACAGUGAACCGGUCUCUUU LNA-128a A[A]AG[A]GA[C]CG[G]TTC[A]CT[G]TGA cluster-mmu-mir-128a(1), 69.0 70.4 0.8 Y 
     cluster-mmu-mir-128b(1) 
 mmu-miR-129 CUUUUUGCGGUCUGGGCUUGC LNA-129 G[C]A[A]GC[C]CA[G]AC[C]GC[A]AA[A]AG cluster-mmu-mir-129-1(2), 76.0 74.0 2.2 Y 
     cluster-mmu-mir-129-2(1) 
 mmu-miR-130a CAGUGCAAUGUUAAAAGGGCAU LNA-130a ATGCCC[T]TT[T]A[A]C[A]T[T]GCAC[T]G cluster-mmu-mir-130a(1) 65.0 64.5 0.1 Y 
 mmu-miR-132 UAACAGUCUACAGCCAUGGUCG LNA-132 C[G]ACCA[T]GG[C]TGT[A]GA[C]TGT[T]A cluster-mmu-mir-132(2) 71.0 65.9 7.6 Y 
 mmu-miR-379 UGGUAGACUAUGGAACGUAGG LNA-379 CCTACG[T]TCC[A]TAG[T]CT[A]CC[A] cluster-mmu-mir-134(33) 63.0 59.9 0.4  
 mmu-miR-300 UAUGCAAGGGCAAGCUCUCUUC LNA-300 GAA[G]AG[A]G[C]TTGC[C]CT[T]GCA[T]A cluster-mmu-mir-134(33) 71.0 75.8 1.3  
 mmu-miR-410 AAUAUAACACAGAUGGCCUGU LNA-410 ACAG[G]C[C]A[T]CTGT[G]T[T]A[T]A[T]T cluster-mmu-mir-134(33) 66.0 72.1 1.4 Y 
 mmu-miR-134 UGUGACUGGUUGACCAGAGGGG LNA-134 C[C]CC[T]CTGG[T]CA[A]CCAG[T]CA[C]A cluster-mmu-mir-134(33) 74.0 74.3 1.5 Y 
 mmu-miR-485 AGAGGCUGGCCGUGAUGAAUUC LNA-485 G[A]AT[T]CA[T]CA[C]GG[C]CA[G]CC[T]CT cluster-mmu-mir-134(33) 74.0 77.5 1.5 
 mmu-miR-382 GAAGUUGUUCGUGGUGGAUUCG LNA-382 CG[A]AT[C]CA[C]CACG[A]AC[A]AC[T]TC cluster-mmu-mir-134(33) 69.0 66.9 2.0 
 mmu-miR-381 UAUACAAGGGCAAGCUCUCUGU LNA-381 ACAGAG[A]GCTTG[C]C[C]TTGTA[T]A cluster-mmu-mir-134(33) 66.0 65.7 1.1 
 mmu-miR-411 UAGUAGACCGUAUAGCGUACG LNA-411 CGT[A]CGC[T]A[T]ACGGT[C]TA[C]TA cluster-mmu-mir-134(33) 64.0 66.5 1.4 
 mmu-miR-376b AUCAUAGAGGAACAUCCACUU LNA-376b AA[G]TGGA[T]G[T]T[C]CTC[T]A[T]G[A]T cluster-mmu-mir-134(33) 65.0 69.9 1.5 
 mmu-miR-32 UAUUGCACAUUACUAAGUUGCA LNA-32 TGCA[A]CT[T]A[G]TA[A]T[G]TGCAA[T]A cluster-mmu-mir-32(1) 61.0 56.3 0.8 
 mmu-miR-135a UAUGGCUUUUUAUUCCUAUGUGA LNA-135a T[C]AC[A]TAGGA[A]TA[A]A[A]A[G]CC[A]TA cluster-mmu-mir-135a-1(2), 62.0 55.3 0.3 
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     cluster-mmu-mir-135a-2(1) 
 mmu-let-7g UGAGGUAGUAGUUUGUACAGUU LNA-let-7g AA[C]TGTA[C]A[A]ACTAC[T]AC[C]T[C]A cluster-mmu-mir-135a-1(3) 64.0 62.4 1.4 Y  
 mmu-miR-135b UAUGGCUUUUCAUUCCUAUGUGA LNA-135b T[C]ACATA[G]G[A]ATG[A]AA[A]GC[C]A[T]A cluster-mmu-mir-135b(1) 68.0 62.5 0.9 Y 
 mmu-miR-139 UCUACAGUGCACGUGUCUCCAG LNA-139 CTG[G]AG[A]CA[C]GT[G]CA[C]TG[T]A[G]A cluster-mmu-mir-139(1) 76.0 75.9 1.2 
 mmu-miR-140 CAGUGGUUUUACCCUAUGGUAG LNA-140 C[T]ACC[A]T[A]GGGT[A]AA[A]CC[A]C[T]G cluster-mmu-mir-140(1) 67.0 65.1 1.1 Y 
 mmu-miR-140* UACCACAGGGUAGAACCACGG LNA-140* C[C]GT[G]GT[T]CTACC[C]TG[T]GGTA cluster-mmu-mir-140(1) 72.0   Y 
 mmu-miR-141 UAACACUGUCUGGUAAAGAUGG LNA-141 CCA[T]CT[T]TA[C]C[A]GA[C]AG[T]G[T]TA cluster-mmu-mir-141(2) 67.0 69.2 1.2 
 mmu-miR-200c UAAUACUGCCGGGUAAUGAUGGA LNA-200c TCC[A]TC[A]TTAC[C]CGGC[A]GTA[T]TA cluster-mmu-mir-141(2) 66.0 58.8 0.1 
 mmu-miR-142-5p CAUAAAGUAGAAAGCACUACU LNA-142-5p AGTAG[T]G[C]T[T]TCTACT[T]TA[T]G cluster-mmu-mir-142(1) 58.0 57.7 0.6 
 mmu-miR-142-3p UGUAGUGUUUCCUACUUUAUGGA LNA-142-3p T[C]CA[T]AA[A]GTAG[G]AA[A]C[A]CTACA cluster-mmu-mir-142(1) 63.0 59.7 0.8 
 mmu-miR-143 UGAGAUGAAGCACUGUAGCUCU LNA-143 [A]GAGC[T][A]C[A]G[T]GCT[T]C[A][T]C[T]C[A] cluster-mmu-mir-143(2) 73.0 78.5 0.3 Y 
 mmu-miR-145 GUCCAGUUUUCCCAGGAAUCCCU LNA-145 AGG[G]AT[T]CCT[G]GG[A]AA[A]CT[G]G[A]C cluster-mmu-mir-143(2) 76.0 74.7 0.8  
 mmu-miR-144 UACAGUAUAGAUGAUGUACU LNA-144 A[G]TACA[T]C[A]T[C]TA[T]A[C]TG[T]A cluster-mmu-mir-144(2) 59.0 65.7 1.4  
 mmu-miR-451 AAACCGUUACCAUUACUGAGUU LNA-451 A[A]C[T]CA[G]TA[A]TG[G]TA[A]CG[G]T[T]T cluster-mmu-mir-144(2) 63.0 62.9 1.7  
 mmu-miR-146a UGAGAACUGAAUUCCAUGGGUU LNA-146a AA[C]CC[A]T[G]GAAT[T]CA[G]TTCT[C]A cluster-mmu-mir-146a(1) 68.0 68.9 1.2  
 mmu-miR-152 UCAGUGCAUGACAGAACUUGG LNA-152 C[C]A[A]G[T]T[C]T[G]TCA[T]G[C]A[C]TGA cluster-mmu-mir-152(1) 73.0 76.0 1.2  
 mmu-miR-153 UUGCAUAGUCACAAAAGUGAUC LNA-153 G[A]TCAC[T]TT[T]GTGA[C]TA[T]G[C]AA cluster-mmu-mir-153(1) 73.0 61.0 1.1 Y 
 mmu-miR-15a UAGCAGCACAUAAUGGUUUGUG LNA-15a CACA[A]AC[C]AT[T]ATGTG[C]TG[C]TA cluster-mmu-mir-15a(4) 64.0 61.0 1.4 Y 
 mmu-miR-16 UAGCAGCACGUAAAUAUUGGCG LNA-16 CG[C]CAA[T]AT[T]T[A]CG[T]GC[T]G[C]TAT cluster-mmu-mir-15a(2), 65.0 71.2 1.1 Y 
    cluster-mmu-mir-15b(2)   
 mmu-miR-17 CAAAGUGCUUACAGUGCAGGUAG LNA-17 C[T]AC[C]TGC[A]CT[G]TA[A]GCA[C]TT[T]G cluster-mmu-mir-17(6) 69.0 70.1 1.1   
 mmu-miR-181b AACAUUCAUUGCUGUCGGUGGGU LNA-181b A[C]CC[A]CC[G]ACA[G]CA[A]TG[A]AT[G]TT cluster-mmu-mir-181a-2(2), 73.0 69.0 1.5  
     cluster-mmu-mir-181a-1(2)  
 mmu-miR-500 AAUGCACCUGGGCAAGGGUUCA LNA-500 TG[A]AC[C]CT[T]G[C]CC[A]GG[T]G[C]A[T]T cluster-mmu-mir-188(5) 80.0 87.3 0.2   
 mmu-miR-188-5p CAUCCCUUGCAUGGUGGAGGG LNA-188-5p CCCT[C]C[A]CC[A]TG[C]AAGGGA[T]G cluster-mmu-mir-188(5) 73.0 69.2 1.0   
 mmu-miR-191 CAACGGAAUCCCAAAAGCAGCUG LNA-191 CAG[C]TG[C]TT[T]TGG[G]AT[T]CCGT[T]G cluster-mmu-mir-191(2) 70.0 72.9 1.1 Y 
 mmu-miR-425 AAUGACACGAUCACUCCCGUUGA LNA-425 TC[A]ACG[G]GAG[T]G[A]TCGTGTCA[T]T cluster-mmu-mir-191(2) 70.0 64.3 1.0  
 mmu-miR-497 CAGCAGCACACUGUGGUUUGUA LNA-497 T[A]CA[A]AC[C]ACAGT[G]TG[C]TGCTG cluster-mmu-mir-195(2) 69.0 63.3 0.8 Y 
 mmu-miR-200a UAACACUGUCUGGUAACGAUGU LNA-200a ACA[T]C[G]T[T]A[C]C[A]G[A]CAGTGTT[A] cluster-mmu-mir-200a(3) 68.0 70.0 0.7  
 mmu-miR-200b UAAUACUGCCUGGUAAUGAUGA LNA-200b T[C]A[T]CA[T]TAC[C]AG[G]CAGTAT[T]A cluster-mmu-mir-200a(3) 63.0 54.7 0.4   
 mmu-miR-204 UUCCCUUUGUCAUCCUAUGCCU LNA-204 AG[G]CA[T]AG[G]ATG[A]CA[A]AG[G]G[A]A cluster-mmu-mir-204(1) 68.7 68.7 1.0   
 mmu-miR-205 UCCUUCAUUCCACCGGAGUCUG LNA-205 C[A]G[A]CTCCGG[T]GGA[A][T]G[A][A]GG[A] cluster-mmu-mir-205(1) 75.0 70.1 1.2   
 mmu-miR-216a UAAUCUCAGCUGGCAACUGUGA LNA-216a T[C]ACAGT[T]G[C]C[A]GCTG[A]G[A]T[T]A cluster-mmu-mir-216a(3) 71.0 70.0 1.1   
 mmu-miR-217 UACUGCAUCAGGAACUGACUGGA LNA-217 T[C]CA[G]TCA[G]TT[C]CTG[A]TG[C]AG[T]A cluster-mmu-mir-216a(3) 72.0 70.4 0.6   
 mmu-miR-218 UUGUGCUUGAUCUAACCAUGU LNA-218 A[C]A[T]GGT[T]A[G]A[T]CA[A]GCAC[A]A cluster-mmu-mir-218-1(1), 69.0 66.3 1.2  
    cluster-mmu-mir-218-2(1) 
 mmu-miR-22 AAGCUGCCAGUUGAAGAACUGU LNA-22 [A]CAGTT[C]TT[C]AACTG[G]CA[G]C[T]T cluster-mmu-mir-22(1) 66.0 65.2 0.1 Y 
 mmu-miR-222 AGCUACAUCUGGCUACUGGGU LNA-222 A[C]CC[A]G[T]AGC[C]A[G]A[T]G[T]A[G]CT cluster-mmu-mir-221(2) 78.0 73.7 0.9   
 mmu-miR-27b UUCACAGUGGCUAAGUUCUGC LNA-27b GCAG[A]A[C]T[T]A[G]C[C]ACTGTG[A]A cluster-mmu-mir-23a(6) 69.0 68.0 1.2   
 mmu-miR-23b AUCACAUUGCCAGGGAUUACC LNA-23b GGTAA[T]CCCTG[G]CAA[T]G[T]GAT cluster-mmu-mir-23a(6) 66.0 68.0 1.2   
 mmu-miR-27a UUCACAGUGGCUAAGUUCCGC LNA-27a GCGG[A]ACT[T]AGCCACTGTG[A]A cluster-mmu-mir-23a(6) 65.0 61.9 1.3 Y 
 mmu-miR-23a AUCACAUUGCCAGGGAUUUCC LNA-23a GG[A]AA[T]CCC[T]G[G]CA[A]TGTG[A]T cluster-mmu-mir-23a(6) 68.0 68.8 0.7   
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 mmu-miR-93 CAAAGUGCUGUUCGUGCAGGUAG LNA-93 C[T]A[C]CTGC[A]CG[A]A[C]AGC[A]CT[T]TG cluster-mmu-mir-25(3) 72.0 71.4 1.1 
 mmu-miR-26a UUCAAGUAAUCCAGGAUAGGCU LNA-26a [A][G]CC[T]A[T]CC[T]GG[A]TT[A]C[T]T[G][A]A cluster-mmu-mir-26a-1(1), 69.0 74.4 1.2 Y 
     cluster-mmu-mir-26a-2(1), 
     cluster-mmu-mir-26a-3(1) 
 mmu-miR-26b UUCAAGUAAUUCAGGAUAGGU LNA-26b A[C]C[T]A[T]C[C]T[G]AATT[A]CTT[G]AA cluster-mmu-mir-26b(1) 64.0 76.0 1.1 Y 
 mmu-miR-28* CACUAGAUUGUGAGCUGCUGGA LNA-28* TC[C]AG[C]AG[C]TCACAA[T]C[T]AGTG cluster-mmu-mir-28(1) 69.0 65.9 1.1   
 mmu-miR-28 AAGGAGCUCACAGUCUAUUGAG LNA-28 CTCAA[T]A[G]A[C]TGTGAGC[T]C[C]TT cluster-mmu-mir-28(1) 65.0 70.1 1.2 Y 
 mmu-miR-298 GGCAGAGGAGGGCUGUUCUUCCC LNA-298 GGG[A]A[G]A[A]C[A]GCCC[T]C[C]T[C]T[G]CC cluster-mmu-mir-296(2) 78.0 83.5 3.9  
 mmu-miR-296-3p GAGGGUUGGGUGGAGGCUCUCC LNA-296-3p GGAG[A]G[C]CTCC[A]CC[C]AA[C]CC[T]C cluster-mmu-mir-296(2) 78.0 80.6 3.0   
 mmu-miR-467a UAAGUGCCUGCAUGUAUAUGCG LNA-467a CGCA[T]AT[A]CA[T]GCAGG[C]ACTTA cluster-mmu-mir-297a-1(46) 66.0 60.7 0.4 Y 
 mmu-miR-29a UAGCACCAUCUGAAAUCGGUUA LNA-29a T[A]ACC[G]ATT[T]CA[G]A[T]GGTG[C]TA cluster-mmu-mir-29a(4) 68.0 68.1 1.0 Y 
 mmu-miR-29b UAGCACCAUUUGAAAUCAGUGUU LNA-29b A[A]CACT[G][A]TT[T]C[A]A[A][T]GGTGC[T]A cluster-mmu-mir-29a(2), 68.0 64.2 0.6 
     cluster-mmu-mir-29b-2(2) 
 mmu-miR-29c UAGCACCAUUUGAAAUCGGUUA LNA-29c T[A]ACCG[A]TT[T]CA[A]A[T]GGTG[C]TA cluster-mmu-mir-29a(4) 64.0 60.2 0.8   
 mmu-miR-30a UGUAAACAUCCUCGACUGGAAG LNA-30a C[T]TCC[A]G[T]CG[A]GG[A]TGTT[T]AC[A] cluster-mmu-mir-30a(4) 68.0 67.4 0.6 Y 
 mmu-miR-30c UGUAAACAUCCUACACUCUCAGC LNA-30c GC[T]G[A]G[A]GTGTAG[G]ATG[T]T[T]ACA cluster-mmu-mir-30c-1(2), 68.0 67.4 1.2  
     cluster-mmu-mir-30a(2) 
 mmu-miR-30e* CUUUCAGUCGGAUGUUUACAGC LNA-30e* G[C]TG[T]AA[A]CA[T]CC[G]ACTG[A]AAG cluster-mmu-mir-30a(4) 67.0 63.2 1.8   
 mmu-miR-30e UGUAAACAUCCUUGACUGGAAG LNA-30e CTTCC[A]G[T]CA[A]GG[A]T[G]TT[T]AC[A] cluster-mmu-mir-30a(4) 66.0 67.4 0.1  
 mmu-miR-30d UGUAAACAUCCCCGACUGGAAG LNA-30d C[T]TCC[A]G[T]C[G]GGG[A]TG[T]T[T]ACA cluster-mmu-mir-30b(2) 66.0 75.2 1.6 Y 
 mmu-miR-322  CAGCAGCAAUUCAUGUUUUGGA LNA-322 TTCA[A]AA[C]ATGAA[T]TG[C]TG[C]TG cluster-mmu-mir-322(7) 63.0 53.2 1.4   
 mmu-miR-384-5p UGUAAACAAUUCCUAGGCAAUGU LNA-384-5p ACA[T]T[G]C[C]T[A]G[G]AA[T]TGTTT[A]CA cluster-mmu-mir-325(2) 66.0 68.9 1.2  
 mmu-miR-384-3p AUUCCUAGAAAUUGUUCACAAU LNA-384-3p ATTG[T]GA[A]CAAT[T]T[C]T[A]G[G]A[A]T cluster-mmu-mir-325(2) 66.0 62.5 1.0   
 mmu-miR-335 UCAAGAGCAAUAACGAAAAAUGU LNA-335 ACA[T]T[T]T[T]CGT[T]AT[T]GCT[C]T[T]GA cluster-mmu-mir-335(1) 62.0 65.9 1.2   
 mmu-miR-34c AGGCAGUGUAGUUAGCUGAUUGC LNA-34c GCAA[T]C[A]GCTA[A]CT[A]CA[C]TG[C]CT cluster-mmu-mir-34b(2) 70.0 67.4 1.1   
 mmu-miR-378 ACUGGACUUGGAGUCAGAAGG LNA-378 CC[T]T[C]T[G]ACT[C]C[A]A[G]TC[C]A[G]T cluster-mmu-mir-378(1) 72.0 77.0 2.3   
 mmu-miR-488 UUGAAAGGCUGUUUCUUGGUCU LNA-488 A[G]ACCA[A]GAAA[C]AGC[C]TTTC[A]A cluster-mmu-mir-488(1) 66.0 56.9 1.1   
 mmu-miR-672 UGAGGUUGGUGUACUGUGUGUGA LNA-672 TC[A]C[A]C[A]CA[G]T[A]CA[C]C[A]A[C]C[T]CA cluster-mmu-mir-672(1) 75.0 77.2 1.2   
 mmu-miR-708* CAACUAGACUGUGAGCUUCUAG LNA-708* CTAGA[A]G[C]T[C]A[C]A[G]TCTAGT[T]G cluster-mmu-mir-708(1) 66.0 69.2 1.3   
 mmu-miR-708 AAGGAGCUUACAAUCUAGCUGGG LNA-708 C[C]CAGCTA[G]A[T]TG[T]AAGCTC[C]TT cluster-mmu-mir-708(1) 67.0 63.3 0.8   
 mmu-miR-744 UGCGGGGCUAGGGCUAACAGCA LNA-744 TGC[T]GT[T]AGC[C]CT[A]GC[C]CC[G]CA cluster-mmu-mir-744(1) 79.0 81.2 1.0 Y 
 mmu-miR-7a UGGAAGACUAGUGAUUUUGUUGU LNA-7a AC[A]ACA[A]AA[T]CA[C]T[A]GT[C]TT[C]CA cluster-mmu-mir-7a-1(1), 66.0 64.5 1.3 Y 
     cluster-mmu-mir-7a-2(1)   
 mmu-miR-872 AAGGUUACUUGUUAGUUCAGG LNA-872 CC[T]G[A]A[C]T[A][A]CAAG[T]A[A]CCTT cluster-mmu-mir-872(1) 64.0 65.0 0.5 Y 
 mmu-miR-874 CUGCCCUGGCCCGAGGGACCGA LNA-874 T[C]GG[T]CCCT[C]GGGCC[A]GGG[C]AG cluster-mmu-mir-874(1) 82.0 85.0 1.2   
 mmu-miR-877 GUAGAGGAGAUGGCGCAGGG LNA-877 CC[C]TG[C]G[C]CA[T]CT[C]CT[C]T[A]C cluster-mmu-mir-877-1(2) 77.0 82.5 0.8   
 mmu-miR-879 AGAGGCUUAUAGCUCUAAGCC LNA-879 GGC[T]TA[G]A[G]C[T]A[T]AA[G]CCT[C]T cluster-mmu-mir-879(1) 67.0 69.1 1.8 
 mmu-miR-9 UCUUUGGUUAUCUAGCUGUAUGA LNA-9 [T]C[A][T][A]C[A]GCT[A]G[A]T[A][A]CC[A][A]AG[A] cluster-mmu-mir-9-1(1), 70.0 69.8 1.2 Y 
     cluster-mmu-mir-9-2(1) 
 mmu-miR-9* AUAAAGCUAGAUAACCGAAAGU LNA-9* AC[T]T[T]C[G]GTT[A]TC[T]A[G]CT[T]T[A]T cluster-mmu-mir-9-1(3) 63.0 70.8 0.5 Y 
 mmu-let-7a UGAGGUAGUAGGUUGUAUAGUU LNA-let-7a A[A]CT[A]TA[C]AA[C]CTA[C]TA[C]C[T]CA cluster-mmu-mir-let-7a-1(3), 66.0 66.4 1.1 Y 
     cluster-mmu-mir-100(3) 
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 mmu-let-7d AGAGGUAGUAGGUUGCAUAGUU LNA-let-7d AA[C]TATG[C]AA[C]CTA[C]TA[C]CT[C]T cluster-mmu-mir-98(13) 67.0 69.7 1.1 Y 
 mmu-let-7f UGAGGUAGUAGAUUGUAUAGUU LNA-let-7f A[A][C]TATA[C]AAT[C]TA[C]TA[C]C[T][C]A cluster-mmu-mir-let-7a-1(3), 64.0 67.2 1.0 Y 
     cluster-mmu-mir-98(2) 
 mmu-let-7b UGAGGUAGUAGGUUGUGUGGUU LNA-let-7b A[A]CC[A]CA[C]AA[C]CT[A]CT[A]CC[T]CA cluster-mmu-mir-98(13) 71.0 69.0 0.2 Y 
 mmu-miR-99a AACCCGUAGAUCCGAUCUUGUG LNA-99a C[A]C[A]AGA[T]C[G][G][A]TCT[A]CG[G]G[T]T cluster-mmu-mir-98(13) 76.0 77.0 1.1 Y 
 mmu-miR-125b UCCCUGAGACCCUAACUUGUGA LNA-125b [T]C[A]C[A]AG[T]T[A]GGG[T]CTC[A]GGGA cluster-mmu-mir-100(3), 70.0 72.8 0.7 
     cluster-mmu-mir-99a(3)    
 mmu-let-7c UGAGGUAGUAGGUUGUAUGGUU LNA-let-7c [A][A]CC[A]TAC[A][A]CCTAC[T][A]CC[T]C[A] cluster-mmu-mir-99a(3), 65.0 67.2 0.9 Y 
     cluster-mmu-mir-let-7b(2) 
 mmu-miR-99b CACCCGUAGAACCGACCUUGCG LNA-99b C[G]CA[A]GG[T]CG[G]TT[C]TACG[G]G[T]G cluster-mmu-mir-99b(3) 78.0 76.8 0.9 Y 
 mmu-miR-125a UCCCUGAGACCCUUUAACCUGUGA LNA-125a T[C]ACAG[G]T[T]A[A]AG[G]GTCTCAG[G]GA cluster-mmu-mir-99b(3) 72.0 68.8 0.9 
 mmu-let-7e UGAGGUAGGAGGUUGUAUAGUU LNA-let-7e AA[C]T[A]TA[C]A[A]CC[T]C[C]TACC[T]CA cluster-mmu-mir-99b(3) 66.0 73.1 0.5 Y 
 mmu-miR-7b UGGAAGACUUGUGAUUUUGUUGU LNA-7b AC[A]AC[A]AA[A]TC[A]CAAGT[C]TTC[C]A cluster-mmu-mir-7b(1) 64.0 55.8 0.4   
 mmu-miR-149 UCUGGCUCCGUGUCUUCACUCCC LNA-149 GGG[A]GTGAA[G]ACACG[G]AG[C]CA[G]A cluster-mmu-mir-149(1) 76.0 67.4 0.5   
 mmu-miR-223 UGUCAGUUUGUCAAAUACCCCA LNA-223 TG[G]GGTA[T]T[T]GACAA[A]C[T]GA[C]A cluster-mmu-mir-223(1) 68.0 64.3 0.1 
 mmu-miR-133b UUUGGUCCCCUUCAACCAGCUA LNA-133b TA[G]CT[G]GT[T]GA[A]GGG[G]ACCA[A]A cluster-mmu-mir-133b(2) 72.0 76.8 1.2 
 mmu-miR-203 GUGAAAUGUUUAGGACCACUAG LNA-203 C[T]AGT[G]GT[C]CTAAACA[T]TT[C]A[C] cluster-mmu-mir-203(1) 65.0 63.6 0.1 
 mmu-miR-671 UCCGGUUCUCAGGGCUCCACC LNA-671 GG[T]GG[A]GCCCTG[A]G[A]A[C]CGG[A] cluster-mmu-mir-671(1) 78.0 77.3 0.6  
 mmu-miR-122 UGGAGUGUGACAAUGGUGUUUG LNA-122 CA[A]ACA[C]C[A]TTGT[C]AC[A]C[T]C[C]A cluster-mmu-mir-122(1) 71.0 73.0 1.1 Y 
 mmu-miR-486 UCCUGUACUGAGCUGCCCCGAG LNA-486 C[T]CGGGGC[A]GCTC[A]GTA[C]AGG[A] cluster-mmu-mir-486(1) 74.0 67.9 0.9  
 mmu-miR-455 GCAGUCCACGGGCAUAUACAC LNA-455 GT[G]TA[T]AT[G]CCC[G]TGGA[C]T[G]C cluster-mmu-mir-455(1) 71.0 72.7 0.9  
 mmu-miR-551b GCGACCCAUACUUGGUUUCAG LNA-551b CT[G]AA[A]CCAA[G]T[A]TGGGT[C]GC  cluster-mmu-mir-551b(1) 68.0 66.1 0.5  
 mmu-miR-449b AGGCAGUGUUGUUAGCUGGC LNA-449b ACCAGCT[A]AC[A]AT[A]C[A]CTGC[C]A cluster-mmu-mir-449a(2) 68.0 61.8 0.4   
 mmu-miR-107 AGCAGCAUUGUACAGGGCUAUCA LNA-107 TGA[T]AGCC[C]TG[T]A[C]AA[T]GCTG[C]T cluster-mmu-mir-107(1) 71.0 71.6 0.4  
 mmu-miR-10a UACCCUGUAGAUCCGAAUUUGUG LNA-10a CACA[A]AT[T]CG[G]ATCTAC[A]GGGTA cluster-mmu-mir-10a(1) 63.0 60.4 0.2   
         
  LNA-modified DNA positions are marked in square brackets.  
 Exiqon TM  (ºC) was calculated with 50 mM salt concentration and 1.5 µM total oligo (target + probe) concentration. 
 Difference between the melting temperature of denaturation (up) and melting temperature of renaturation (down).  
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Table Supplementary Table 2. List of miRNA clone counts and frequencies from mouse cerebellum, prefrontal cortex, parietal cortex and hypothalamus. 
Summation of clone counts* Cerebellum Prefrontal_Cortex Hypothalamus Cortex_parietal Hippocampus Amygdala
Name Clone count Clone fraction Clone count Clone fraction Clone count Clone fraction Clone count Clone fraction Clone count Clone fraction Clone count Clone fraction Clone count Clone fraction
mmu-miR-124 8352 8.8049 2871 16.9831 577 5.2897 656 4.2016 2187 13.2233 1396 9.3266 665 4.3269
mmu-miR-9 8214 8.7207 2296 13.5818 774 7.0957 843 5.3993 1842 11.1373 1477 9.8677 982 6.3895
mmu-miR-125b 5410 6.1228 474 2.8039 935 8.5717 1300 8.3264 833 5.0366 965 6.4471 903 5.8755
mmu-miR-128 3904 4.7548 288 1.7036 818 7.4991 370 2.3698 1170 7.0742 470 3.1400 788 5.1272
mmu-let-7c 3780 4.1315 944 5.5841 441 4.0429 604 3.8686 499 3.0171 655 4.3760 637 4.1447
mmu-miR-127 3224 3.9207 177 1.0470 478 4.3821 955 6.1167 334 2.0195 352 2.3517 928 6.0381
mmu-miR-29a 3461 3.5374 551 3.2594 358 3.2820 547 3.5035 897 5.4235 767 5.1243 341 2.2188
mmu-miR-26a 3167 3.2824 1290 7.6309 192 1.7602 257 1.6461 692 4.1840 553 3.6945 183 1.1907
mmu-let-7a 2507 2.7691 580 3.4309 252 2.3102 501 3.2089 277 1.6748 402 2.6857 495 3.2208
mmu-miR-138 1939 2.2542 81 0.4791 324 2.9703 211 1.3514 291 1.7595 308 2.0577 724 4.7108
mmu-let-7f 1811 1.9427 368 2.1769 247 2.2644 326 2.0880 263 1.5902 362 2.4185 245 1.5941
mmu-let-7g 1690 1.9362 455 2.6915 198 1.8152 331 2.1200 220 1.3302 221 1.4765 265 1.7243
mmu-miR-101a 1623 1.9048 344 2.0349 175 1.6043 278 1.7806 229 1.3846 179 1.1959 418 2.7198
mmu-let-7b 1629 1.7229 367 2.1710 181 1.6593 223 1.4283 229 1.3846 326 2.1780 303 1.9715
mmu-miR-125a 1429 1.6668 326 1.9284 208 1.9069 293 1.8766 198 1.1972 185 1.2360 219 1.4249
mmu-miR-29b 1511 1.5569 86 0.5087 107 0.9809 440 2.8182 306 1.8502 322 2.1513 250 1.6267
mmu-let-7d 1359 1.4923 339 2.0053 126 1.1551 219 1.4027 191 1.1548 216 1.4431 268 1.7438
mmu-let-7i 1208 1.3880 275 1.6267 177 1.6227 156 0.9992 161 0.9735 175 1.1692 264 1.7177
mmu-miR-103 1166 1.3461 117 0.6921 204 1.8702 267 1.7101 130 0.7860 191 1.2761 257 1.6722
mmu-miR-30c 1262 1.3278 315 1.8634 132 1.2101 161 1.0312 304 1.8381 243 1.6235 107 0.6962
mmu-miR-7a 852 1.0556 10 0.0592 25 0.2292 505 3.2345 18 0.1088 41 0.2739 253 1.6462
mmu-miR-24 907 1.0509 130 0.7690 156 1.4301 113 0.7238 207 1.2516 135 0.9019 166 1.0801
mmu-miR-181a 844 0.9655 147 0.8696 139 1.2743 139 0.8903 175 1.0581 131 0.8752 113 0.7352
mmu-miR-22 819 0.9500 58 0.3431 128 1.1735 148 0.9479 152 0.9190 123 0.8218 210 1.3664
mmu-miR-29c 903 0.9094 158 0.9346 81 0.7426 161 1.0312 218 1.3181 205 1.3696 80 0.5205
mmu-miR-99a 778 0.8984 98 0.5797 135 1.2376 171 1.0952 103 0.6228 124 0.8284 147 0.9565
mmu-miR-30d 787 0.8614 300 1.7746 95 0.8709 76 0.4868 120 0.7256 127 0.8485 69 0.4490
mmu-miR-221 665 0.8303 31 0.1834 166 1.5218 76 0.4868 83 0.5018 85 0.5679 224 1.4575
mmu-miR-30a 777 0.8186 246 1.4552 81 0.7426 61 0.3907 166 1.0037 146 0.9754 77 0.5010
mmu-miR-30e 801 0.7941 185 1.0944 76 0.6967 75 0.4804 168 1.0158 192 1.2827 105 0.6832
mmu-miR-126-3p 693 0.7897 85 0.5028 86 0.7884 110 0.7045 126 0.7618 103 0.6881 183 1.1907
mmu-let-7e 643 0.7176 106 0.6270 81 0.7426 138 0.8839 69 0.4172 108 0.7215 141 0.9174
mmu-miR-222 568 0.7154 25 0.1479 129 1.1826 77 0.4932 78 0.4716 62 0.4142 197 1.2818
mmu-miR-132 630 0.6993 19 0.1124 135 1.2376 73 0.4676 155 0.9372 134 0.8952 114 0.7418
mmu-miR-143 497 0.6208 57 0.3372 98 0.8984 81 0.5188 93 0.5623 47 0.3140 121 0.7873
mmu-miR-136-5p 528 0.5869 54 0.3194 33 0.3025 152 0.9735 116 0.7014 75 0.5011 98 0.6376
mmu-miR-21 539 0.5866 83 0.4910 41 0.3759 103 0.6597 97 0.5865 89 0.5946 126 0.8198
mmu-miR-218 595 0.5743 86 0.5087 50 0.4584 53 0.3395 162 0.9795 154 1.0289 90 0.5856
mmu-miR-101b 471 0.5472 56 0.3313 68 0.6234 96 0.6149 67 0.4051 67 0.4476 117 0.7613
mmu-miR-126-5p 432 0.5267 30 0.1775 54 0.4950 63 0.4035 80 0.4837 40 0.2672 165 1.0736
mmu-miR-136-3p 433 0.5034 40 0.2366 38 0.3484 125 0.8006 72 0.4353 51 0.3407 107 0.6962
mmu-miR-16 486 0.4996 170 1.0056 30 0.2750 45 0.2882 102 0.6167 91 0.6080 48 0.3123
mmu-miR-30b 460 0.4905 148 0.8755 41 0.3759 56 0.3587 106 0.6409 78 0.5211 31 0.2017
mmu-miR-338 422 0.4637 35 0.2070 54 0.4950 98 0.6277 71 0.4293 78 0.5211 86 0.5596
mmu-miR-27b 459 0.4278 66 0.3904 36 0.3300 41 0.2626 146 0.8828 128 0.8552 42 0.2733
mmu-miR-137 451 0.4154 5 0.0296 46 0.4217 83 0.5316 111 0.6711 141 0.9420 65 0.4229
mmu-miR-191 365 0.4012 46 0.2721 44 0.4034 78 0.4996 61 0.3688 65 0.4343 71 0.4620
mmu-miR-153 408 0.3982 25 0.1479 31 0.2842 89 0.5700 99 0.5986 104 0.6948 60 0.3904
mmu-miR-33 307 0.3920 18 0.1065 64 0.5867 56 0.3587 49 0.2963 26 0.1737 94 0.6116
mmu-miR-7b 324 0.3904 2 0.0118 14 0.1283 201 1.2874 6 0.0363 26 0.1737 75 0.4880
mmu-miR-135a 343 0.3636 28 0.1656 26 0.2384 151 0.9671 33 0.1995 67 0.4476 38 0.2473
mmu-miR-129-3p 294 0.3528 39 0.2307 35 0.3209 97 0.6213 30 0.1814 30 0.2004 63 0.4099
mmu-miR-434-3p 338 0.3465 43 0.2544 33 0.3025 81 0.5188 71 0.4293 75 0.5011 35 0.2277
*"Summation of clone counts" represents the summation of clone counts derived from the five regions of mouse brain analyzed.
miRNA profiles were derived from 454 sequencing of small RNA cDNA libraries prepared from size-fractionated total RNA. Mouse miRNA precursors were mapped to 
the genome. Host transcripts were identified and the unigene ID together with the name and an identifier. Furthermore it is indicated whether the miRNA gene is 
expressed in the cerebellum, prefrontal cortex, parietal cortex or hypothalamus.  
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mmu-miR-23b 329 0.3437 55 0.3253 34 0.3117 44 0.2818 58 0.3507 69 0.4610 69 0.4490
mmu-miR-328 262 0.3221 18 0.1065 52 0.4767 75 0.4804 27 0.1633 31 0.2071 59 0.3839
mmu-miR-300 284 0.3144 22 0.1301 53 0.4859 63 0.4035 44 0.2660 58 0.3875 44 0.2863
mmu-miR-100 253 0.3051 31 0.1834 48 0.4400 70 0.4483 32 0.1935 32 0.2138 40 0.2603
mmu-miR-376a 259 0.2872 13 0.0769 17 0.1558 91 0.5828 38 0.2298 40 0.2672 60 0.3904
mmu-miR-34a 249 0.2713 75 0.4437 15 0.1375 41 0.2626 73 0.4414 34 0.2272 11 0.0716
mmu-miR-376b-5p 222 0.2665 12 0.0710 16 0.1467 71 0.4547 22 0.1330 20 0.1336 81 0.5270
mmu-miR-26b 253 0.2598 105 0.6211 16 0.1467 23 0.1473 42 0.2539 47 0.3140 20 0.1301
mmu-miR-497 220 0.2526 119 0.7039 20 0.1834 18 0.1153 28 0.1693 21 0.1403 14 0.0911
mmu-miR-139 231 0.2413 8 0.0473 26 0.2384 29 0.1857 43 0.2600 52 0.3474 73 0.4750
mmu-miR-204 231 0.2402 124 0.7335 3 0.0275 35 0.2242 12 0.0726 35 0.2338 22 0.1431
mmu-miR-181b 213 0.2334 29 0.1715 20 0.1834 51 0.3267 34 0.2056 36 0.2405 43 0.2798
mmu-miR-23a 201 0.2325 18 0.1065 33 0.3025 27 0.1729 53 0.3205 30 0.2004 40 0.2603
mmu-miR-99b 185 0.2320 35 0.2070 50 0.4584 30 0.1921 21 0.1270 22 0.1470 27 0.1757
mmu-miR-382 178 0.2311 6 0.0355 36 0.3300 63 0.4035 9 0.0544 13 0.0869 51 0.3318
mmu-miR-107 187 0.2266 14 0.0828 33 0.3025 48 0.3074 19 0.1149 23 0.1537 50 0.3253
mmu-miR-434-5p 190 0.2232 17 0.1006 26 0.2384 42 0.2690 27 0.1633 25 0.1670 53 0.3449
mmu-miR-376b-3p 193 0.2092 7 0.0414 23 0.2109 58 0.3715 30 0.1814 38 0.2539 37 0.2407
mmu-miR-381 212 0.2008 33 0.1952 19 0.1742 37 0.2370 41 0.2479 59 0.3942 23 0.1497
mmu-miR-151-5p 169 0.1978 11 0.0651 39 0.3575 36 0.2306 20 0.1209 30 0.2004 33 0.2147
mmu-miR-27a 183 0.1891 23 0.1361 24 0.2200 25 0.1601 57 0.3446 41 0.2739 13 0.0846
mmu-miR-219-5p 222 0.1888 19 0.1124 5 0.0458 51 0.3267 49 0.2963 73 0.4877 25 0.1627
mmu-miR-744 154 0.1850 8 0.0473 16 0.1467 79 0.5060 6 0.0363 16 0.1069 29 0.1887
mmu-miR-708-5p 154 0.1708 3 0.0177 24 0.2200 20 0.1281 28 0.1693 30 0.2004 49 0.3188
mmu-miR-369-3p 145 0.1688 7 0.0414 19 0.1742 38 0.2434 26 0.1572 20 0.1336 35 0.2277
mmu-miR-219-3p 161 0.1685 21 0.1242 18 0.1650 43 0.2754 18 0.1088 35 0.2338 26 0.1692
mmu-miR-34c 158 0.1606 8 0.0473 28 0.2567 41 0.2626 9 0.0544 44 0.2940 28 0.1822
mmu-miR-383 129 0.1599 0 0.0000 38 0.3484 32 0.2050 16 0.0967 20 0.1336 23 0.1497
mmu-miR-129-5p 128 0.1585 16 0.0946 32 0.2934 23 0.1473 21 0.1270 16 0.1069 20 0.1301
mmu-miR-379 135 0.1560 17 0.1006 19 0.1742 45 0.2882 9 0.0544 20 0.1336 25 0.1627
mmu-miR-148a 123 0.1526 8 0.0473 15 0.1375 49 0.3138 5 0.0302 10 0.0668 36 0.2342
mmu-miR-341 135 0.1519 6 0.0355 15 0.1375 54 0.3459 14 0.0846 22 0.1470 24 0.1562
mmu-miR-378 125 0.1506 26 0.1538 17 0.1558 19 0.1217 8 0.0484 13 0.0869 42 0.2733
mmu-miR-185 114 0.1499 5 0.0296 23 0.2109 33 0.2114 18 0.1088 6 0.0401 29 0.1887
mmu-miR-149 124 0.1433 17 0.1006 11 0.1008 44 0.2818 16 0.0967 15 0.1002 21 0.1366
mmu-miR-370-3p 97 0.1417 0 0.0000 43 0.3942 18 0.1153 6 0.0363 5 0.0334 25 0.1627
mmu-miR-411 134 0.1411 20 0.1183 12 0.1100 29 0.1857 31 0.1874 26 0.1737 16 0.1041
mmu-miR-598 136 0.1370 25 0.1479 7 0.0642 45 0.2882 9 0.0544 30 0.2004 20 0.1301
mmu-miR-195 107 0.1252 81 0.4791 4 0.0367 2 0.0128 15 0.0907 4 0.0267 1 0.0065
mmu-miR-541 102 0.1219 4 0.0237 20 0.1834 31 0.1986 9 0.0544 15 0.1002 23 0.1497
mmu-miR-652 112 0.1219 23 0.1361 8 0.0733 33 0.2114 14 0.0846 18 0.1203 16 0.1041
mmu-miR-130a 100 0.1177 21 0.1242 4 0.0367 29 0.1857 12 0.0726 8 0.0534 26 0.1692
mmu-miR-140-3p 104 0.1177 13 0.0769 20 0.1834 15 0.0961 19 0.1149 19 0.1269 18 0.1171
mmu-miR-150 112 0.1174 18 0.1065 7 0.0642 21 0.1345 24 0.1451 21 0.1403 21 0.1366
mmu-miR-433 119 0.1169 5 0.0296 11 0.1008 38 0.2434 9 0.0544 32 0.2138 24 0.1562
mmu-miR-15a 109 0.1147 18 0.1065 15 0.1375 10 0.0640 17 0.1028 24 0.1603 25 0.1627
mmu-miR-330-5p 105 0.1091 11 0.0651 10 0.0917 27 0.1729 12 0.0726 23 0.1537 22 0.1431
mmu-miR-320 85 0.1074 25 0.1479 16 0.1467 20 0.1281 6 0.0363 6 0.0401 12 0.0781
mmu-miR-674-5p 75 0.0991 5 0.0296 20 0.1834 10 0.0640 6 0.0363 6 0.0401 28 0.1822
mmu-miR-335-5p 74 0.0953 5 0.0296 18 0.1650 17 0.1089 6 0.0363 7 0.0468 21 0.1366
mmu-miR-344 84 0.0925 9 0.0532 9 0.0825 17 0.1089 7 0.0423 15 0.1002 27 0.1757
mmu-miR-301a 88 0.0923 14 0.0828 5 0.0458 36 0.2306 4 0.0242 17 0.1136 12 0.0781
mmu-miR-324-5p 74 0.0914 9 0.0532 14 0.1283 15 0.0961 6 0.0363 8 0.0534 22 0.1431
mmu-miR-98 88 0.0901 10 0.0592 8 0.0733 23 0.1473 11 0.0665 20 0.1336 16 0.1041
mmu-miR-181d 72 0.0892 12 0.0710 6 0.0550 17 0.1089 8 0.0484 4 0.0267 25 0.1627
mmu-miR-331 72 0.0891 5 0.0296 14 0.1283 16 0.1025 8 0.0484 8 0.0534 21 0.1366
mmu-miR-495 86 0.0886 6 0.0355 6 0.0550 19 0.1217 22 0.1330 18 0.1203 15 0.0976
mmu-miR-93 79 0.0866 7 0.0414 16 0.1467 15 0.0961 16 0.0967 17 0.1136 8 0.0521
mmu-miR-140-5p 77 0.0849 18 0.1065 5 0.0458 15 0.0961 13 0.0786 11 0.0735 15 0.0976
mmu-miR-873-5p 66 0.0828 0 0.0000 11 0.1008 11 0.0705 10 0.0605 6 0.0401 28 0.1822
mmu-miR-135b 76 0.0825 8 0.0473 4 0.0367 26 0.1665 16 0.0967 12 0.0802 10 0.0651
mmu-miR-384-3p 75 0.0806 11 0.0651 7 0.0642 24 0.1537 8 0.0484 14 0.0935 11 0.0716
mmu-miR-186 72 0.0792 5 0.0296 11 0.1008 12 0.0769 14 0.0846 14 0.0935 16 0.1041
mmu-miR-487b 67 0.0790 3 0.0177 10 0.0917 16 0.1025 12 0.0726 9 0.0601 17 0.1106
mmu-miR-148b 88 0.0789 10 0.0592 8 0.0733 11 0.0705 22 0.1330 28 0.1871 9 0.0586
mmu-miR-384-5p 81 0.0778 9 0.0532 6 0.0550 15 0.0961 23 0.1391 21 0.1403 7 0.0455
mmu-miR-369-5p 58 0.0744 1 0.0059 7 0.0642 13 0.0833 6 0.0363 3 0.0200 28 0.1822
mmu-miR-106b 67 0.0734 13 0.0769 12 0.1100 10 0.0640 16 0.0967 13 0.0869 3 0.0195
mmu-miR-582 58 0.0733 7 0.0414 11 0.1008 12 0.0769 5 0.0302 5 0.0334 18 0.1171
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mmu-miR-484 64 0.0730 30 0.1775 6 0.0550 5 0.0320 8 0.0484 7 0.0468 8 0.0521
mmu-miR-326 60 0.0729 0 0.0000 10 0.0917 26 0.1665 9 0.0544 7 0.0468 8 0.0521
mmu-miR-181c 60 0.0717 19 0.1124 2 0.0183 16 0.1025 11 0.0665 3 0.0200 9 0.0586
mmu-miR-330-3p 59 0.0711 0 0.0000 11 0.1008 18 0.1153 8 0.0484 8 0.0534 14 0.0911
mmu-miR-340 66 0.0680 19 0.1124 2 0.0183 9 0.0576 24 0.1451 11 0.0735 1 0.0065
mmu-miR-770-3p 54 0.0664 0 0.0000 4 0.0367 24 0.1537 3 0.0181 4 0.0267 19 0.1236
mmu-miR-770-5p 62 0.0663 0 0.0000 2 0.0183 33 0.2114 5 0.0302 11 0.0735 11 0.0716
mmu-miR-361 60 0.0661 15 0.0887 6 0.0550 7 0.0448 17 0.1028 9 0.0601 6 0.0390
mmu-miR-410 71 0.0655 8 0.0473 2 0.0183 18 0.1153 7 0.0423 20 0.1336 16 0.1041
mmu-miR-872 54 0.0649 3 0.0177 5 0.0458 14 0.0897 10 0.0605 5 0.0334 17 0.1106
mmu-miR-551b 60 0.0596 0 0.0000 1 0.0092 15 0.0961 19 0.1149 13 0.0869 12 0.0781
mmu-miR-194 55 0.0574 27 0.1597 3 0.0275 3 0.0192 9 0.0544 9 0.0601 4 0.0260
mmu-miR-676 45 0.0571 0 0.0000 8 0.0733 8 0.0512 4 0.0242 4 0.0267 21 0.1366
mmu-miR-145-5p 48 0.0551 8 0.0473 5 0.0458 5 0.0320 13 0.0786 6 0.0401 11 0.0716
mmu-miR-219 56 0.0531 5 0.0296 1 0.0092 16 0.1025 13 0.0786 14 0.0935 7 0.0455
mmu-miR-708-3p 40 0.0501 0 0.0000 7 0.0642 12 0.0769 3 0.0181 4 0.0267 14 0.0911
mmu-miR-665 40 0.0495 2 0.0118 5 0.0458 10 0.0640 9 0.0544 3 0.0200 11 0.0716
mmu-miR-337-5p 37 0.0466 3 0.0177 6 0.0550 8 0.0512 4 0.0242 3 0.0200 13 0.0846
mmu-miR-212-3p 35 0.0461 1 0.0059 13 0.1192 5 0.0320 10 0.0605 4 0.0267 2 0.0130
mmu-miR-485-5p 33 0.0457 1 0.0059 11 0.1008 8 0.0512 2 0.0121 2 0.0134 9 0.0586
mmu-miR-154-5p 45 0.0451 2 0.0118 0 0.0000 13 0.0833 14 0.0846 9 0.0601 7 0.0455
mmu-miR-874 36 0.0447 4 0.0237 8 0.0733 8 0.0512 6 0.0363 4 0.0267 6 0.0390
mmu-miR-329-5p 34 0.0446 0 0.0000 7 0.0642 6 0.0384 7 0.0423 2 0.0134 12 0.0781
mmu-miR-380-3p 39 0.0438 2 0.0118 4 0.0367 17 0.1089 7 0.0423 6 0.0401 3 0.0195
mmu-miR-19b 46 0.0437 8 0.0473 7 0.0642 5 0.0320 7 0.0423 14 0.0935 5 0.0325
mmu-miR-190 40 0.0430 5 0.0296 3 0.0275 8 0.0512 8 0.0484 7 0.0468 9 0.0586
mmu-miR-25 39 0.0419 8 0.0473 6 0.0550 10 0.0640 5 0.0302 8 0.0534 2 0.0130
mmu-miR-206 35 0.0416 33 0.1952 0 0.0000 0 0.0000 0 0.0000 0 0.0000 2 0.0130
mmu-miR-409-5p 31 0.0407 0 0.0000 7 0.0642 5 0.0320 7 0.0423 2 0.0134 10 0.0651
mmu-miR-339 33 0.0397 3 0.0177 3 0.0275 12 0.0769 4 0.0242 3 0.0200 8 0.0521
mmu-miR-151-3p 31 0.0395 4 0.0237 8 0.0733 5 0.0320 7 0.0423 3 0.0200 4 0.0260
mmu-miR-323 32 0.0390 4 0.0237 4 0.0367 7 0.0448 3 0.0181 3 0.0200 11 0.0716
mmu-miR-17 31 0.0375 2 0.0118 4 0.0367 7 0.0448 8 0.0484 3 0.0200 7 0.0455
mmu-miR-543 34 0.0367 0 0.0000 4 0.0367 15 0.0961 3 0.0181 7 0.0468 5 0.0325
mmu-miR-187 42 0.0363 8 0.0473 0 0.0000 4 0.0256 5 0.0302 13 0.0869 12 0.0781
mmu-miR-409-3p 23 0.0346 0 0.0000 9 0.0825 5 0.0320 0 0.0000 0 0.0000 9 0.0586
mmu-miR-134 31 0.0344 3 0.0177 3 0.0275 13 0.0833 5 0.0302 5 0.0334 2 0.0130
mmu-miR-152 31 0.0341 5 0.0296 5 0.0458 4 0.0256 5 0.0302 6 0.0401 6 0.0390
mmu-miR-370-5p 23 0.0339 0 0.0000 8 0.0733 7 0.0448 2 0.0121 0 0.0000 6 0.0390
mmu-miR-34b 52 0.0330 7 0.0414 1 0.0092 11 0.0705 3 0.0181 26 0.1737 4 0.0260
mmu-miR-532-5p 30 0.0322 6 0.0355 4 0.0367 7 0.0448 3 0.0181 6 0.0401 4 0.0260
mmu-miR-154-3p 25 0.0320 1 0.0059 7 0.0642 8 0.0512 1 0.0060 3 0.0200 5 0.0325
mmu-miR-345-5p 30 0.0311 6 0.0355 2 0.0183 7 0.0448 4 0.0242 6 0.0401 5 0.0325
mmu-miR-376c 24 0.0308 1 0.0059 3 0.0275 9 0.0576 5 0.0302 1 0.0067 5 0.0325
mmu-miR-322 27 0.0302 1 0.0059 2 0.0183 3 0.0192 7 0.0423 4 0.0267 10 0.0651
mmu-miR-146b 31 0.0295 4 0.0237 6 0.0550 5 0.0320 5 0.0302 10 0.0668 1 0.0065
mmu-miR-92b 31 0.0277 3 0.0177 2 0.0183 5 0.0320 3 0.0181 10 0.0668 8 0.0521
mmu-miR-324-3p 21 0.0271 1 0.0059 3 0.0275 4 0.0256 4 0.0242 1 0.0067 8 0.0521
mmu-miR-212-5p 20 0.0270 0 0.0000 5 0.0458 3 0.0192 4 0.0242 1 0.0067 7 0.0455
mmu-miR-500 23 0.0264 2 0.0118 2 0.0183 10 0.0640 3 0.0181 3 0.0200 3 0.0195
mmu-miR-377 24 0.0262 2 0.0118 4 0.0367 6 0.0384 3 0.0181 5 0.0334 4 0.0260
mmu-miR-1 24 0.0254 0 0.0000 1 0.0092 6 0.0384 11 0.0665 4 0.0267 2 0.0130
mmu-miR-142-3p 28 0.0252 1 0.0059 2 0.0183 9 0.0576 3 0.0181 9 0.0601 4 0.0260
mmu-miR-210 18 0.0248 0 0.0000 3 0.0275 2 0.0128 2 0.0121 0 0.0000 11 0.0716
mmu-miR-20a 22 0.0243 3 0.0177 3 0.0275 7 0.0448 2 0.0121 4 0.0267 3 0.0195
mmu-miR-805 22 0.0238 0 0.0000 4 0.0367 3 0.0192 4 0.0242 5 0.0334 6 0.0390
mmu-miR-92a 24 0.0238 0 0.0000 4 0.0367 3 0.0192 4 0.0242 7 0.0468 6 0.0390
mmu-miR-488 22 0.0233 0 0.0000 6 0.0550 2 0.0128 7 0.0423 6 0.0401 1 0.0065
mmu-miR-146a 18 0.0232 0 0.0000 3 0.0275 5 0.0320 5 0.0302 1 0.0067 4 0.0260
mmu-miR-19a 15 0.0222 1 0.0059 8 0.0733 1 0.0064 1 0.0060 1 0.0067 3 0.0195
mmu-miR-199a-3p 16 0.0213 1 0.0059 4 0.0367 3 0.0192 2 0.0121 1 0.0067 5 0.0325
mmu-miR-425 21 0.0211 1 0.0059 2 0.0183 5 0.0320 6 0.0363 5 0.0334 2 0.0130
mmu-miR-345-3p 16 0.0210 5 0.0296 4 0.0367 3 0.0192 0 0.0000 1 0.0067 3 0.0195
mmu-miR-486 16 0.0210 4 0.0237 4 0.0367 6 0.0384 1 0.0060 1 0.0067 0 0.0000
mmu-miR-145-3p 15 0.0205 3 0.0177 3 0.0275 3 0.0192 2 0.0121 0 0.0000 4 0.0260
mmu-miR-672 15 0.0203 0 0.0000 2 0.0183 8 0.0512 1 0.0060 0 0.0000 4 0.0260
mmu-miR-423-3p 19 0.0200 0 0.0000 6 0.0550 3 0.0192 0 0.0000 6 0.0401 4 0.0260
mmu-miR-346 25 0.0195 0 0.0000 1 0.0092 6 0.0384 5 0.0302 10 0.0668 3 0.0195
mmu-miR-192 15 0.0189 8 0.0473 1 0.0092 4 0.0256 1 0.0060 0 0.0000 1 0.0065
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mmu-miR-380-5p 16 0.0188 1 0.0059 2 0.0183 7 0.0448 2 0.0121 2 0.0134 2 0.0130
mmu-miR-296-3p 14 0.0185 1 0.0059 1 0.0092 6 0.0384 0 0.0000 0 0.0000 6 0.0390
mmu-miR-329-3p 16 0.0180 0 0.0000 3 0.0275 1 0.0064 5 0.0302 3 0.0200 4 0.0260
mmu-miR-496 15 0.0175 2 0.0118 2 0.0183 3 0.0192 2 0.0121 2 0.0134 4 0.0260
mmu-miR-666-5p 13 0.0171 0 0.0000 1 0.0092 5 0.0320 3 0.0181 0 0.0000 4 0.0260
mmu-miR-335-3p 14 0.0171 0 0.0000 1 0.0092 1 0.0064 4 0.0242 1 0.0067 7 0.0455
mmu-miR-540-5p 17 0.0170 1 0.0059 1 0.0092 1 0.0064 3 0.0181 4 0.0267 7 0.0455
mmu-miR-133a 17 0.0161 5 0.0296 0 0.0000 4 0.0256 2 0.0121 4 0.0267 2 0.0130
mmu-miR-32 11 0.0160 1 0.0059 4 0.0367 2 0.0128 3 0.0181 0 0.0000 1 0.0065
mmu-miR-667-3p 13 0.0158 1 0.0059 1 0.0092 8 0.0512 1 0.0060 1 0.0067 1 0.0065
mmu-miR-674-3p 16 0.0157 0 0.0000 3 0.0275 2 0.0128 2 0.0121 5 0.0334 4 0.0260
mmu-miR-431 15 0.0153 1 0.0059 0 0.0000 2 0.0128 2 0.0121 3 0.0200 7 0.0455
mmu-miR-142-5p 12 0.0151 2 0.0118 2 0.0183 1 0.0064 0 0.0000 1 0.0067 6 0.0390
mmu-miR-879 11 0.0147 0 0.0000 1 0.0092 5 0.0320 1 0.0060 0 0.0000 4 0.0260
mmu-miR-873-3p 12 0.0146 0 0.0000 1 0.0092 6 0.0384 1 0.0060 1 0.0067 3 0.0195
mmu-miR-540-3p 10 0.0145 0 0.0000 3 0.0275 3 0.0192 1 0.0060 0 0.0000 3 0.0195
mmu-miR-199a-5p 12 0.0141 1 0.0059 0 0.0000 3 0.0192 0 0.0000 1 0.0067 7 0.0455
mmu-miR-668 12 0.0138 0 0.0000 2 0.0183 3 0.0192 2 0.0121 2 0.0134 3 0.0195
mmu-miR-374 11 0.0131 2 0.0118 1 0.0092 2 0.0128 2 0.0121 1 0.0067 3 0.0195
mmu-miR-28-5p 13 0.0129 5 0.0296 1 0.0092 3 0.0192 0 0.0000 3 0.0200 1 0.0065
mmu-miR-1224-5p 10 0.0127 0 0.0000 0 0.0000 2 0.0128 3 0.0181 0 0.0000 5 0.0325
mmu-miR-490 8 0.0125 0 0.0000 4 0.0367 2 0.0128 0 0.0000 0 0.0000 2 0.0130
mmu-miR-375 8 0.0123 2 0.0118 4 0.0367 1 0.0064 0 0.0000 0 0.0000 1 0.0065
mmu-miR-298 9 0.0121 0 0.0000 1 0.0092 6 0.0384 0 0.0000 0 0.0000 2 0.0130
mmu-miR-203 10 0.0119 2 0.0118 1 0.0092 2 0.0128 1 0.0060 1 0.0067 3 0.0195
mmu-miR-296-5p 10 0.0115 0 0.0000 0 0.0000 8 0.0512 0 0.0000 1 0.0067 1 0.0065
mmu-miR-467a 9 0.0113 0 0.0000 2 0.0183 4 0.0256 1 0.0060 1 0.0067 1 0.0065
mmu-miR-467b 9 0.0113 0 0.0000 2 0.0183 4 0.0256 1 0.0060 1 0.0067 1 0.0065
mmu-miR-299-5p 12 0.0113 1 0.0059 0 0.0000 6 0.0384 2 0.0121 3 0.0200 0 0.0000
mmu-miR-667-5p 7 0.0112 0 0.0000 4 0.0367 3 0.0192 0 0.0000 0 0.0000 0 0.0000
mmu-miR-193b 9 0.0107 0 0.0000 3 0.0275 2 0.0128 0 0.0000 2 0.0134 2 0.0130
mmu-miR-351 7 0.0106 0 0.0000 3 0.0275 0 0.0000 1 0.0060 0 0.0000 3 0.0195
mmu-miR-764 8 0.0103 0 0.0000 0 0.0000 3 0.0192 0 0.0000 0 0.0000 5 0.0325
mmu-miR-15b 10 0.0102 0 0.0000 0 0.0000 4 0.0256 1 0.0060 2 0.0134 3 0.0195
mmu-miR-532-3p 9 0.0102 0 0.0000 0 0.0000 3 0.0192 2 0.0121 1 0.0067 3 0.0195
mmu-miR-760 9 0.0101 0 0.0000 2 0.0183 3 0.0192 0 0.0000 2 0.0134 2 0.0130
mmu-miR-592 8 0.0101 0 0.0000 0 0.0000 4 0.0256 3 0.0181 0 0.0000 1 0.0065
mmu-miR-199b 7 0.0100 0 0.0000 2 0.0183 2 0.0128 1 0.0060 0 0.0000 2 0.0130
mmu-miR-337-3p 12 0.0100 1 0.0059 0 0.0000 2 0.0128 3 0.0181 4 0.0267 2 0.0130
mmu-miR-362-5p 7 0.0094 0 0.0000 3 0.0275 2 0.0128 0 0.0000 1 0.0067 1 0.0065
mmu-miR-362-3p 10 0.0093 1 0.0059 1 0.0092 2 0.0128 2 0.0121 3 0.0200 1 0.0065
mmu-miR-671-5p 8 0.0090 0 0.0000 0 0.0000 6 0.0384 0 0.0000 1 0.0067 1 0.0065
mmu-miR-485-3p 10 0.0090 0 0.0000 0 0.0000 7 0.0448 0 0.0000 3 0.0200 0 0.0000
mmu-miR-188 7 0.0085 4 0.0237 0 0.0000 1 0.0064 1 0.0060 0 0.0000 1 0.0065
mmu-miR-700-5p 7 0.0084 5 0.0296 0 0.0000 1 0.0064 1 0.0060 0 0.0000 0 0.0000
mmu-miR-501-3p 6 0.0075 0 0.0000 2 0.0183 1 0.0064 1 0.0060 1 0.0067 1 0.0065
mmu-miR-421 6 0.0074 1 0.0059 0 0.0000 0 0.0000 3 0.0181 0 0.0000 2 0.0130
mmu-miR-350 9 0.0073 1 0.0059 2 0.0183 1 0.0064 1 0.0060 4 0.0267 0 0.0000
mmu-miR-666-3p 5 0.0070 0 0.0000 1 0.0092 1 0.0064 0 0.0000 0 0.0000 3 0.0195
mmu-miR-455-3p 5 0.0069 1 0.0059 1 0.0092 2 0.0128 0 0.0000 0 0.0000 1 0.0065
mmu-miR-1224-3p 5 0.0064 0 0.0000 0 0.0000 4 0.0256 0 0.0000 0 0.0000 1 0.0065
mmu-miR-18a 7 0.0063 0 0.0000 0 0.0000 4 0.0256 1 0.0060 2 0.0134 0 0.0000
mmu-miR-325-5p 5 0.0062 2 0.0118 0 0.0000 0 0.0000 1 0.0060 0 0.0000 2 0.0130
mmu-miR-215 4 0.0062 1 0.0059 2 0.0183 0 0.0000 0 0.0000 0 0.0000 1 0.0065
mmu-miR-574-3p 5 0.0061 3 0.0177 0 0.0000 2 0.0128 0 0.0000 0 0.0000 0 0.0000
mmu-miR-423-5p 4 0.0057 0 0.0000 1 0.0092 2 0.0128 0 0.0000 0 0.0000 1 0.0065
mmu-miR-539 5 0.0055 1 0.0059 1 0.0092 1 0.0064 1 0.0060 1 0.0067 0 0.0000
mmu-miR-130b 6 0.0052 0 0.0000 0 0.0000 1 0.0064 0 0.0000 2 0.0134 3 0.0195
mmu-miR-503 5 0.0052 0 0.0000 0 0.0000 2 0.0128 0 0.0000 1 0.0067 2 0.0130
mmu-miR-28-3p 4 0.0051 0 0.0000 0 0.0000 1 0.0064 1 0.0060 0 0.0000 2 0.0130
mmu-miR-669a-5p 4 0.0051 0 0.0000 0 0.0000 2 0.0128 1 0.0060 0 0.0000 1 0.0065
mmu-miR-544-5p 4 0.0050 0 0.0000 0 0.0000 2 0.0128 2 0.0121 0 0.0000 0 0.0000
mmu-miR-700-3p 4 0.0050 1 0.0059 0 0.0000 2 0.0128 1 0.0060 0 0.0000 0 0.0000
mmu-miR-325-3p 4 0.0049 2 0.0118 0 0.0000 2 0.0128 0 0.0000 0 0.0000 0 0.0000
mmu-miR-544-3p 5 0.0049 0 0.0000 0 0.0000 1 0.0064 3 0.0181 1 0.0067 0 0.0000
mmu-miR-720 4 0.0049 0 0.0000 2 0.0183 0 0.0000 1 0.0060 1 0.0067 0 0.0000
mmu-miR-365 5 0.0044 0 0.0000 1 0.0092 1 0.0064 0 0.0000 2 0.0134 1 0.0065
mmu-miR-412-5p 3 0.0044 0 0.0000 1 0.0092 2 0.0128 0 0.0000 0 0.0000 0 0.0000
mmu-miR-299-3p 5 0.0039 0 0.0000 0 0.0000 0 0.0000 0 0.0000 2 0.0134 3 0.0195
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mmu-miR-877-3p 3 0.0039 0 0.0000 0 0.0000 2 0.0128 0 0.0000 0 0.0000 1 0.0065
mmu-miR-448-3p 3 0.0038 0 0.0000 0 0.0000 3 0.0192 0 0.0000 0 0.0000 0 0.0000
mmu-miR-494 3 0.0038 0 0.0000 0 0.0000 3 0.0192 0 0.0000 0 0.0000 0 0.0000
mmu-miR-455-5p 3 0.0038 1 0.0059 0 0.0000 0 0.0000 0 0.0000 0 0.0000 2 0.0130
mmu-miR-542-5p 3 0.0038 1 0.0059 0 0.0000 0 0.0000 0 0.0000 0 0.0000 2 0.0130
mmu-miR-669a 3 0.0038 0 0.0000 0 0.0000 2 0.0128 1 0.0060 0 0.0000 0 0.0000
mmu-miR-467c 4 0.0037 2 0.0118 0 0.0000 0 0.0000 0 0.0000 1 0.0067 1 0.0065
mmu-miR-133b 3 0.0035 3 0.0177 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-182 3 0.0035 3 0.0177 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-449a 2 0.0030 1 0.0059 1 0.0092 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-223 2 0.0026 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 2 0.0130
mmu-miR-31 2 0.0026 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 2 0.0130
mmu-miR-448-5p 2 0.0026 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 2 0.0130
mmu-miR-297c 2 0.0026 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 1 0.0065
mmu-miR-504 3 0.0026 0 0.0000 0 0.0000 1 0.0064 0 0.0000 1 0.0067 1 0.0065
mmu-miR-216b 2 0.0026 0 0.0000 0 0.0000 2 0.0128 0 0.0000 0 0.0000 0 0.0000
mmu-miR-217-5p 2 0.0026 0 0.0000 0 0.0000 2 0.0128 0 0.0000 0 0.0000 0 0.0000
mmu-miR-466a-5p 2 0.0026 0 0.0000 0 0.0000 2 0.0128 0 0.0000 0 0.0000 0 0.0000
mmu-miR-758 3 0.0026 0 0.0000 0 0.0000 2 0.0128 0 0.0000 1 0.0067 0 0.0000
mmu-miR-491 2 0.0025 0 0.0000 0 0.0000 1 0.0064 1 0.0060 0 0.0000 0 0.0000
mmu-miR-301b 4 0.0024 0 0.0000 0 0.0000 0 0.0000 2 0.0121 2 0.0134 0 0.0000
mmu-miR-429 2 0.0024 0 0.0000 0 0.0000 0 0.0000 2 0.0121 0 0.0000 0 0.0000
mmu-miR-297a 2 0.0024 1 0.0059 0 0.0000 0 0.0000 1 0.0060 0 0.0000 0 0.0000
mmu-miR-10a 3 0.0024 2 0.0118 0 0.0000 0 0.0000 0 0.0000 1 0.0067 0 0.0000
mmu-miR-501-5p 2 0.0024 2 0.0118 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-184 1 0.0018 0 0.0000 1 0.0092 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-291a-5p 1 0.0018 0 0.0000 1 0.0092 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-291b-5p 1 0.0018 0 0.0000 1 0.0092 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-327 1 0.0018 0 0.0000 1 0.0092 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-465c-5p 1 0.0018 0 0.0000 1 0.0092 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-669a-3p 1 0.0018 0 0.0000 1 0.0092 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-673-5p 2 0.0018 0 0.0000 1 0.0092 0 0.0000 0 0.0000 1 0.0067 0 0.0000
mmu-miR-742 1 0.0018 0 0.0000 1 0.0092 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-183 1 0.0013 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0065
mmu-miR-452 1 0.0013 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0065
mmu-miR-499 1 0.0013 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0065
mmu-miR-654 1 0.0013 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0065
mmu-miR-669c 1 0.0013 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0065
mmu-miR-671-3p 2 0.0013 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0067 1 0.0065
mmu-miR-122 3 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 2 0.0134 0 0.0000
mmu-miR-200c 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-216a 2 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 1 0.0067 0 0.0000
mmu-miR-217-3p 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-293 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-412-3p 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-449c 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-466b-3p 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-466d-5p 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-466f-3p 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-467d 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-483 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-505-5p 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-653 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-669b 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-877-5p 1 0.0013 0 0.0000 0 0.0000 1 0.0064 0 0.0000 0 0.0000 0 0.0000
mmu-miR-193 1 0.0012 0 0.0000 0 0.0000 0 0.0000 1 0.0060 0 0.0000 0 0.0000
mmu-miR-200a 1 0.0012 0 0.0000 0 0.0000 0 0.0000 1 0.0060 0 0.0000 0 0.0000
mmu-miR-20b 2 0.0012 0 0.0000 0 0.0000 0 0.0000 1 0.0060 1 0.0067 0 0.0000
mmu-miR-670 2 0.0012 0 0.0000 0 0.0000 0 0.0000 1 0.0060 1 0.0067 0 0.0000
mmu-miR-802 1 0.0012 0 0.0000 0 0.0000 0 0.0000 1 0.0060 0 0.0000 0 0.0000
mmu-miR-211 1 0.0012 1 0.0059 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-467e 1 0.0012 1 0.0059 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-615-3p 1 0.0012 1 0.0059 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-96 1 0.0012 1 0.0059 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-155 1 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0067 0 0.0000
mmu-miR-466a-3p 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-466d-3p 1 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0067 0 0.0000
mmu-miR-466e-3p 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000
mmu-miR-880 1 0.0000 0 0.0000 0 0.0000 0 0.0000 0 0.0000 1 0.0067 0 0.0000
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sum 90302 100 16905 100 10908 100 15613 100 16539 100 14968 100 15369 100
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Supplementary Table 3. List of miRNA, mismatch (MM) LNA probes and sequence used in this study; melting profiles for miRNA/LNA probe pairs also presented 
LNA probe   LNA probe sequence (5’ to 3’) Φ Exp TM  (ºC)  Exiqon TM  (ºC)Ψ   
LNA-124  GGCA[T][T]C[A]CCGCGTGCC[T][T][A]   67.5  75.0   
LNA-124/C3A  GGAA[T][T]C[A]CCGCGTGCC[T][T][A]  66.4  72.0   
LNA-124/C9A  GGCA[T][T]C[A]ACGCGTGCC[T][T][A]  58.0  73.0   
LNA-124/T19A  GGCA[T][T]C[A]CCGCGTGCC[T][A][A]  66.8  73.0   
LNA-124/C9AC10A GGCA[T][T]C[A]AAGCGTGCC[T][T][A]   52.9  70.0   
 
Φ LNA-modified DNA positions are marked in square brackets. Mismatch bases are in bold and underlined. 
Ψ  Exiqon TM  (ºC) was calculated with 50 mM salt concentration and 1.5 µM total oligo (target + probe) concentration. 
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